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Medium chain length-PHAs (MCL-PHAs) have properties that make them exceptional for 
applications in cardiac tissue engineering. Cardiovascular diseases (CVD) are a major cause of 
death worldwide. Cardiac patches aim to facilitate the normal functioning of the heart muscle 
by providing repair and support to the infarcted tissue post myocardial infarction. In this 
project, two MCL-PHAs, poly(3-hydroxyoctanoate) (P(3HO) homopolymer and poly(3-
hydroxynonanoate-co-3-hydroxyheptanoate) P(3HN-co-3HHP) were produced from 
Pseudomonas mendocina CH50 using sodium octanoate and sodium nonanoate respectively as 
the carbon source and the growth profiles were monitored for 48 h. The polymers were 
characterised to confirm the chemical structure of the polymers. Different types of scaffolds 
were fabricated like plain films, random fibres and aligned fibres, using different ratios of 
P(3HO) and P(3HN-co-3HHP) which were 100:0 (P(3HO)), 20:80 (P(3HO):P(3HN-co-
3HHP), 50:50 (P(3HO):P(3HN-co-3HHP), 80:20 (P(3HO):P(3HN-co-3HHP) and 0:100 
P(3HN-co-3HHP). The mechanical and thermal properties of the films were analysed along 
with the wettability of all the scaffolds.  In vitro cytocompatibility studies were also conducted 
on all the different scaffolds (films, random and aligned fibres) by growing human induced 
pluripotent stem cell derived cardiomyocytes (hiPSC-CM) on them. The cells were found to 
be viable and healthy with comparable beating rates and calcium transients to that measured 
on gelatin which was used as the positive control. The cell alignment quantification on the 
aligned fibres indicated around 50% of the cells were aligned in one direction. Porous 5 wt% 
2D scaffolds and porous 20 wt% 3D structure were fabricated using P(3HO) and different 
concentrations of the porogen, sucrose and NaCl respectively, to obtain pores in the size range 
of 250-300 µm which exhibited decreased hydrophobicity compared to the neat scaffolds. In 
vitro cell culture with C2C12 exhibited higher cell proliferation rate on the porous P(3HO) 
structures as compared to the neat P(3HO) film. The P(3HO) and PANI (polyaniline) blend 
scaffolds were fabricated to introduce electrical conductivity and they were analysed for their 
material characteristics. The effect of the addition of PANI on cardiomyocyte proliferation was 
studied using neonatal ventricular rat myocardial cells (NVRM). A one step method involving 
the use of poly(ethylene oxide-stat-propylene oxide) with isocyanate end groups (NCO-sP(EO-
stat-PO) was used for the incorporation of  RGD, YIGSR peptides and the vascular endothelial 
growth factor (VEGF) on the surface of P(3HO)/P(3HN-co-3HHP) (80:20) electrospun fibres 
and enhanced cell viability was studied using NVRMs. 
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1.1. Heart Anatomy 
The heart is an important organ of the body responsible for pumping blood to the different 
organs. Figure 1.1 depicts a typical mammalian heart. As depicted in Figure 1.2, the heart wall 
is comprised of three layers, the pericardium, endocardium and the myocardium 
(Kierszenbaum et al., 2015). The two layer membrane of the pericardium, called the fibrous 
pericardium and parietal layer of serous pericardium covers and protects the heart. The 
epicardium, within the pericardium also called the visceral layer of serous pericardium is the 
outermost layer of the heart wall is mainly composed of connective tissue. The endocardium is 
the innermost layer and is comprised of a thin endothelial layer along with connective tissue 
that line the various chambers of the heart. The myocardium forms the functional layer of the 
heart. This region is responsible for the various contraction and relaxation cycles of the heart 
for blood circulation which is initiated by the electrical impulses. This region is formed of 
cardiomyocytes, extracellular matrix and blood vessels. The cardiomyocytes are terminally 
differentiated muscular cells which are connected via gap junctions and are responsible for the 
contractile activity of the heart. The extracellular matrix is mainly composed of Type I and 
Type III collagen, and provides a framework that couples and aligns adjacent myocytes to 
optimize and distribute force development in the ventricular walls and avoids deformation 
(Sutton and Sharpe, 2000).  
 
The human heart is divided into four chambers. The two lower thick walled muscular chambers 
are the ventricles (right ventricle and left ventricle) and the two upper chambers, are the atria 
(right atria and left atria). The upper atrial chambers receive the blood coming from all parts of 
the body and the lower chambers, i.e. ventricles pump blood out of the heart to the rest of the 
body. The right atrium and ventricle are responsible for pumping blood to and from the 
pulmonary region and the left atrium and ventricle are responsible for the peripheral 
circulation. Oxygenation of the blood takes place in the lungs and is pumped to the heart via 
the pulmonary veins to the left atrium and is then passed to the left ventricle via the bicuspid 
valve which is then circulated to the different organs through the aorta. The deoxygenated 
blood from the rest of the body is pumped to the right atrium via the vena cava, which then 
flows into the right ventricle through the tricuspid valves and is circulated to the lungs via the 
pulmonary artery. Thus the heart controls the circulation and oxygenation of the blood in 





Figure1.1: The structure of a mammalian heart showing the various chambers, blood vessels. 
(http://www.rbch.nhs.uk) 
 
Figure 1.2: Diagram depicting the different layers of heart wall including pericardium, 





1.2. Heart Physiology and contraction  
The cardiac muscle is a highly organised tissue and converts chemical energy to physical 
energy, and uses this energy to pump blood to the whole body. The cardiac muscle comprises 
of muscle fibres that are surrounded by numerous elongated mitochondria as the heart needs 
continuous energy supply. These fibres branch and are parallel to each other and at the end of 
each fibres are extensive folds of cell membrane called intercalated discs. They provide strong 
bond between the fibres and help in cell cohesion. The heart muscle thus acts as a syncytium 
i.e. a multinucleated mass. Therefore when one of the cells is excited, the action potential 
spreads from cell to cell through the latticework interconnections fast and the syncytium as a 
whole contracts.  The sarcoplasmic reticulum is an important store of Ca2+ and also participates 
in muscle metabolism (Figure 1.4). The mechanical properties of human myocardial tissue 
have been measured. This included a Young’s modulus value of 0.2- 0.5 MPa, elongation at 
break 100-300% and tensile strength 3-15 KPa. (Watanabe et al., 2006).  
 
The ultrastructure of a cardiomyocyte comprises of sarcomeres which are the basic contractile 
units consisting of a dark anisotropic myosin rich central band (A band) and two actin rich light 
isotropic bands (I band). The region where the A band and I band overlap and provide support 
to the contractile proteins is called the Z-line (Figure 1.3) (Hanson et al., 1953, Huxley et al., 
1953). The cardiomyocytes are connected via specialized structures known as the intercalated 
discs, which are present at the Z line of the sarcomere. There are gap junctions between the 
intercalated discs which is essential for the rapid conductance of electrical stimulus in the 
cardiac muscle. The T system of transverse tubules is located at the Z line, which is continuous 
with the sarcolemma of the muscle fiber, forms a grid perforated by the individual muscle 
fibrils. It provides a path for the rapid transmission of the action potential from the cell 
membrane to all the fibrils in the muscle. The cardiomyocytes are mononucleated cells, ~120 
µm in length, and contain centrally located nuclei. These cells remain mononucleated during 
all stages of human heart development. Collagen I is the main extracellular matrix protein 
produced by the cardiac fibroblasts which were considered to be the dominant cell type until 
recently (Bergmann et al., 2015). In recent studies endothelial cells were observed to be in 
abundance in the human adult ventricles representing 45-55% of total cell count (compared to 
~30% cardiomyocytes and ~15% fibroblasts) (Pinto et al., 2016; Shadrin et al., 2016). Figure 





Figure 1.3: Ultrastructure of a sarcomere showing the A band, I band and Z line. (Taken from 
Castro-Ferreira et al., 2010) 
 
 






Figure 1.5: Immunostaining showing the interrelation of fibroblasts and cardiomyocytes in 
cardiac tissue. (A) Fibroblasts labelled with anti-DDR2 (blue) separate phalloidin-labelled 
myocytes (green) in mouse ventricular tissue (red label: connexin43). (B) Fibroblasts labelled 
with anti-vimentin (blue) form layers between anti-myomesin labelled myocytes (green) in 
sheep ventricular tissue (red: connexin43). Scale bar: 20 µm (Taken from Camelliti et al., 
2005) 
 
The electrical conductance in the heart that causes the cardiac contractions is controlled by a 
specialised conduction system comprised of the sinoatrial node (SA node), atrioventricular 
node (AV node) and Purkinje fibres.  The SA node is the pacemaker of the heart and generates 
electrical impulses in the heart. It consists of a cluster of cells that are situated in the upper part 
of the wall of the right atrium. The Purkinje fibres are located in the inner ventricular walls of 
the heart and are responsible for the synchronised contractions of the ventricles. 
The atrioventricular (AV) node is located at the lower back of the interatrial septum and 
conducts the electrical impulses from the atria to the ventricles. There is a special mechanism 
and coordination between the SA node, AV node and Purkinje fibres for transmission of the 
electrical impulse. The initiation of the heartbeat occurs in the SA node which acts as a 
pacemaker and the impulse is rapidly conducted to the heart through the AV node and the 
branches of Purkinje fibres (Hall et al., 2016). This process thus synchronises the heart 
contraction and optimizes the ejection fraction of the heart. The conduction system comprises 
of excitatory cells having the pacemaker channels (If) on the membranes. These channels 
belong to the HCN (Hyperpolarization-activated, Cyclic Nucleotide gated channels) family 
channels and are responsible for the generation of an electrical gradient across the cardiac cell 
membrane. The maintenance of the electrical gradient is due to various ion pumps and 
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exchange mechanisms, which use ATP to pump ions against their electrochemical gradient, 
some of which include the Na+-K+ ion exchange pump, the Na+-Ca+2 exchanger current and 
the IK1 inwardly rectifying K
+ current. The electrical conductance is a vital process in the body 
and dysfunctional pacing results in life threatening arrhythmias which can be cured using 
electronic pacemakers. The dependence of the electronic pacemakers on batteries and 
electronic control systems indicate potential advantages of biological and bioelectronic 
approaches to cardiac pacing including genetic engineering and cell implantation (Capulli et 
al., 2016). 
 
The cardiomyocyte excitation-contraction cycle initiates when the K+ ions enter through the 
connexin channels of the cell membrane from the adjacent cardiomyocytes and renders it in a 
depolarized state. This depolarisation triggers the Na+ ions to enter the cell through the voltage 
gated-sodium channels. Rapid depolarization of the membrane inactivates the Na+ channels 
and activates the K+ and Ca+2 channels. This triggers the influx of Ca+2 ions into the cells which 
in turn causes the release of Ca+2 ions from the sarcoplasmic reticulum through the ryanodine 
channels (RyR) into the cytoplasm via a process called calcium-induced calcium release 
(CICR). This raises the Ca+2 concentration inside the cell, which binds to the troponin complex 
and activates the contractile system. The cardiomyocyte cell relaxation occurs when there is a 
drop in the Ca+2 ion concentration due to the activation of the Ca+2-uptake pump from the 
cytosol to the sarcoplasmic reticulum pump called SERCA and by the exchange of Na+ with 
Ca+2 ions with the extracellular fluid through the sodium pump called sodium calcium 
exchanger (NCX) on the cell membrane (Bedada et al., 2016). The intracellular Na+ 
equilibrium is maintained by the Na+/ K+ pump on the cell membrane (Bedada et al., 2016, 
Knollmann et al., 2008). This is explained in detail in Figure 1.6. The Ca+2 ion transients thus 
plays a crucial role in the contraction process of the heart. The rapid fluctuations in the 
intracellular Ca+2 concentration regulates the electrical and mechanical activity of the heart and 
hence control the other major processes in the body such as hormonal responses, physiological 
interventions and disease conditions (Lee et al., 1987). 
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Figure 1.6: A schematic representation of the mechanism of calcium transients through the 
tubules of a myocyte during cardiac contraction (Adapted from Knollmann et al., 2008) 
 
1.3. Cardiovascular Diseases 
Cardiovascular diseases (CVD) are one of the major causes of death in the world. 
Approximately 2.5 million deaths and 1.8 million deaths are reported in the US and UK 
respectively every year caused by cardiovascular diseases. Major CVDs include coronary heart 
disease, hypertension, peripheral artery disease, rheumatic heart disease and congenital heart 
disease and many others are caused due to abnormalities in the cardiac tissue and their blood 
vessels (Chen et al., 2008, Zimmermann et al., 2003, Robinson et al., 2005). Myocardial 
infarction (MI) and congestive heart failure (CHF) account for around 40% of the annual 
mortality rate in the major developing countries of the world. The necrotic tissue produced due 
to myocardial infarction causes inflammation, apoptosis of the adjoining tissues and results in 
decreased pumping efficiency which finally leads to heart failure. There is also evident 
weakening of the extracellular collagen which causes the thinning of the heart wall and 
ventricular dilation. These events result in a damaged heart wall and permanent loss of the 
regenerative property of the heart tissue (Vacanti et al., 2006; Young et al. 2004).  A cascade 
of cell signals which trigger ventricular dilation causes the structural and functional changes in 
the ventricles called ventricular remodelling. This can be divided into two phases: early 
remodelling and late remodelling. The early remodelling includes physical changes involving 
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the formation, thinning and elongation of the necrotic scar which causes stress on the diastolic 
and systolic wall. As a result of the rise in wall stress the tissue enters the late remodelling 
stage which is characterized by myocyte hypertrophy and production of interstitial collagen 
with an increased wall mass and chamber enlargement. Heart failure results in the release and 
activation of various toxic humoral factors, such as catechol amines, angiotensin-converting 
enzyme and aldosterone. Hence, myocardial infarction may lead to an irregularity in the 
systolic and diastolic function of the heart and may give rise to arrhythmia and other long term 
complications. Various clinical and preclinical studies are being conducted to restore the 
damaged myocardium which include cell delivery to the heart, cardiac tissue engineering and 
angiogenic therapies (Pons et al., 2009; Liu et al., 2016). Cell suspension injections have been 
injected into the blood circulation or directly onto the myocardium, but there is a disadvantage 
of cell loss in the process. 
 
The heart is a dynamic organ and is capable of modulating itself depending on various external 
and internal stimuli including work load or injury. The development of heart failure is a cascade 
effect of a sequence of events that may involve multiple causes and may affect several organs. 
Hemodynamic stress or neuroendocrine signalling associated with myocardial infarction, 
hypertension, aortic stenosis, and valvular dysfunction initiate a pathologic remodelling 
response through the activation of intracellular signalling pathways and transcriptional 
mediators in cardiomyocytes. There are many reasons which are responsible for causing the 
different cardiac pathologies including heart failure (Weber et al., 1991). Cardiac remodelling 
involves molecular, cellular changes in the heart which eventually bring about change in size, 
shape and function of heart after stress stimulation or injury. Cardiac hypertrophy is a common 
type of cardiac modelling which involves the enlargement of the heart and individual 
cardiomyocytes as a means to reduce the stress on the ventricular and septal wall when under 
influence of increased workload or injury. Left Ventricular Hypertrophy (LVH) is the major 
risk factor associated with the myocardial failure. Severe hypertension can lead to pronounced 
LV hypertrophy, which in some cases can gradually transform into a picture of dilated 
cardiomyopathy. Likewise, valvular heart disease, congenital heart disease can all lead to the 
syndrome of congestive heart failure (CHF) (Kehat et al., 2010).  From a morphological point 
of view in LVH, there is an increased collagen production as compared to its degradations, thus 
causing an accumulation of myocardial mass and wall. The fibroblasts which contain the 
messenger RNA for the synthesis of type I and type III collagens, the major fibrillar collagens 
of the myocardium that constitute the normal structural proteins are responsible for the 
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production. There is also a noted increase in the cardiomyocyte cell width and/or length which 
increases the myocardial thickness thus contributing to the cellular hypertrophy. In addition to 
ventricular and cellular hypertrophy, pathologic hypertrophy involves molecular remodelling 
re-expression of fetal genes, alterations in the expression of proteins involved in excitation– 
contraction (E-C) coupling, and changes in the energetic and metabolic state of the myocyte 
which ultimately lead to cell death caused by necrosis or apoptosis (Francis et al., 2001). There 
are several pathologic hypertrophic signalling pathways which also assist in the response of 
heart failure. One such pathway is mediated by the calcium/calmodulin-activated protein 
phosphatase calcineurin (PP2B). Calcineurin is activated by sustained elevations in 
intracellular calcium, which facilitates binding to its primary downstream effector, nuclear 
factor of activated T cells (NFAT). It was observed that the activation of the calcineurin-NFAT 
pathway in the heart of transgenic mice overexpressing an activated mutant of calcineurin, 
causes a dramatic increase in heart size (Molkentin et al., 1998). Another molecule that plays 
an important role in the pathological hypertrophy response in heart is Ca2+/calmodulin–
dependent kinase II (CaMKII). CaMKII expression and activity are observed to increase in 
failing human myocardium and in many animal models of cardiac hypertrophy and heart 
failure. Transgenic mice that overexpress CaMKII developed significant cardiac dilation with 
reduced function, cardiomyocyte enlargement, and fibrosis, suggesting that CaMKII is 
involved in the pathological response to stress (Zhang et al., 2003). 
 
1.4. Cardiac tissue engineering 
The main aim of tissue engineering is to combine biomaterials, cells, growth factors, drugs and 
active molecules to restore the biological function. In recent times, different fields such as cell 
biology, chemistry, material science, nanotechnology, micro and nanofabrication are being 
integrated towards the development of a suitable scaffold for tissue engineering.   
 
Cardiac tissue engineering is based on regeneration of cardiac tissue by implanting 
biocompatible and biodegradable scaffolds cultured with cells that are capable of forming 
cardiomyocytes in the infarcted region of the heart (Figure 1.7) (Dubey et al., 2014). In addition 
to providing a source of healthy cardiomyocytes, the scaffold further replaces the infarcted 
myocardium and provides temporary support to the infarct region, thus acting like a cardiac 
patch (Dubey et al., 2014). A complete understanding of the scaffold and cardiomyocyte 
interaction is essential for myocardial regeneration. The cardiomyocytes are composed of 
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aligned intracellular cytoskeleton and anisotropic contraction. Hence, simple seeding of the 
cardiomyocytes on 2-dimensional scaffolds is not sufficient to recover the lost myocardial 
structure and function. The major challenge in myocardial regeneration is to provide a scaffold 
which helps in the formation of highly aligned myofibres, which are essential to provide the 
strength and flexibility, characteristic of the myocardium (Coulombe et al., 2014). To fulfil 
these requirements, micro and nanofabrication technologies have been employed for the 
production of scaffolds capable of replacing the infarcted myocardium and recreating the 
topography of the cardiac microenvironment.  
Figure 1.7: Schematic representation of Cardiac Tissue Engineering 
 
There are various methods that can be used to achieve the main goals mentioned above to 
restore myocardial activity. Techniques such as electrospinning, micromoulding, 
microablation, photolithography, microcontact printing are few of the techniques which when 
combined or used individually could provide a scaffold which could mimic the functional 
requirements of the cardiac muscle. Guillemette et al.(2010) combined micromoulding and 
microablation of poly(glycerol sebacate) to form a scaffold which could provide the required 
alignment and orientation to the seeded mouse myoblast cell line, C2C12 cells. Salick et al. 
(2014) combined the high resolution photolithography and microcontact printing of Matrigel 
(which consists of 60% laminin, 30% collagen IV, and 8% entactin) and fibronectin to fabricate 
a two dimensional micropatterned structure of various geometries. The seeded cardiomyocytes 
showed high degree of alignment, and features with widths between 30 and 80 μm resulted in 
a dramatic increase in sarcomere alignment relative to the long axis of the pattern. Aligned 
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conductive fibres were electrospun by Hsiao et al. using PLGA and polyaniline and used as a 
scaffold for cardiomyocyte adhesion and electrical stimulation (Hsiao et al., 2013). Fibrous 
scaffolds were also fabricated using electrospinning of poly(glycerol sebacate) and gelatin and 
were tested for stiffness and anisotropy. Cardiomyocytes seeded on the aligned scaffolds were 
shown to have an anisotropically organised structure along with synchronised beating of the 
cells (Kharaziha et al., 2014).  
 
1.4.1. Biomaterials used in myocardial tissue engineering 
The material used for the development of a scaffold is one of the most important aspects to be 
considered before its fabrication. There are specific criteria which should be considered before 
selecting a material. Firstly, the material should be biodegradable. Secondly, the in vivo 
degradation rate of the material should match with the rate of tissue regeneration. The material 
should be able to deliver cells and promote cell attachment, growth and differentiation. Thirdly, 
the scaffold should be able to provide mechanical support to the cells and surrounding tissues 
until new extracellular matrix is synthesised by the cells. Fourthly, there should be inherent 
porosity in the structure which would promote vascularisation and exchange of nutrients and 
gases within the scaffold. In addition, the material should be processable and amenable to the 
fabrication of a desired structure to match the defect to be repaired. Finally, the synthesis and 
fabrication of the material should be relatively easy to commercialise and introduce to the clinic 
(Chen et al., 2008). Presently, the most widely used surgical solutions for repairing damaged 
cardiac tissue are the synthetic patch materials Dacron (polyethylene terephthalate, PET) and 
Gore-Tex (expanded polytetrafluoroethylene or ePTFE), or naturally occurring materials such 
as autologous, allogeneic, and xenogeneic pericardium. There are several limitations to the use 
of these materials. Despite of the low immunogenicity of these materials, they provide limited 
support to the damaged tissue, do not promote cell regeneration and do not remodel with the 
changes in the native tissue. Hence, various researchers are focused on modulating the material 
for the provision of more efficient functional support to the heart (Chu et al., 2002). 
 
Natural and synthetic non-conducting polymers  
Many synthetic and naturally occurring biomaterials pre-seeded with different cell sources 
have been implanted in the necrotic heart tissue for the regeneration of the myocardium. 
Natural protein-based matrices (e.g. collagen, alginate and fibrin), synthetic polymers 
including poly(L-lactic acid) acid (PLLA) and synthetic polymers (e.g. polyglycolic acid 
(PGA), poly lactic-co-glycolic acid (PLGA) and poly ε-caprolactone (PCL) are the most 
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common biomaterials used to fabricate 3D scaffolds for tissue engineering applications. In 
addition, biological biomaterials such as autologous muscle and decellularized biological 
matrices seeded with adult stem cells or cell sheets have also been used (Leor et al., 2005; Leor 
and Cohen, 2004).  
 
Natural polymer-based biomaterials have also been widely used in cardiac regeneration 
through cardiac patches.  Natural polymers mainly comprise of polysaccharide and protein 
based matrices which are made of biomolecules that mimic and interact with the components 
in the extracellular matrix (ECM). This helps in a better interaction of the scaffold with the 
internal tissue environment. It promotes cell adhesion and proliferation and hence does not 
induce any immunogenic response. Unlike the synthetic biodegradable polymers, the natural 
polymers are degraded into biomolecules which are completely non-toxic to the tissue and get 
easily resorbed in the body (Contu et al., 2009). These characteristics hence offer better cell 
delivery and enhance the improvement of heart function for which scaffolds are implanted 
during early stage of MI. Collagen, a natural biopolymer, is an abundant protein found in the 
human body and has been extensively used in cardiac applications (Silva et al., 2016). In a 
study by Kofidis et al., neonatal rat cardiomyocytes were seeded in vivo onto a commercially 
available collagen matrix and the cellular engraftment was observed and examined for a period 
of 2 weeks. The results showed that the embedded cardiomyocytes were evenly distributed in 
the matrix with good cell attachment and contraction (Kofidis et al., 2002). But there were 
many drawbacks observed due to inadequate geometry, weak mechanical properties, low 
biocompatibility and high production costs. In another study, 3D porous alginate scaffolds were 
seeded with foetal cardiac cells and the constructs were implanted in vivo onto the injured rat 
myocardium. This resulted in better heart functioning and attenuation of the left ventricular 
dilation. However, macrophages and lymphocyte infiltration was observed indicating a mild 
inflammatory response of the tissue towards the scaffold (Leor et al., 2000).  In another study, 
a core/shell poly(glycerol sebacate) (PGS)/ﬁbrinogen fibre scaffold was fabricated by 
Ravichandran et al., where PGS formed the core and provided suitable mechanical support and 
fibrinogen formed the shell and enhanced the cell-scaffold  attachment. Neonatal 
cardiomyocytes were seeded on to these scaffolds and a significantly higher cell proliferation 
rate was observed as compared to the fibrinogen scaffold, confirming the structure to be 
suitable for cardiac applications (Ravichandran et al., 2014).  Yang et al. fabricated a hybrid 
cardiac patch using silk fibrion (SF) with polysaccharide microparticles of chitosan or 
hyaluronic acid (HA) and rat bone marrow mesenchymal stem cells (rBM-MSCs) were seeded 
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on these scaffolds. It was observed that the hybrid scaffolds of SF/chitosan and SF/chitosan-
hyaluronic acid demonstrated higher cell growth and higher expression of cardiac genes and 
proteins when compared to induced rBM-MSCs cultured on SF patches alone. The higher 
growth rate and expression on the hybrid scaffolds can be explained by the fact that the 
combination of proteins and polysaccharides mimic the cellular environment and enhance the 
interaction of the cells with the infarct cardiac tissue (Yang et al., 2009). 
 
Many synthetic materials have also been used for cardiac tissue engineering as they have 
predictable and reproducible mechanical and physical properties (e.g., tensile strength, elastic 
modulus, and degradation rate), and they can be manufactured with great precision. However, 
there are shortcomings with the use of some synthetic polymers where the degradation products 
induce an inflammatory response in the tissue, or the material is unable to integrate with the 
host tissue. Among them, aliphatic polyesters (PLA, PGA and PCL) have been widely applied 
as scaffolding materials for 3D tissue engineering constructs. A few non-degradable synthetic 
polymers, including polytetrafluoroethylene (PTFE) and polyethylene (PE), have also been 
investigated for certain tissue engineering approaches, such as congenital heart disease, 
especially in the context of vascular tissue engineering. A scaffold constructed using PTFE, 
polylactide mesh, and type I and IV collagen hydrogel resulted in minimal inflammation 
without aneurysmal dilatation. Successful transplantation and differentiation of mesenchymal 
progenitor cells was accomplished using this scaffold. No ventricular arrhythmias was 
observed from the infarcted tissue in vivo (Krupnick et al., 2002). Ozawa et al. studied a non-
biodegradable PTFE, a biodegradable non-woven PGA mesh, a biodegradable poly-L-lactide 
knitted fabric, and a 50% ε-caprolactone and 50% L-lactide spongy polymer (PCLA). These 
were used to transplant the right ventricular outflow tract. The unique structure of the PCLA 
patch with a spongy matrix favoured in vivo cell colonization relative to other patches (Ozawa 
et al., 2002). Jin et al. also studied poly(lactide-co-ε-caprolactone) scaffolds which served as a 
replacement of the ECM. These were seeded with bone marrow MSCs, which survived, 
differentiated into CMs, ultimately regenerating the myocardium and improving cardiac 
function (Jin et al., 2009). In another work, scaffolds were prepared consisting of 50% 
polylactic acid (PLA) and 50% polyglycolic acid (PGA) and were used as myocardial grafts 
by seeding bone marrow mesenchymal stem cells on them, in vivo, in rats. It was observed that 
the PLGA constructs could resemble the function and structure of the heart and hence revive 
the scarred tissue.  However, long term analysis was required to determine the capability of the 
construct to support and revive the myocardial infarcted tissue (Xing et al., 2012). Additionally, 
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due to the cyclic and constant beating of the myocardial tissue, a plastic deformation and failure 
might occur when thermoplastic polymers such as PGA, PLA, PCL and their copolymers are 
exposed to long term cyclic strain.  This aspect also needs to be studied in depth. 
 
Synthetic Conducting polymers 
Conducting polymers (CPs) are polymers with conducting properties similar to that of metals 
and inorganic semi-conductors. They can be easily synthesised and processed and hence due 
to their unique properties have various applications in the microelectronics industry, including 
battery technology, photovoltaic devices, light emitting diodes, and most recently in 
biomedical applications (Bendrea et al., 2011). The human body is a system which responds to 
electrical impulses which are generated within many organs in the body. The key tissues which 
are electrically responsive are brain, heart and skeletal muscles. The introduction of CPs in the 
biomedical applications brings about a unique coupling of the conducting materials with human 
tissue, generating a therapeutic-body interface. Most CPs have various advantages for 
biomedical applications since their electrical, chemical and other inherent properties can be 
altered to suit requirements of the particular tissue under consideration. These unique 
characteristics are useful in many biomedical applications, such as biosensors, tissue 
engineering scaffolds, neural probes and drug-delivery devices (Guimard et al., 2007). 
Conductivity in CPs arise due to the presence of conjugated double and single bonds between 
the carbon atoms along the backbone of the polymer structure. Every bond in the backbone 
contains a localized ‘sigma’ (σ) bond, which forms a strong chemical bond and every double 
bond also contains a less strongly localized ‘pi’ (л) bond (Wise et al. 1998; Heeger et al. 2000). 
The introduction of a dopant ion in the structure carries the charge in the form of an electron 
across the backbone of the polymer, thus rendering it conductive. On application of a potential 
across the film, a flux of ions enters in or out of the film, dependent on the dopant charge and 
motility, resulting in the passage of charge through the polymer film. Several CPs used in tissue 
engineering include polypyrrole (PPy), polyaniline (PANI), polythiophenes (PT) and poly(3,4-
ethylenedioxythiophene) (PEDOT) (Ravichandran et al., 2010). 
 
Polyaniline (PANI) is an intrinsically conductive polymer which can potentially have extensive 
applications in cardiac tissue regeneration (Humpolicek. et al., 2012). PANI has been of 
interest as a suitable conducting polymer because of several reasons. The polymerisation 
process of PANI is inexpensive (low cost of aniline) and straightforward with a high yield. The 
conducting form has good chemical stability combined with relatively high levels of electrical 
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conductivity. PANI also exhibits properties such as biocompatibility, conductivity, high level 
of cellular adhesion, which are all required for cardiac tissue engineering (Kai et al., 2011). 
Due to its low solubility in organic solvents it is difficult to process the polymer. However, 
PANI can be processed by blending with some conventional polymers without altering its 
structure and retaining the properties of both PANI (electrical conductivity) and the matrix 
polymer (Narkis et al., 2000). The cells grown on such conductive scaffolds receive electrical 
signals directly from the substrate rather than from the culture medium (Meng et al., 2005). 
Polyaniline exists in three different states, reduced leucoemeraldine base, the completely 
oxidised pernigraniline base and the emeraldine base consisting of alternating oxidized and 
reduced repeat units in its structure. The emeraldine base form is inherently non-conductive 
and can be converted into conductive emeraldine salt form by doping using proton donors such 
as acids (Figure 1.8). 
 
 
Figure 1.8: Chemical structures of the different forms of polyaniline (Adapted from Qazi et al., 
2014)  
 
1.4.2. Active molecules involved in cardiac tissue engineering 
Growth factors play an important role in the formation of a capillary network near the infarct 
region. The growth factors thus promote angiogenesis. Vascular Endothelial Growth Factor 
(VEGF), fibroblast growth factor (FGFs) and Notch signalling control the endothelial cell 
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activation, behaviour and selection. This promotes the differentiation of perivascular cells and 
smooth muscle cells to enhance vessel tightness and stabilisation which is regulated by the 
platelet-derived growth factor (PDGF) and transforming growth factor-beta (TGF-β). Finally, 
angiopoietins (ANGs) regulate vessel tightness, endothelial cell sprouting and angiogenesis. 
VEGF, FGFs, Notch, and ANGs also play key roles during coronary vasculature development. 
Thus these factors are used as novel additives for revascularisation in the infarcted myocardium 
(Olivey and Svensson, 2010). The VEGF receptors are expressed in the epicardium and sub 
epicardium, suggesting that this growth factor family is involved in myocardial-epicardial 
signalling. The introduction of these growth factors in the polymer material allows localised 
release of the factors along with the control on the rate of release by altering the polymer 
degradation rates (Patra et al., 2015). These factors can be added to the tissue engineered 
scaffold in three different ways. The first approach is to mix the growth factor with the polymer 
solution before the fabrication of the construct. The second approach is by pre encapsulating 
the growth factor in polymer microspheres and then incorporating these microspheres in the 
final construct (Richardson et al., 2001). The last and final approach involves surface 
functionalisation with growth factors immobilised on the scaffold. 
 
An important aspect of the engineered construct involves the interaction of the scaffold with 
the cells. This is an essential requirement as it can otherwise lead to rejection of the construct, 
foreign body reactions, thrombosis and embolization (Thull et al., 2001). For this purpose 
various cell-adhesion mediating proteins or peptide sequences can be either physically 
adsorbed or covalently attached onto the scaffold surface to have a controlled positive 
interaction between the cells and the material. There have been many peptides which have 
proven to be efficient in promoting cell adhesion and proliferation. Some of these are the 
glycine-arginine-glycine-aspartate-serine peptide (GRGDS), arginine-glycine-aspartate 
tripeptide (RGD) which promote cell attachment and proliferation and tyrosine-isoleucine-
glycine-serine-arginine peptide (YIGSR) which inhibits metastasis and tumour formation 
(Hersel et al., 2003, Ota et al., 2005, Yoon et al., 2004; Hirano et al., 1993). Due to the 
widespread distribution of the RGD peptide, it is used in a range of organisms and due to its 
high biological effect on cell adhesion, cell behaviour and cell survival, the RGD sequence is 
one of the most effective active molecules used in tissue engineering (Hersel et al., 2003). For 
example, the effect of neonatal rat cardiac cells were analysed on the RGD-immobilised 
alginate and unmodified alginate scaffolds. It was observed that cell adherence on the RGD 
immobilised constructs was higher as compared to the unmodified alginate scaffolds and 
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enhanced cardiac tissue regeneration was observed on the RGD-immobilised alginate 
scaffolds, (Shachar et al., 2011). Bagdadi et al., immobilised RGD and VEGF growth factors 
on P(3HO) films and studied the cell proliferation rates. A significant increase in cell 
proliferation was observed when VEGF and RGD were incorporated into the P(3HO) cardiac 
patches. A synergistic effect was observed when both VEGF and RGD were incorporated 
together, showing a highly significant effect on cell proliferation (Bagdadi et al., 2016). 
 
Although several strategies have been used by researchers for the covalent attachment of 
different peptide motifs onto the polymer scaffold surface, these methods have been typically 
time consuming and involve several activation and coupling steps. An alternative method 
which involves combination of the material with a star shaped additive poly(ethylene oxide-
stat-propylene oxide) with isocyanate (NCO) end groups, NCO-sP(EO-stat-PO) and the 
peptide motif can be used to functionalise the outer surface of electrospun fibres in a single 
step, as described by Grafahrend  et al., 2010. The peptide is found on the surface of the fibres, 
attached to the NCO sequences of the NCO-sP(EO-stat-PO), forming urethane bridges (Figure 
1.9). The electrospun fibres of PLGA with NCO-sP(EO-stat-PO) and GRGDS were fabricated 
and seeded with human dermal fibroblasts. The modified fibres showed a much higher cellular 
adhesion on the GRGDS containing constructs as compared to the fibres with no peptide 
immobilisation (Grafahrend et al., 2010). 
 
Figure 1.9: A schematic representation of NCO-sP(EO-stat-PO) on the surface of PLGA/ 
NCO-sP(EO-stat-PO) fibres. The NCO groups (red) on the fibre surface covalently bind to the 
amino groups on the peptide, GRGDS (green), resulting in urethane bridges (schematically 
highlighted as yellow dots). Taken from(Grafahrend et al., 2010). 
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1.4.3. Cells used in cardiac tissue engineering 
During myocardial infarction the heart tissue gets damaged and the tissue loses its capability 
to regenerate and hence there is a need to transplant specific stem cells/primary cells with the 
biomaterial in order to help repair the necrotic area and resume its functioning. The typical type 
of cell source for a myocardial patch needs to be one that is easy to harvest, has high cell 
proliferative property, is non-immunogenic and has the ability to mature and differentiate into 
adult cardiomyoctes. These cells can be categorised as autologous (from the same body), 
allogenic (different body, same species) and xenogenic (animal origin), depending on the origin 
of the cells. Out of these, autologous cells do not induce any immunogenic response due to the 
source being from the same body as the patient, but it is difficult to harvest and culture these 
cells. Allogenic and xenogenic donor cells can potentially trigger an immunogenic response 
when transplanted due to their origin but they are comparatively easier to harvest and maintain 
(Chen et al., 2008). Various cell types including mesenchymal stem cells (MSCs), embryonic 
stem cells (ESCs), adipose-derived mesenchymal stem cells (ADMSCs) have been clinically 
tried and delivered to the cardiac injury site to restore tissue functionality (Wang et al., 2010). 
There are a variety of cell models which are under investigation. Depending on the stage of 
differentiation of the cells they can be divided into three different cell types, (1) somatic muscle 
cells, such as foetal or neonatal cardiomyocytes, (2) myocardium-generating cells, such as 
embryonic stem cells which include bone marrow-derived mesenchymal stem cells, adipose 
stem cells and induced pluripotent stem cells; and (3) angiogenesis-stimulating cells, including 
fibroblasts and endothelial progenitor cells.  
 
The two major stem cell types used for myocardial tissue engineering are the embryonic stem 
cells (ESC) which are differentiated into cardiaomyocytes and human induced pluripotent stem 
cell derived cardiomyocytes (hiPSC-CMs). Recently human induced pluripotent stem cell 
derived cardiomyocytes (hiPSC-CMs) have gained a lot of attention and are being considered 
as one of the main potential cell source. Human induced pluripotent stem cells (hiPSC)s  can 
be generated from somatic cells such as fibroblasts via delivery and ectopic expression of the 
Yamanaka factors (Oct4, Sox2, Klf4, and c-Myc), also known as OKSM. Recent studies have 
also demonstrated the successful derivation of iPSCs from other sources, including amniotic 
fluid, human blood, and keratinocytes. This is ground breaking research which has given rise 
to a completely new area of stem cell research and avoids many of the ethical problems 
associated with human embryonic stem cells (hESC)s. Once pluripotency is established, 
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hiPSCs can be differentiated using various methods into CMs and are termed as human induced 
pluripotent stem cell derived cardiomyocytes (hiPSC-CM)s (Mordwinkin et al., 2013). Recent 
studies showed that hiPSCs can differentiate into cardiomyocytes with cardiomyocyte-like 
molecular, structural, and functional properties (Zwi et al., 2009). Nelson et al. observed that 
intramyocardial delivery of iPSCs into infarcted murine hearts restored contractile performance 
and ventricular wall thickness. This was a result of the iPSCs differentiating into cardiac, 
smooth muscle and endothelial cells (Nelson et al., 2009).  Another advantage of hiPSC-CMs 
are their ready availability from different companies, Cellular Dynamics International (CDI), 
Axiogenesis and Pluriomics. HiPSC-CMs express most, if not all, structural and regulatory 
elements present in a human cardiomyocyte, display a cross-striated ultrastructure, contract 
spontaneously and show basic functional properties of the human heart, including typical 
responses to drugs. However, some characteristics of the hiPSC-CMs differ from the adult 
cardiomyoctes such as, hiPSC-CMs beat spontaneously, show a low degree of ultrastructure 
organisation and have no T-tubules. Hence extensive research is currently being pursued in 
order to validate and improve the maturation and function of these cells (Eder et al., 2016). 
 
1.5. Technologies used for scaffold fabrication of cardiac patches 
There are different ways to fabricate biocompatible structural materials which fulfil the 
requirements of restoring the damaged tissue in cardiac tissue engineering applications. The 
main aim of these scaffolds is to bio-mimic, restore and revive the necrotic tissue and to 
resynthesize the original tissue (Langer et al., 1993). There are several microfabrication 
techniques such as micromachining, photolithography, metal deposition, electrospinning, wet 
and dry etching, thin-film growth, and 3D printing which have been used to create scaffolds 
with micro and nano scale features using a range of different materials (Limongi et al., 2016). 
 
1.5.1. Solvent casting technology 
The solvent casting technology is one of the most common and easily achievable techniques 
that is widely used for the fabrication of porous and non-porous 2D scaffolds. This technique 
is simple and can be used to incorporate porous structures with controlled pore sizes (Figure 
1.10).  It involves the use of a water soluble porogen which is added to the polymer solution in 
an organic solvent, followed by casting of the scaffold in a mould. The porogen is finally 
removed using water (Siemann et. al., 2005; Ikada et al., 2011).This is a simple and cheap 
process and can be used for a range of different polymers. The major advantage of the solvent 
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cast method is that the scaffold with a specific and controlled pore size can be fabricated while 
the disadvantage lies in the uncertainty of the interconnectivity of the pores. 
 
Figure 1.10: A schematic representation of the solvent casting technology used for the 
production of porous 2D polymer scaffolds  
 
1.5.2. Electrospinning 
Electrospinning is a versatile technique which produces ultrathin fibres ranging from microns 
to nanometers in diameter which are either nonwoven or aligned and provide the required 
nanotopography found in the cardiac ECM (Figure1.11). These fibres have high porosity and 
high interconnectivity which allow efficient exchange of nutrients and gases within the 
structure. In addition, the fibre alignment and incorporation of the conducting polymers in the 
electrospun fibres can be easily modulated to mimic the cardiac tissue microenvironment 
(Orlova et al., 2011). Electrospinning helps to fabricate polymeric scaffolds with specific 
mechanical and biological properties similar to native ectracellular matrix (ECM) in order to 
modulate cellular behaviour (Pham et al., 2006).  These are some of the advantages of this 
technique. Major disadvantage of this technique is that there could be fibre breakage if the 
speed of the rotating drum collector is too high. The common problem with the electrospun 
scaffolds is the smaller pore size which inhibits tissue ingrowth due to lack of cellular 
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infiltration and cell accommodation in the pores. Various electrospinning techniques and post 
electrospinning modifications are taking place to overcome this limitation while maintaining 
the fibre morphology and pore interconnectivity (Rnjak-Kovacina et al., 2011). 
 
In this technique, a polymer solution is loaded and pumped through a syringe fitted with a 
nozzle connected to a voltage source. The suspended droplet created by either gravity or 
mechanical pumping at the tip of the nozzle, is electrically charged creating a repulsion force 
against the mechanical force provided by the pump. As the intensity of the electric field is 
increased, the surface of the droplet elongates to form a conical shape called the Taylor cone 
(Taylor 1969). When the electric charges overcome the surface tension of the droplet, a charged 
jet is ejected from the tip of the Taylor cone. As the jet is ejected from the droplet and travels 
through air, the solvent evaporates and fibres are deposited on the collector. There are various 
factors which affect the size and shape of the electrospun fibres. The properties of the polymer 
solution affecting the fibre parameter are its viscosity, conductivity and surface tension. On the 
other hand, the controlled variables include electric potential, the distance between the nozzle 
tip and the collector and speed of the rotating collector (for aligned fibres). Finally, the 
environmental parameters including temperature, humidity and air velocity also have 
significant effect on the fabricated fibres. Different non-woven, nano- or micro-scaled, porous, 
aligned or random fibres can be fabricated with different synthetic or natural materials, by 
adjusting one or more of the above parameters (Smith et al., 2009).  
 
Electrospinning has been extensively used on various synthetic and natural materials including 
PLGA, PLLA, poly(vinyl alcohol) (PVA), poly(ethylene oxide) (PEO), poly(caprolactone) 
(PCL), PHAs, collagen, gelatin, dextran, silk protein and fibrinogen and various conductive 
polymers and blends (Pham et al., 2006).  The composite mesh of polyaniline/poly(lactic-co-
glycolic acid) (PLGA) was electro-spun and it offered to mimic the anisotropic environment 
of the cardiac tissue and provided a better electrical conductance across the scaffold (Hsiao et 
al., 2013). In a study conducted on P(3HO) electro-spun fibres of different diameters, the 
highest cell proliferation rate of 196.8±16.0 was  observed on the C2C12 cells grown on the 
750 nm diameter P(3HO) fibres. This indicated high biocompatibility of the P(3HO) fibres 




Figure 1.11: A schematic diagram of the electrospinning setup. (Taken from Athira et al., 
2014) 
 
1.5.3. 3D Printing 
3D-Bioprinting is one of the promising new techniques that is used in the fabrication of 3D 
constructs through controlled deposition of biomaterials and cells. Most of the experiments 
conducted involve the use of sacrificial bioprinting where the bioink is printed inside the 
hydrogel and after drying, the ink is washed off leaving a hollow vessel mimicking structure. 
The bioprinted scaffold is then seeded with different cells to impart a biological function to the 
scaffold (Kolesky et al., 2014, ; Lee et al., 2014). This is a complex process and hence the size, 
morphology and functionality of these scaffolds can be limited. However, due to some recent 
advancements, this process has become more achievable and convenient and methods that are 
easy to bioprint desirable scaffolds using a single method have been successfully developed 
(Jia et al., 2016). 
 
Hot pressing or compression moulding can also be achieved by using a hot press, where the 
biomaterial can be moulded depending on the structural parameters required for the scaffold. 
The final structure can be controlled by changing the temperature of the press and the force 





1.5.4. Electron beam (EBL) and Focused ion beam (FIBL) Lithography 
EBL and FIBL are the latest direct-write technologies that are able to create nanometric 
patterning on the biomaterial by the use of focused accelerated particle beams to scan the 
surface of the scaffold. This technology is used to make grooves ranging from 20-1000 nm 
widths. EBL has been used to fabricate nanopillared moulds which were then used to emboss 
PCL surfaces with nanometric topology.  
 
FIBL uses electrostatic and magnetic fields to focus on a low energy ion beam to create a 
topography of around 50 nm. FIBL is generally used in hard biomaterials such as silicon but it 
has also been used in biomedical tasks involving tuning the morphology and modulus of 
hydrogels. Unique nanoscale pore parameters were achieved by this technique which could be 
changed by the angle of the incident ion beam (Limongi et al., 2016). 
 
1.5.5. Plasma etching 
Plasma etching is a surface treatment technique, which helps to modify the surface properties 
without changing the bulk properties of different biomaterials. This is useful in enhancing the 
biocompatibility of the scaffold with the cells. It also helps in areas required to monitor wear, 
friction and roughness of the scaffold and thus changes the topography of the interacting 
surface of the biomaterial with the cells (Chu et al., 2002). Nano textured biocompatible PCL 
films were fabricated on silicon wafer by using plasma etching by Cesca et al.(2014). These 
scaffolds could then be peeled off the silicon wafer and used for cell culture. Due to increased 
roughness these PCL scaffolds provided high cellular adhesion.  
 
1.6. Polyhydroxyalkanoates (PHAs) 
Polyhyroxyalkanoates (PHAs) are natural polymers which have a great potential to be used in 
cardiac tissue engineering. They are well known biopolyesters of 3-, 4-, 5- and 6-
hydroxyalkanoic acids (Figure 1.12 (A) and (B)). They are synthesized by a wide range of 
bacteria such as Bacillus cereus, Pseudomonas putida, Pseudomonas oleovorans as an 
intracellular energy source, under nutrient limiting conditions. An essential nutrient such as 
nitrogen, phosphorus, sulphur or magnesium is provided in limiting conditions along with 
excess of carbon. These elements play a vital role and are constituents of essential cellular 
components such as amino acids (nitrogen), nucleotides (phosphorous), enzymes, coenzymes 
or act as a cofactors for vital enzymes (magnesium). These limiting conditions hinder cell 
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growth and division and switch on the biosynthetic pathway of the PHAs (Valappil et al., 2007, 
2008; Hyakutake et al., 2011). Hence, bacteria including Cuprivadus necator, Alcaligenes 
latus, Pseudomonas mendocina accumulate these polyesters as insoluble inclusions in the 
cytoplasm that provide an intracellular carbon and energy source under limiting nutrient 
conditions. These water insoluble polymers are biodegradable, thermoplastic, exhibit high 
molecular weight. The molecular weight of the PHAs range from 2 × 105 to 3×106 Daltons 
depending on the microorganism used and the growth conditions provided during polymer 
production (Byrom et al., 1994). They are being considered for several applications in the 
packaging industry, medicine, pharmacy, agriculture and food industry, or as raw materials for 
the synthesis of enantiomerically pure chemicals and the production of paints (Halami et al., 
2008). In addition, these polymers are highly biocompatible and hence have several medical 
applications.  
 
The physical properties of PHAs are greatly influenced by the length of the side chain. Hence, 
PHAs can be divided into two main classes: Short-chain-length PHAs (SCL-PHAs), that have 
monomers consisting of 3-5 carbons, are partially crystalline, thermoplastic in nature. They 
generally lack toughness and hence are brittle polymers and have high melting points. Medium-
chain-length PHAs (MCL-PHAs) have monomers consisting of 6–14 carbons and these 
polymers are elastomeric in nature with low crystallinity, low tensile strength, low melting 
point and high elongation at break (Nomura et al., 2007). Both SCL-PHAs and MCL-PHAs 
have been extensively explored in various medical and industrial applications (Shishatskaya et 
al., 2002; Witholt et al., 1999). SCL-PHAs are produced by numerous bacteria such as 
Cuprivadus necator, Alcaligenes latus, Bacillus megaterium and Bacillus cereus while  
MCL-PHAs are synthesized by bacteria such as Pseudomonas putida, Pseudomonas 
mendocina and Pseudomonas oleovorans. Examples of SCL-PHAs include  
poly(3-hydroxybutyrate) (P(3HB)), poly-4-hydroxybutyrate (P(4HB)) and  
poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (P(3HB-co-3HV)). Examples of MCL-PHAs 
include polyhydroxyundecenoate (PHU) and Poly(3-hydroxyoctanoate) (P(3HO)) (Dufresne et 
al., 2000; Rai et al., 2011). The P(3HO) described in Rai et al., (2011) is completely different 
from the P(3HO) described in Dufresne et al (2000). The former is a unique homopolymer 
produced using P. mendocina, whereas the other P(3HO)s are copolymers containing 
monomers 3-hydroxyhexanoate and 3-hydroxydecanoate with the dominant monomer being 3-





  (B) 
Figure 1.12: (A) The general structure of polyhydroxyalkanoates (x = 1, 2, 3; n = 100-30000; 
R1, R2 = alkyl groups, C1-C13 units) (B) The chiral general structure of polyhydroxyalkanoates 
exhibiting the R- stereo-regular configuration. 
 
PHAs have many advantages over the synthetic polymers in the context of biomedical 
applications. These are natural polymers, and hence do not have remnants of chemical 
catalysts, leading to lower cytotoxicity. PHAs degrade by surface erosion rather than bulk 
erosion as observed for PLA and PLGA, hence leading to longer term structural stability of the 
scaffolds. The degradation products of PHAs (hydroxyacids) have lower acidity as compared 
to the degradation products of PLA (lactic acid) which leads to low immunogenicity. The 
length of the side chain and its functional group also has a direct effect on the polymer’s 
physical properties such as flexibility, crystallinity, melting point and glass transition 
temperature (Volvoa et al., 2004). Hence, another very important advantage of PHAs is that 
their material properties and degradation rates can be controlled and changed by varying the 
polymer production conditions including the bacterial strain, carbon source, media composition 
and fermentation conditions (Rai et al., 2011). In particular, medium chain length PHAs (MCL-
PHAs) exhibit a larger structural diversity including C6-C14 containing monomer units and 
provide a huge range of polymer types. Hence, their mechanical properties can be modified as 
per the requirement of specific application (Philip et al., 2007). These polymers being 
elastomeric in nature can be used in soft tissue engineering, cardiovascular applications 














spite of having a wide range of applications, due to the lack of availability of these polymers 
in large quantities, there are limited studies on MCL-PHAs (Rai et al., 2011).  
 
1.6.1. Biosynthesis of PHAs 
Over 300 different species of Gram positive and Gram negative bacteria have been reported to 
produce different types of PHAs. The bacteria store the polymer in the form of an energy 
reserve in the cytoplasm. Based on the conditions required for production, bacteria can be 
categorised into two groups. The first group requires the limitation of an essential nutrient such 
as phosphorous, nitrogen, sulphur or magnesium with an excess of carbon during its production 
process such as Pseudomonas mendocina, Protomonas extorquens and Protomonas oleovorans 
(Chen et al., 2010). The second group of bacteria do not require any nutrient limiting condition 
and generally include mutants (Azotobacter vinelandii) or recombinant strains of E.coli. There 
are various wild type and recombinant species of bacteria that are used for the production of 
PHAs. Some of them include Cupriavidus necator, Azotobacter sp., Bacillus sp., Pseudomonas 
sp., Burkholderia sp., Halomonas sp., Haloferax sp., Aeromonas sp. and recombinant E.coli to 
name a few (Akaraonye et al., 2011; De Smet et al., 1983; Haywood et al., 1989; Rai et al., 
2011; Povolo et al., 2010). In a study conducted with B. subtilis 1604-phaC1 recombinant 
strain showed a higher PHA accumulation of 32% dcw when compared to B. subtilis wild type 
and B. subtilis containing the vector with no insert, which showed a PHA accumulation of 3% 
dcw (Bagdadi et al., 2013).  A wide range of carbon sources have been used for the production 
of PHAs including cheap carbon sources for economical production. Some of them include 
sodium octanoate, glucose, glycerol, fats; oils; industrial byproducts such as sugarcane 
molasses; agricultural wastes such as soyabean/sunflower cake, corn steep liquor; some 
household wastes including waste potato starch, waste cooking oil, sesame oil; waste water and 
fatty acids. Specialized carbon sources like 4-hydroxybutyric acid, γ-butyrolactone and 1,4-
butanediol give rise to 4HB monomers along with 3HB monomer. 
 
PHA biosynthesis can take place via three different pathways (Figure 1.12). The biosynthetic 
pathway for the production of PHAs involves the combination of enzymes present in the 
cytoplasm of the bacterial cell. Pathway I is observed in Cupriavidus necator and it best 
explains PHA biosynthesis using sugar as the carbon source. In this pathway, condensation of 
two acetyl CoA molecules leads to the generation of 3HB monomers which further forms 
acetoacetyl-CoA with the help of the enzyme β-ketothiolase. The acetoacetyl-CoA reductase 
then acts on the acetoacetyl-CoA molecule to form 3-hydroxybutyryl-CoA. In the end, 
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esterification of 3-hydroxybutyryl-CoA into poly(3-hydroxybutyrate) (P(3HB)) takes place, 
which is the key polymerisation reaction catalysed by the PHA synthase. This pathway can 
also be utilised for the synthesis of P(3HB-co-3HV). Pathway II and III are involved in fatty 
acid oxidation and biosynthesis respectively which eventually lead to the formation of the 
corresponding hydroxyalkanoate monomer depending on the carbon source used. Pathways II 
and III are mainly found in bacteria producing medium chain length PHAs (mcl-PHAs).  
Pathway II is the fatty acid β-oxidation pathway which involves the production of the 
hydroxyacyl substrate related to the fatty acids used as the carbon source. This substrate can 
be polymerised by the PHA synthases of Pseudomonads belonging to the ribosomal RNA-
homology group I and are mainly found in organisms such as Pseudomonas aeruginosa 
(Kabilan et al., 2012). As shown in the Figure 1.13, the PHA synthase catalyses the 
polymerization of the hydroxyacyl substrates into PHA. Pathway III is the fatty acid de novo 
synthetic pathway which is used by the organisms when grown on sugars such as glucose as 
the carbon source. The (R)-3-hydroxyacyl intermediates from the fatty acid biosynthetic 
pathway are converted from the acyl carrier protein (ACP) form to the CoA form by the enzyme 
acyl-ACP-CoA transacylase (encoded by phaG). Therefore, this enzyme is the key link 
between the fatty acid biosynthetic pathway and PHA biosynthesis (Rehm et al., 2003).  
 
 
Figure 1.13: The three main PHA biosynthetic pathways used by different organisms for the 
production of PHAs.  
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PHA synthases are the key enzymes of PHA biosynthesis. They catalyse the conversion of  
3-hydroxyacyl-CoA substrates to PHAs, accompanying the release of CoA. PHA synthases are 
classified into 4 classes on the basis of their activities toward substrates with different carbon 
chain lengths and their subunit compositions (Table 1.1). Class I and II have a similar type of 
subunit, PhaC, whereas the Class III enzyme comprises of the PhaEC complex including 
subunits PhaC and PhaE and Class IV enzymes have a PhaRC complex comprising of PhaR 
(molecular mass of approx. 22 kDa) and PhaC. Class I, III and IV synthases polymerise short 
chain length (SCL) monomers (C3-C5), whereas Class II synthases polymerise medium chain 
length (MCL) monomers (C6-C14). The PHA synthases of Ralstonia eutropha, Pseudomonas 
aeruginosa and Allochromatium vinosum and Bacillus megaterium represent Classes I, II, III, 
and IV respectively.  
 
Table 1.1: Classes of PHA synthases showing different subunits. 
Class Subunits Size Substrate Species 
I PhaC (60-73 KDa) 3HASCL C. necator 
II PhaC (60-65 KDa) 3HAMCL P. aeruginosa 
III PhaC PhaE (40 KDa)/(40KDa) 3HASCL A. caviae 
IV PhaC PhaR (40 KDa)/(22KDa) 3HASCL B. cereus SPV 
 
1.6.2. Biodegradability / Bioresorbability of Polyhydroxyalkanoates 
Biodegradability or Bioresorbability is an important property of PHAs which makes them 
suitable for their use in a range of medical applications. Within the biological tissue PHAs are 
subject to degradation by the action of lipases, esterases and other hydrolytic enzymes (Wu et 
al., 2009; Williams et al., 1999). Wu et al. studied in vivo degradation of P(3HB-co-4HB) and 
observed that the polymer degraded into its monomeric units, i.e. 3- and 4- hydroxybutyric acid 
(Wu et al., 2009).  There are many factors which affect the biodegradability of PHAs including 
stereochemistry of the polymeric units, molecular weight, monomeric composition, chemical 
structure (which affects the interaction of the functional groups with the enzymes and the 
wettability), presence of an ordered structure in the polymer like crystallinity, orientation, 
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morphological properties and exposure of the polymer surface to the degrading enzymes. The 
effect of alkyl side chain length on the biodegradability of PHAs was studied by Quinteros et 
al., (1999), showing an increment in the degradation rates with the change in proportion of the 
side chain repeating units in the PHA. They also observed that polymers with high crystallinity 
had lower degradation rates. As polymer with low melting temperatures, will melt sooner and 
so have low crystallinity. So the higher melting temperature (Tm) of the crystalline phase of the 
polymer, there is a decrease in the degradation rate of the polymer. Thus, the MCL-PHAs with 
low crystallinity and low melting temperature are more prone to degradation as compared to 
the SCL-PHAs with higher crystallinity and Tm (Wang et al., 2005).  
 
In the context of tissue engineering, it is important that the rate of degradation of the polymer 
should match the rate of regeneration of the tissue. Various in vitro and in vivo degradation 
studies have been conducted with PHA scaffolds. One of the studies was conducted in vivo 
where P(3HO-co-3HHx) subcutaneous implants in mice showed a decrease in Mw to 65,000 
from an initial implantation weight of 137,000 in 40 weeks (Williams et al., 1999). Further to 
this experiment, Wang et al., 2005 blended P(3HO-co-3HHx) with gelatin and found a higher 
degradation rate of the scaffold as compared to the neat P(3HO-co-3HHx). After 2 months, 
there was about 15% weight loss in P(3HO-co-3HHx) blending with 30% gelatin. Blending 
with gelatin increased the hydrophilicity, porosity and decreased the crystallinity of the 
scaffold. Hence, the hydrolytic enzymes were able to access a higher surface area of the 
polymer leading to a faster degradation rate. The in vitro degradation behaviour was also 
studied on P(3HO) homopolymer films by Rai et al., 2011. They showed 15% degradation 
after 3 months in DMEM media. This could be explained due to the semi crystalline nature of 
the material. In a study carried out by Tepha Inc., monofilament fibres were prepared by melt 
spinning of Poly-4-hydroxybutyrate (P(4HB) “PHA4400”. In vitro and in vivo degradation 
studies were studied in Dulbecco's phosphate buffered saline and rabbit respectively. It was 
observed after 26 weeks of the study that the Mw of the implanted sutures and the control 
PHA4400 sutures in vitro decreased to approximately 43% of their original Mw implying that 
the hydrolytic stability of the implanted sample was very similar to the in vitro control (Martin 
et al., 2016). 
 
1.6.3. Biocompatibility of Polyhydroxyalkanoates 
Biocompatibility is one of the most important requirements for a material to be suitable for 
medical applications. Various parameters influence the biocompatibility of PHA scaffolds 
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which include size, porosity, shape, surface topography, chemical and molecular structure of 
the material.  The material composition and the degradation products are also an important 
parameter which affect the biocompatibility of PHAs. The absence of any non-toxic compound 
produced during polymer degradation along with it being non-immunogenic are essential 
requirements for the acceptance of the scaffold by the body (Zhao et al., 2003; Zheng et al., 
2005). The monomer for P(3HB),  (R)-3-hydroxybutyric acid (3HB) is present at 
concentrations of 3-10 mg per 100 ml blood in healthy adults and is a normal metabolite found 
in human blood. There are various lipoproteins found in the body where presence of low 
molecular weight P(3HB) have been detected (Hocking and Marchessault, 1994; Williams et 
al., 1999). Hence, P(3HB) is expected to be highly biocompatible. The effect of PHA 
degradation products was established by Sun et al., where cellular responses of the mouse 
fibroblast cell line L929 were studied in the presence of PHA degradation products. It was 
observed that MCL-PHAs are even more biocompatible than the SCL-PHAs (Sun et al., 2007). 
It is also important for the biomaterial implants which are in contact with blood for a long term 
application, to not have any antigenic responses, nor induce thrombosis or embolism and 
should not cause destruction of plasma proteins. In vivo studies conducted on P(3HB-co-3HHx) 
as a blood contact graft material showed that it reduced thrombogenicity and attachment of 
blood platelets as compared to gelatin coated films, thus promoting haemocompatibility (Qu et 
al., 2006). Sevastianov et al., 2003 used purified P(3HB) and P(3HB-co-3HV) films for 
haemocompatibility studies and it was observed that the films did not cause any blood 
coagulation or thrombosis and were suitable to be used in contact with blood.  The in vivo 
response of the cells towards the biomaterial used is important to decide whether the material 
is suitable for medical applications. The cytotoxicity of P(3HB) and P(3HB-co-HV) fibres were 
analysed by implanting them in Wistar rats for a period of 6 months. There was no adverse 
effect reported in their physiological and biochemical processes, confirming the 
biocompatibility of the polymers (Shishatskaya et al., 2002). In a study conducted on a 
subcutaneous poly(3-hydroxyoctanoate-co-3-hydroxyhexanoate) (P(3HO-co-HHx)), the 
scaffolds were implanted in mice for 40 days. There was a thin layer of fibroblast growth on 
the implant with no macrophage infiltration and no significant inflammatory response observed 
at the end of the experiment (Williams et al., 1999).  Chen et al. observed that  
poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) scaffolds initiated far less inflammatory 
response as compared to the polylactides, attributing this to a slower degradation rate and less 




In a study conducted on P(3HB-co-3HHx) seeded with mice-iPSCs, it was observed there was 
a higher cell activity and adhesion on the PHA construct as compared to the tissue culture 
plastic. Hence, P(3HB-co-3HHx) was found to be highly biocompatible enabling growth, 
proliferation and myocardial cell differentiation of the mice-iPSCs (Shijun et al., 2016). In 
another study it was observed that the inoculated chondrocyte cells grew and proliferated well 
on the P(3HB)-co-(3HHx)/ PHB blend scaffold. After an incubation of 14 days, the outside 
layer of P(3HB)-co-(3HHx)/ PHB blend scaffold was covered  with proliferated cells and the 
cells merged on some of the scaffold surfaces to form cell layers confirming the 
biocompatibility of the polymers (Zhao et al., 2003). Saito et al. also reported no inflammatory 
reaction on the chorioallantoic membrane of the developing egg with the interaction of P(3HB) 
sheets, thus confirming it to be a biocompatible material (Saito et al., 1991). Furthermore, 
Tepha Inc. have fabricated surgical sutures using poly-4-hydroxybutyrate P(4HB) in 2007 and 
FDA has approved its use for clinical applications. This was an important achievement and 
confirmed the biocompatible nature of PHAs (Martin et al., 2012).  
 
1.6.4. Applications of Polyhydroxyalkanoates 
PHAs are an emerging group of polymers which are now being used in various industrial and 
medical applications due to their unique properties. As discussed above, the material 
characteristics of PHAs can be varied from being highly rigid to highly elastomeric in nature. 
They are optically active molecules, piezoelectric in nature and water insoluble materials. 
These features of PHAs make them highly suitable for a variety of applications.  
 
Industrial applications 
PHAs have been used in various industrial applications. They have a wide range of applications 
due to their novel features. Biopol is one of the commercial products which is a copolymer of 
poly (3-hydroxybutyrate-co-3-hydroxyvalerate). It is a thermoplastic and has a melting point 
of 140-180 ºC. It can also be injection moulded and vacuum formed. Hence it has its 
applications in packaging, shampoo bottles, disposable razors, disposable cups, surgical 
stitches, surgical pins, disposable knives and forks, woven medical patches and nappy linings. 
Nodax is another PHA copolymer consisting of 3-hydroxybutyrate and three MCL units which 
include 3-hydroxyhexanoate, 3-hydroxyoctanoate and 3-hydroxydecanoate. Procter and 
Gamble have developed this polymer and it is available as foams, fibres or nonwovens, films 
and latex among others. Biogreen is another product which is P(3HB) produced from methanol. 
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It is produced by a Japan based company Mitsubishi Gas Chemicals. Due to its piezoelectric 
nature, PHAs can be used for making pressure sensors for keyboards, stretch and acceleration 
measuring instruments, material testing, shockwave sensors, lighters, gas lighters; acoustics: 
microphone, ultra-sonic detectors, sound pressure measuring instruments, oscillators, 
headphones, loudspeakers, for ultrasonic therapy and atomization of liquids. The gas barrier 
property of P(3HB-3HV) is useful for applications in food packaging and for making plastic 
beverage bottles. For agricultural purposes, PHAs have been used as mulch films, herbicides, 
insecticides, bacterial inoculants used to enhance nitrogen fixation in plants. 
 
Medical applications 
PHAs are natural biomaterials that have a potential to be used in medical applications due to 
their natural source, biocompatibility, biodegradability, non-toxic nature, their ability to 
provide mechanical support to the injured region and to promote cell growth and proliferation 
(Valappil et al., 2006).  A large number of PHAs are currently under investigation and need to 
be researched and evaluated as a potential material for medical applications. These include 
P(3HB) (Basnett et al., 2013; Akaraonye et al., 2016), P(3HB-co-3HV), poly-4-
hydroxybutyrate, P(4HB), poly(3-hydroxybutyrate-co-3-hydroxyhexanoate), P(3HB-co-
3HHx), and P(3HO) (Bagdadi et al., 2016; Rai et al., 2011; Byrom, 1992, Chen et al., 2001, 
Hrabak, 1992). They are used as bone plates, osteosynthetic materials, surgical sutures, dusting 
powders, wound dressings, nerve conduits, soft tissue repair, dental and maxillofacial treatment 
and cardiovascular implants (patches and heart valves) (Chen et al., 2005). They can also be 
utilized in the slow release of drugs and hormones in the affected tissue. One such example 
includes, P(3HB) which is used in the synthesis of Merck’s anti-glaucoma drug “Truspot” due 
to its ability to hydrolyze instantly to R-3-hydroxybutyric acid. A monofilament suture was 
fabricated using P(3HB) and P(3HB-co-3HV) and was implanted intramuscularly in Wister 
rats. These sutures did not cause any acute vascular reactions at the site of implantation or any 
adverse effects such as inflammation, necrosis, and calcification of fibrous capsule or 
malignant tumour formation after a period of 1 year of implantation (Shishatskaya et al., 2004).  
An in vivo study was conducted by implantation of a composite which was fabricated using 
hydroxyapatite (HA) and polyhydroxybutyrate/polyhydroxyvalerate.  Lamellar bone was 
formed at the interface, which replaced the degrading polymer matrix, while engulfing HA 
filler particles. Osteoblasts and osteocytes were identified throughout the interface region. The 
thickness of the newly formed bone also increased significantly. These materials were thus 




One of the greatest contribution of PHAs to medicine have been in the cardiovascular area 
(pericardial and atrial septal repair patches, scaffolds for regeneration of arterial tissues, 
vascular grafts, cardiovascular stents and heart valves). There are different PHAs which have 
been used for these applications. MCL-PHAs due to their elastomeric properties and flexible 
nature have been commercially used in cardiac tissue engineering especially in heart valve 
development. Poly(4-hydroxybutyrate) (P(4HB)), an SCL-PHA, also has elastomeric 
properties and has been found to be useful in cardiac tissue applications (Chen and Wu, 2005). 
Tepha Inc. has produced commercially available P(4HB) TephaFLEX® for various 
applications including heart valve development. Sodian et al. (2000), fabricated a 
biodegradable, biocompatible and porous trileaflet heart valve using P(3HO) produced by 
Tepha Inc., and seeded vascular cells from sheep carotid arteries in vitro. The P(3HO) valve 
was monitored for 120 days and was found to be functional and suitable to be implanted in 
pulmonary valve position in the pulmonary artery in the lambs. The valve also showed cell 
proliferation and accumulation which confirmed it to be a suitable material for valve 
development (Chen and Qiong, 2005). P(4HB) and poly(3-hydroxyoctanoate-co-3-
hydroxyhexanoate) (PHOH) produced by Tepha Inc. were used to fabricate a trileaflet valve 
scaffold using stereolithography. This valve had an advantage that it could be moulded without 
the need for suturing to the tissue (Sodian et al., 2002). In another study, P(3HO-co-3HHx) 
produced by Metabolix Inc. was used as a copolymer of polyglycolic acid (PGA) for the 
fabrication of a two component tubular vascular graft which was seeded with autologous cells 
where PGA formed the inner layer and P(3HO-co-3HHx) formed the outer layer of the conduit. 
This construct was implanted in the aortic tissue of the lambs. An increased cell density, 
collagen formation was observed along with insignificant inflammatory response (Shum-Tim 
et al., 1999). A P(3HO) polymer patch was also fabricated and was implanted in the pulmonary 
artery of sheep. The scaffold was seeded with autologous ovine cells. It was observed that at 
the end of 24 weeks there was an organised viable accumulation of cells on the graft containing 
endothelial cell lining. There was no stenosis or thrombosis reported at the end of the 
experiment (Stock et al., 2000). In an in vivo study conducted using P(3HB-co-3HHx), it was 
observed that a coating of the polymer on the decellularised porcine aortic valves, decreased 
calcification and promoted cell proliferation and migration on the engineered valve (Wu et al., 
2007). Another PHA used in cardiac applications is poly(3-hydroxybutyrate-co-3-
hydroxyvalerate) P(3HB-co-3HV). A 3D microfibrous scaffold was electrospun using a blend 
of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (P(3HB)-co-(3HV), poly(L-D,L-lactic acid) 
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(P(L-D,L)LA) and poly(glycerol sebacate) (PGS). The scaffolds were seeded with 
mesenchymal stem cells (MSCs) which were developed from human umbilical cord matrix 
(Wharton’s Jelly) cells. These were found to align in parallel to each other, mimicking the 




1.7. AIMS OF PROJECT 
The main aim of this project was the development of a “cardiac patch” involving the use of 
novel biodegradable materials, MCL-PHAs particularly, poly(3-hydroxyoctanoate) 
homopolymer, P(3HO), (as described by Rai et al., 2011 and Bagdadi et al., 2016) and  
poly(3-hydroxynonanoate-co-3-hydroxyheptanoate) P(3HN-co-3HHP).  
The specific aims which led to the fulfilment of the main aim stated above included: 
1. Production and characterization of MCL-PHAs including Poly(3-hydroxyoctanoate), 
P(3HO), and Poly(3-hydroxynonanoate-co-3-hydroxyheptanoate), P(3HN-co-3HHP) 
using Pseudomonas mendocina CH50.  
2. Fabrication and characterization of cardiac patches using solvent casting and 
electrospinning of neat P(3HO), P(3HN-co-3HHP) and their blends. 
3. Preparation of 3D porous scaffolds of P(3HO) and their characterization. 
4. Production and characterisation of polyaniline/P(3HO) blend scaffolds to introduce 
electrical conductivity in the scaffolds.  
5. Functionalization of the scaffolds using a star PEG mediated incorporation of peptides 
and growth factors in order to allow efficient host cell recruitment, adhesion, 
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2.1. Chemicals and Reagents 
All the chemicals were purchased from Sigma-Aldrich or BDH Ltd. (Dorset, UK) or VWR 
(Leicestershire, UK) and TCI, UK. For Nuclear Magnetic Resonance (NMR), chromatography 
grade reagents were used while for the analytical work, analytical grade reagents were used. 
Cell culture studies were carried out using cell culture grade media and reagents from Sigma-
Aldrich, UK, and Lonza, UK. The primary antibody was bought from abcam and Millipore. 
The live and dead assay kit and the secondary antibody was purchased from Invitrogen.  
 
2.2. Bacterial strains and cell line 
P(3HO) and P(3HN-co-3HHP) was produced using the Gram-negative bacterium 
Pseudomonas mendocina CH50 which was obtained from the National Collection of Industrial 
and Marine Bacteria (NCIMB 10541), Aberdeen, UK. The C2C12 cell line was obtained from 
Sigma-Aldrich. Cell culture studies were carried out using the human induced pluripotent stem 
cell derived cardiomyocytes (hiPSC-CM) purchased from Cellular Dynamics International and 
neonatal ventricular rat myocytes (NVRM) which were isolated from neonatal mice at the 
National Heart and Lung Institute, Imperial College and provided for this work. 
 
2.3. Production of Poly (3-hydroxyoctanoate) (P(3HO)) and Poly (3-hydroxynonanoate-
co-3-hydroxyheptanoate) (P(3HN-co-3HHP)) 
The production of P(3HO) and P(3HN-co-3HHP) can be divided into four phases as depicted 
in Figure 2.1.  
These include: 
• Growth of P. mendocina CH50 in nutrient broth; growth in second stage mineral salt 
medium (MSM) for the production of an inoculum for the final fermentation; finally, 
the production stage MSM was used for the production of PHAs.  
• Harvesting the cells and their lyophilisation by freeze drying. 
• Solvent extraction of PHAs from the freeze dried bacterial cells followed by differential 
precipitation 






Figure 2.1: Pictorial representation of the production of P(3HO) and P(3HN-co-3HHP) from 
P. mendocina CH50 
 
2.3.1. Media composition 
Composition of Nutrient Broth (g/L) 
 
Table 2.1: Composition of nutrient broth no 2 used in this work, was purchased from Sigma 
Aldrich 
Meat peptone 4.3 
Casein peptone 4.3 
Sodium chloride 6.4 
 
The final pH of the media was maintained at 7.5±0.2 and was stored at 25ºC. Fifteen grams of 
the nutrient broth was dissolved in 1L of distilled water and was used after sterilising it using 
autoclave at 121°C for 15 minutes. 
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Composition of the second stage MSM (g/L) 
Chemicals Composition (g/L) 
 




Mg SO4.7H20 0.80 
Trace element solution 1 ml/L 
 
 
Composition of the production stage MSM (g/L) 
Chemicals Composition (g/L) 
 




Mg SO4.7H20 0.80 






Trace element solution (TE) 
Chemicals Composition (g/L) 
 
Table 2.4: Composition of the trace element solution (Rai et al., 2011) 




CrCl6. H2O 0.11 
CuSO4. 6H2O 0.16 
 
 
The carbon source used for the production of P(3HO) and P(3HN-co-3HHP) were sodium 
octanoate and sodium nonanoate respectively. The molar ratio of C/N for the two productions 
were kept as 20 and hence the concentration of sodium octanoate used was 3.32 g/L while that 
of sodium nonanoate was 3.60 g/L respectively. The salts were sterilised by autoclaving at 
121oC for 15 minutes. The carbon sources, sodium octanoate and sodium nonanoate and 
magnesium sulphate were sterilised separately. Trace element (TE) solution was prepared by 
dissolving all the chemicals in 1N HCl. The TE solution was filter sterilised before use. The 
pH of the media, sodium octanoate/sodium nonanoate and magnesium sulphate was adjusted 
to 7.00 using 1N HCl or 1M NaOH before autoclaving.  
 
2.3.2. Fermentation for the production of P(3HO) and P(3HN-co-3HHP) 
Nutrient broth inoculation of P. mendocina CH50 
A single colony of P. mendocina CH50 was used to inoculate the nutrient broth. The culture 
was incubated at 30oC at 200 rpm for 24 hours. This was used as the seed culture.  
Second stage inoculation  
The seed culture described above was used to inoculate the second stage MSM (section 2.3.1). 
The bacteria were cultured in this medium for 16 h at 30oC at 200 rpm. This was used as the 
inoculum in the final fermentation for polymer production. 
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Production stage MSM inoculation 
The second stage culture described above was used to inoculate the production stage MSM 
(section 2.3.1). Sodium octanoate and sodium nonanoate were used as the carbon source at 
both stages for the production of P(3HO) and P(3HN-co-3HHP) respectively. The culture was 
incubated for a period of 48 hours before being harvested (Rai et al., 2011). The final 
production was carried out in 2 L fermenters. 
 
2.3.3. Extraction and purification of the PHA by soxhlet extraction 
After 48 h of growth, the cells were harvested by centrifuging the cultures at 4600 rpm for  
30 min. The cell pellet obtained was then lyophilised. The dry cells were placed in a thimble 
and fitted onto the soxhlet apparatus. Methanol was added in the round bottom flask of the set 
up and the soxhlet was left to reflux for a minimum of 3 h. This dissolved all the impurities 
from the cells in methanol. The methanol was then discarded and replaced with chloroform. 
The cells were refluxed with chloroform for 12 h which enabled polymer extraction and 
dissolution. Later this chloroform layer was evaporated using a rotary evaporator and the 
polymer was precipitated using an ice cold solution of 50:50 methanol: ethanol. 
 
2.3.4. Analytical studies  
Biomass estimation 
Estimation of the biomass was carried out by centrifuging 1 ml of the culture sample at 12,000g 
for 10 min. The cell pellets obtained were freeze dried and weighed. 
pH estimation 
The supernatant was collected from the above mentioned centrifuged samples and the pH was 
measured and recorded.  
Estimation of nitrogen concentration 
The reagents required for this analysis were prepared as follows: 
• Phenol nitroprusside buffer: Sodium phosphate tribasic (3 g), sodium citrate (3 g) and 
ethylene tetraacetic acid (EDTA) (0.3 g) were dissolved in HPLC water. pH was adjusted 
to 12. To this, 6 g of phenol and 20 mg of sodium nitroprusside were added. 
• Alkaline hypochlorite reagent: This reagent was prepared by mixing 2.5 ml of sodium 




The estimation of nitrogen in the medium was carried out using the phenol hypochlorite 
reaction (Rai et al., 2011). The sample was prepared by centrifuging the culture at 12,000 g for 
10 min. The supernatant obtained was used for analysis by diluting 1:100 times with Millipore 
water. 1 ml of phenol nitroprusside buffer was added to 2.5 ml of the diluted sample and mixed 
by swirling. Next, 1.5 ml of the hypochlorite reagent was added rapidly and vortexed. The 
sample was then incubated for 45 min in the dark. The absorbance was measured at 635 nm. 
 
2.3.5. Processing of PHAs into 2D/3D scaffolds 
Scaffold formation- neat P(3HO), P(3HN-co-3HHP) and P(3HO) / P(3HN-co-3HHP) 
blend 2D film production 
The neat P(3HO), P(3HN-co-3HHP), blend P(3HO)/P(3HN-co-3HHP) scaffolds were 
prepared using solvent casting. Neat and blend scaffolds were prepared by dissolving 0.5 g of 
the neat polymer or polymer mixture in 10 mL of chloroform and casting into a 6-cm diameter 
petri dish. The blend films were prepared by mixing P(3HO) and P(3HHN-co-3HP) in the ratio 
of 80:20, 50:50, 20:80 in wt% respectively. These films were left for air drying for 1 week and 
in the freeze drier for 3 weeks.  
 
Fibre formation- neat P(3HO), P(3HN-co-3HHP) and P(3HO)/ P(3HN-co-3HHP) blend 
random and aligned fibre formation using electrospinning 
The random and aligned fibres were electrospun using electrospinning technology. For random 
fibre formation of these polymers, P(3HO), P(3HN-co-3HHP) and the blend of P(3HO) and 
P(3HN-co-3HHP) in weight ratio of 20:80, 50:50 and 80:20 were dissolved in acetone with a 
final polymer concentration of 8 wt % and stirred for 12 h. These solutions were electrospun 
from a 1 ml syringe with a 18G stainless steel needle, at a flow rate of 1.25 ml/h. A high voltage 
of 14kV was applied when the polymer solution was drawn into fibres and collected on an 
aluminium foil wrapped collector, kept at a distance of 10 cm from the needle.  For collecting 
aligned fibres, a rotating drum was place at 10 cm and the speed of the rotating disc was set at 
3000 rpm. The fibre were collected on 15 mm coverslips. The fibre coated coverslips were 







Preparation of porous scaffolds 
Fabrication of 2D porous P(3HO) scaffolds using porogen leaching  
 
The scaffolds were prepared using solvent casting. Three different 5 wt% porous P(3HO) 
scaffolds were prepared. For this, 0.5 g of the polymer was dissolved in 10 ml of chloroform, 
and 50 mg, 100 mg and 150 mg of sucrose, used as the porogen, with particle size of  
250-300 µm was added to cast three different porous films. This solution was poured in a petri 
dish and left on the bench for 1 week for air drying followed by 3 weeks in a freeze drier. To 
achieve the required pore size, sucrose was first sieved through a 300 µm sieve followed by 
sieving through 250 µm pore size sieve. The sucrose particles which remained on the sieve 
were >250 µm and <300 µm in diameter, and were used for further work.  
 
After the neat and sucrose containing scaffolds were dried, water was added in the petri-dish 
and left for 2 h. Water was then removed and the scaffolds were peeled off. In the presence of 
water it was easier to peel off the scaffolds. The sucrose in the porogen containing scaffolds 
was dissolved by water and the scaffold was also easily removed from the petri-dish, leaving 
behind a porous scaffold. The scaffolds were then left to air dry on the bench.  
 
Fabrication of 3D porous P(3HO) scaffolds 
P(3HO) 3D porous scaffolds were fabricated by the salt leaching method using sodium chloride 
as a porogen. A mould was prepared using a vial of 1 cm2 diameter. It was cut into a 2 cm long 
cylinder. One end of this cylinder was stuck to a slide using a silicon based glue. This set up 
was left for drying for 24 h.   
 
In this mould, a 1 ml solution of 20% P(3HO) in chloroform was added and 4 g of sodium 
chloride was added (in excess). The sodium chloride particles were of particle size between 
250 μm -300 μm. The scaffold set up was left for air drying for 1 week and was freeze dried 
for another week. The scaffold set up was then immersed in water and the sodium chloride was 
washed out. Water was changed every 12 h. This washing with water was carried out for 2 




2.4. Characterisation of the PHAs  
Chemical characterisation 
Fourier Transform Infrared Spectroscopy (FTIR) 
Preliminary confirmation of the polymer structure was determined by FTIR. The conditions 
under which this analysis was performed were as follows: spectral range 4000 to 600 cm-1; 
window material, CsI: 10 scans and resolution 4 cm-1. Polymer sample (2 mg) was used to 
carry out this analysis at the Department of Biomaterials and Tissue Engineering, Eastman 
Dental Institute, University College London, UK. 
 
Nuclear Magnetic Resonance Spectroscopy (NMR) 
The final confirmation and structural characterisation of the polymer produced by P.mendocina 
CH50 was carried out using 13C and 1H NMR. For this, 20 mg of the purified polymer was 
dissolved in 1 mL of deuterated chloroform. These samples were sent to the Department of 
Chemistry, University College London, UK for NMR analysis. Chemical shifts were 
referenced against the residual solvent signal (7.26 ppm and 77.0 ppm for 1H and 13C 
respectively). 
 
Material characterisation of the neat and blend scaffolds 
Mechanical testing 
Mechanical properties of the films were measured using the Perkin–Elmer Dynamic 
Mechanical Analyser (DMA) as described in Misra et al., 2008. Polymer film strips (n=5) were 
cut with dimensions of 23 mm length, 5 mm width. The program for the test was set with a rate 
of deformation of 10 mm/min. This analysis was carried out to measure the Young’s modulus, 
tensile strength and the elongation at break values.  
 
Thermal property: Differential Scanning Calorimetry (DSC) 
Thermal properties of the films such as melting temperature (Tm) and the glass transition 
temperature (Tg) were measured by DSC using a Perkin Elmer Pyris Diamond (Perkin Elmer 
Instrument). Film samples were used for the analysis. Prior to the analysis, these samples were 
encapsulated in the standard aluminium pans and the tests were performed under nitrogen 
atmosphere. The sample was heated and then cooled and then heated again at the rate of 





The wettability analysis was carried out by measuring the water contact angle on the film 
samples (n=9) by using KSV Cam 200 optical contact angle meter (KSV instruments Ltd) as 
described in Misra et al., 2008. This analysis gave an indication about the hydrophobicity of 
the sample. This experiment was done at the Department of Biomaterials and Tissue 
Engineering, Eastman Dental Institute, University College London, UK. 
 
Surface morphology: Scanning Electron Microscopy (SEM) 
Surface characterisation of the films was carried out using a JOEL 5610L scanning electron 
microscope (JOEL). The polymer samples were placed on the 8mm diameter aluminium stubs 
and gold coated for 2 min using the gold sputtering device (EMITECH-K550). Images were 
then recorded at different magnifications and acceleration voltages to study the surface 
topography of the sample (Misra et al., 2008). The operating pressure of 7 x 10-2 bar and 
deposition current of 20 mA, for 2 min, was used. SEM analysis was carried out at the 
Department of Biomaterials and Tissue Engineering, Eastman Dental Institute, University 
College London, UK. 
 
The samples with cells grown were analysed for their surface properties and the cell samples 
were prepared before viewing under SEM. The cells grown on different scaffolds were fixed 
in 3% paraformaldehyde for 30 min at room temperature and stored in PBS. Before imaging, 
the samples were dehydrated in a series of ethanol solutions (50%, 70%, 90% and 100%), 
incubating 10 minutes in each solution. Samples were air dried, coated and examined under the 
SEM, as described above in this section. 
 
Porosity measurements  
The porosity of the porous films was determined using equation 2.1.  
 
       ........................................2.1 
Where ρn is density of neat films, ρp is density of porous films. 
Porosity measurements were made in triplicates.  
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Micro Computed Tomography (Micro-CT) analysis 
Micro-CT analysis was used to analyse the interconnectivity of pores of the 3D scaffold 
structure. Surface characterisation of the films were carried out using a JOEL 5610Lv scanning 
electron microscope (JOEL). 
 
Degradation studies 
Degradation study was carried out by incubating film samples in phosphate buffered saline 
solution (PBS) and at 37◦C with mild shaking at 80 rpm. Phosphate buffered saline (PBS) is an 
isotonic solution containing: NaCl 8g/L, KCL 0.2 g/L, Na2HPO4 1.44 g/L and KH2PO4 
0.24g/L. Film samples 25 cm long and 0.5cm long were analysed for water uptake, weight loss 
and pH change for 3 months. The samples were analysed in triplicates. 
 
The in vitro degradation analysis was also conducted on the P(3HO)-PANI films containing  
10 vol%, 20 vol% and 30 vol% PANI. The study was conducted for a period of 1 month and 
different parameters were measured at 3 days, 15 days and 30 days. The samples used were 
1cm long and 0.5cm width and were immersed in PBS. These immersed samples were kept in 
the incubator set at 37⁰ C with mild shaking at 80 rpm. The samples were analysed in triplicates. 
 
Water uptake and Weight loss 
Prior to the incubation, the samples were weighed Mo (Mo, dry the initial weight of the sample). 
After this, the samples were immersed in PBS under mild shaking of 80 rpm, at 370 C, for a 
period of one and three months. At the end of the incubation period, the samples were 
withdrawn from PBS and their weight loss (%WL) and water uptake (%WA) behaviour was 
analysed as described in Misra et al., 2008. The following equations were used to calculate 






Mo, dry = the initial weight of the sample. 
Mw, wet = Mw, the weight of the samples after the immersion in PBS 
Mt, dry = Mt, the dry weight of the samples after the incubation in PBS followed by drying 
(Misra et al., 2008). 
 
pH measurements 
After the samples were removed from PBS, pH was measured to record change in pH during 
the given time period.  
 
2.5. In vitro biocompatibility studies 
2.5.1. Growth of human induced pluripotent stem cell derived cardiomyocytes (hiPSC-
CMs) on the scaffolds: 
Polymer coated coverslips were prepared using neat P(3HO) and P(3HN-co-3HHP). 
Coverslips were also coated with the P(3HO)/ P(3HN-co-3HHP) blend polymer solutions and 
left to dry. The hiPSC-CMs were grown for 14 days, with regular change in media, on the 
PHAs and gelatin coated coverslips were used as positive controls.  
 
In vitro culture of human induced pluripotent stem cell derived cardiomyocytes (hiPSC-
CMs) 
Cell culture was carried out under sterile conditions in a Biomat 2 class II microbial safety 
cabinet and cells were incubated in a CO2 incubator (Sanyo, MCO-5M) at 37°C and 5% CO2.  
In vitro culture of the hiPSC-CM were conducted on P(3HO), P(3HN-co-3HHP) and blend 
(80:20,50:50,20:80) coated coverslips while  0.1% gelatin coated coverslips were used as the 
positive control. The hiPSC-CM from Cellular Dynamics International, iCell Cardiomyocytes, 
were thawed in iCell cardiomyocytes plating medium (CMM-100-110-001) as per the 
guidelines provided by the manufacturer. The scaffolds were placed in a 12-well tissue culture 
plate and were sterilized with 70% ethanol and further sterilized for 1 h UV light prior to the 
seeding of cells. After sterilization, 60,000 cells were seeded on the scaffolds as a 100 µl drop 
and left for a few hours. Later in iCell cardiomyocytes plating medium (CMM-100-110-001) 
was added to the wells in the culture plate and left for 2 days for the cells to stick on the 
scaffolds. Two days later the cells were seen to adhere to the scaffolds and the media was 
changed to the iCell cardiomyocyte maintaining medium (CMM-100-120-001) (CDI 2013). 
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The cardiomyocytes were left to grow for 14 days and media was changed every 2 days. On 
day 14 they were used to conduct various biocompatibility experiments. 
 
Live and dead assay 
Live and dead assay was conducted on day 14 on the hiPSC-CMs grown on P(3HO), P(3HN-
co-3HHP) and P(3HO)/ P(3HN-co-3HHP) scaffolds and gelatin which was used as positive 
control. A live/ dead cell cytotoxicity assay was used to label the cells. Cells were washed in 
sterile PBS and a 100 μL of 2 μM calcein AM and 4 μM ethidium homodimer-1 solution was 
added to each well for 30 min in the dark at room temperature. Following incubation, the 
samples were mounted in fresh PBS and imaged using an inverted Zeiss LSM-780 confocal 
microscope. Cells were counted using the Fiji image processing software (ImageJ). 
 
Functional assays for cardiomyocytes 
Optical mapping- calcium transients of hiPSC-CMs with fluo-4 AM- The cells were 
analysed for their calcium transient channels which are the major drivers for the beating of the 
cells. This work was carried out with assistance from Ms. Eleanor Humphrey, Imperial College 
London. The scaffolds were placed in a mattik dish and cells were seeded onto them. Cells 
were loaded with 20 μM fluo-4 AM in DMEM and left in the incubator. After 20 min the 
DMEM was refreshed and left in the incubator for 20 min.  
 
Recording Calcium Transients- The scaffolds were mounted on the stage of an upright Nikon 
eclipse FN1 microscope in a glass bottom dish (MatTek Corporation) and observed through a 
40x water immersion objective. Throughout the experiment the cells were superfused at 37°C 
with Normal Tyrode’s (NT) solution containing 140 mM NaCl, 4.5 mM KCl, 10 mM glucose, 
10 mM HEPES, 1 mM MgCl2, 1.8 mM CaCl2, adjusted to pH 7.4 using 2 M NaOH. The hiPSC-
CMs were field stimulated at 0.5, 1 and 1.5 Hz using an external stimulator and upon 
stimulation the fluorescence signal (excitation wavelength= 300-520 nm and emission 
wavelength= 480-620 nm) was recorded using a RedShirt CMOS camera (128x 128 pixels,  
2 ms frame rate) and dedicated Neuroplex software (IDL, Research Systems Inc.). The 
fluorescence signal was then analysed using a custom MatLab code®. The transients were 
analysed to determine four main parameters: normalised amplitude (f1/f0) which is the peak 
transient amplitude divided by the baseline value of the signal; time to peak (Tp) which is the 
time taken to reach peak amplitude; time to 50% decay (T50) and 90% decay (T90) which are 
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the time taken for the transient to decrease from Tp to 50% and 90% of the transient amplitude 
respectively, during the recovery phase of the transient. 
 
Beat rate measurements 
hiPSC-CMs were placed on the stage of a Nikon eclipse TE2000-E inverted light microscope 
at 37 °C and the number of beats per minute counted and recorded using a Nikon digital sight 
DS-2Mv camera.   
 
Immunofluorescence staining (F-actin, Myosin Heavy Chain (MHC), Nuclei) 
Immunofluorescence of the cells was analysed by staining the cells for myosin heavy chain 
(MHC), F-actin and nuclei. F-actin was stained with phalloidin and nuclei with DAPI. For 
immunofluorescence, at day 14 the beating cardiomyocyte monolayers were fixed with 4% 
paraformaldehyde for 20 mins, permeabilised with 0.1% Triton-X-100, and blocked with 4% 
FBS in PBS  for 1 h. Cardiomyocytes were then stained with mouse anti-myosin heavy chain 
(α/β) primary antibody (Table 2.5) (1:200) for 1 h, washed three times with PBS, and then 
stained with donkey anti-mouse Alexa 546 secondary antibody (1:400) and FITC-phalloidin 
(1:200) for 45 min in 3% BSA in PBS. After staining, the cardiomyocytes were washed an 
additional three times in PBS. They were then mounted in vectashield mounting medium 
containing DAPI. Immunofluorescence imaging was performed using an inverted Zeiss LSM-
780 confocal microscope.  
 
Sarcomere staining  
Cells were washed in phosphate buffered saline (PBS), fixed with ice-cold methanol for 5 min 
and blocked in 1% bovine serum albumin (BSA) (subsequently used for all antibody dilutions) 
for 1 hour. Cells were stained with a primary antibody overnight at 4°C and then incubated 
with a secondary antibody for 1 hour at room temperature before mounting in vectashield 
(Vectalabs) mounting medium containing DAPI (Table 2.5). The cells were imaged using an 










Table 2.5: Different antibodies used for immunoflourescence staining of the sarcomere (α-actinin) 
and Myosin heavy chain (MHC) 
Immunofluorescence 
labelling  
Primary antibody  Secondary antibody  
α-actinin mouse anti- α actinin 
antibody (1:1000 dilution) 
(Sigma)  
anti-mouse Cy3 antibody 
(1:500 dilution) (Millipore)  
MHC (α/β) mouse anti-myosin heavy 
chain (α/β) primary 
antibody (abcam) (1:200) 
donkey anti-mouse Alexa 




2.5.2. C2C12 myoblast proliferation  
The C2C12 myoblast cell line was used to assess cell proliferation in the P(3HO) porous 
constructs by the MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 
colorimetric assay and SEM.  
 
C2C12 cell growth  
C2C12 myoblast cells were grown in a DMEM supplemented with 10% of foetal calf serum, 
1% w/v penicillin and 1% w/v streptomycin solution and grown in a 75 cm2 tissue culture flask 
at 37 ºC with 5% of CO2. Media was pre-warmed at 37ºC and filter sterilized prior to use. Cell 
passages were carried out before confluence, every one or two days. For the passages, cells 
were detached from the flask using 5% trypsin at 37ºC for 2.5 minutes and the reaction was 
stopped by adding an equal volume of the supplemented DMEM. Samples were centrifuged at 
400 g for 10 min and the resulting pellet was dissolved in freshly supplemented DMEM. Cells 
were seeded in sterile 75cm2 tissue culture flasks.  
 
C2C12 cell seeding  
C2C12 myoblast cells in 70% confluence were used for the cell seeding on the scaffolds. The 
cells were grown on the scaffolds in a 24 well tissue culture plate. Scaffdex® cell crowns were 
used to hold the cells on the well’s surface on the films. Around 20,000 cells were seeded on 
the pre-wetted constructs in a 24 well plate. As a positive control, cells were seeded in the wells 
without films. For the negative control, films were incubated in supplemented DMEM without 
cells. Plates were incubated at 37ºC with 5% of CO2 and media was changed every 2 days. Cell 






Cell proliferation study using the MTT assay  
The MTT assay was performed on the constructs containing cells at 24hrs. For this, 100 μl of 
a 5 mg/ml MTT solution in distilled water were added to each well at 24hrs and the plates were 
incubated for two hours at 37ºC with 5% of CO2. After this, films were transferred to new 24 
well tissue culture plates and 500μl of DMSO were added. After a 5 minute incubation, 100μl 
of the resulting solution were transferred to 96 well plates and the absorbance at 540nm was 
measured on a Thermomax® microtitre plate reader. The absorbance of the samples were 
normalised with respect to the positive control. The difference in the surface areas of the tissue 
culture plate wells and the films were considered for the calculation of % cell viability on the 
films. 
 
2.5.3. Growth of neonatal ventricular rat myocytes (NVRM) on the polymers 
The biocompatibility of the scaffolds were also analysed by growing NVRMs on the different 
films. This work was carried out by cell biologists at National Heart and Lung Institute, 
Imperial College. NRVMs were isolated from Sprague-Dawley rats 0-2 days after birth by 
excising the hearts and isolating the ventricles. All work was carried out under the Animals 
(Scientific Procedures) Act 1986 and the EU Directive 2010/63/EU. A Gentle MACs neonatal 
heart dissociation kit (Miltenyi Biotec) was used to enzymatically digest the ventricles to 
produce a cell suspension that was pre-plated for 1 hour to remove the fibroblasts.  Two 
hundred thousand (200,000) NRVMs were seeded per P(3HO):PANI constructs, NCO-sP(EO-
stat-PO): P(3HO):P(3HHN-co-3HHP) fibres with either one/two or three active molecules 
(RGD,YIGSR and VEGF) and the collagen construct which was used as a positive control.  
These cells were grown in NRVM medium: 67% Dulbecco’s modified Eagle medium 
(DMEM), 16% Medium 199, 10% Horse serum (HS) (Gibco), 4% foetal bovine serum (FBS) 
(Gibco), 2% HEPES (4-(2-hydroxyethyl)-1- piperazineethanesulfonic acid) buffer and 1% 
penicillin-streptomycin. The live and dead assay was conducted at 3 days post seeding.  
 
Image analysis  
Image processing software Fiji (ImageJ) was used for all image analysis. The live, dead cell 
numbers and nuclei density was quantified using Fiji to count the cells and nuclei, which it 




Sarcomere length was measured by viewing the profile plot of a line drawn perpendicular 
across the α-actinin bands. The distance between each peak on the graph was measured and 
averaged to give sarcomere length. 
 
Alignment analysis of the cells grown on aligned fibres 
The alignment of the cells grown on aligned fibres were quantified by using the angle tool of 
the Image J software. The nuclei were stained using DAPI and the modulus of the deviation of 
the individual angles were calculated with respect to the mean angle. The percentage of cells 
in a given range were plotted for each scaffold which gave a quantification of the cell 
alignment.  
2.6. Development of conductive scaffolds 
Production of P(3HO):PANI blends to introduce electrical conductivity in the scaffold. 
 
Polyaniline (PANI) synthesis 
PANI-HCl synthesis 
Polyaniline-HCl (PANI-HCl) is formed by oxidising aniline hydrochloride with ammonium 
peroxidisulphate in aqueous medium. For this, 0.2 M aniline hydrochloride and 0.25 M 
ammonium peroxidisulphate were each kept for dissolving with stirring in 50 ml of distilled 
water. Both solutions were kept for 1 h at room temperature (~18–24 °C), then mixed in a 
beaker, briefly stirred, and left undisturbed to polymerize. Next day, the PANI precipitate was 
collected on a filter, washed with three 100-mL portions of 0.2 M HCl, and similarly with 
acetone until a clear filtrate was obtained. Polyaniline (emeraldine) hydrochloride powder was 
dried in air and then in an oven at 60°C (Stejskal et al., 2002). 
 
PANI-base synthesis 
The PANI-HCl was dissolved in excess of 3% ammonium hydroxide to convert to blue 
coloured non-conducting PANI-base. The solution was filtered next day and washed thrice 
with 200 ml of acetone. The PANI-base pellet was left for air drying followed by drying in an 
oven at 60°C. 
 
Fabrication of the P(3HO)-PANI blends 
Blends of P(3HO) and PANI were prepared by dissolving P(3HO), PANI-base and camphor 
sulfonic acid (CSA) in chloroform. Camphor sulfonic acid (CSA) was used as a dopant to 
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convert the non-conducting PANI-base to conducting PANI-CSA. Initially, PANI-base and 
CSA in the ratio of 0.78:1 were dissolved in 10 ml of chloroform and left for stirring for 2 days. 
The PANI-doped CSA solution was filtered twice and the filtrate was collected.  P(3HO) was 
added to the PANI filtrate solution and kept for dissolving overnight. Three different solutions 
were prepared, containing 10 vol%, 20 vol% and 30 vol% of PANI and by dissolving P(3HO) 
in it. The solutions were cast in Teflon moulds and left for 2 days to form a film. The films 
were peeled off and various other characterization were carried out with the films. 
 
Electrical conductivity measurement 
The electrical conductivity of the films were measured using a 2 probe technique. The films 
were attached to two probes which in turn were connected with a multimeter and a voltage 
source in series. The voltage was applied through the films and the current passing through the 




Where ρ = electrical resistivity, V = voltage, I = current, and l=length of the sample, A= area 
of the cross-section. The electrical conductivity was then calculated using the following 
equation 
             ........................................2.5 
 
Where σ = electrical conductivity 
 
2.7. Incorporation of growth factors and peptides in the polymer scaffolds for promoting 
cell adhesion 
Growth factors and peptides were incorporated with the P(3HO): P(3HHN-co-3HHP) (80:20) 
blend fibres by adding a functional amphiphilic macromolecule based on star-shaped poly 
ethylene oxide (PEO). The additive is a six-armed star-shaped poly(ethylene oxide-stat -
propylene oxide) with isocyanate end groups (NCO-sP(EO-stat-PO)) with 80% EO content and 
a molecular weight of 12 kDa. The molecule was obtained from Dr. Jochen Salber, University 
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Hospital Knappschaftskrankenhaus, Bochum, Germany. For incorporation of growth factors 
and peptides, four types of fibres were electrospun. One batch had 2 µg VEGF as an additive 
along with the 30% polymer solution. Another batch had 2.7 mmoles of RGD and YIGSR as 
an additive while a third had a combination of 2 µg VEGF and 2.7 mmoles RGD and YIGSR 
in the 30% polymer solution. The fourth batch was spun without any incorporated peptides or 
growth factors and acted as a control. The NCO-sP(EO-stat-PO) was dissolved in acetone and 
30% polymer solution was prepared by further dissolving P(3HO) and P(3HN-co-3HHP) in 
80:20 ratio. The various additives of peptides and VEGF was added to the respective solutions 
as mentioned above. This solution was immediately used for electrospinning. The polymer was 
spun at a rate of 1ml/hr, at a speed of 3000 rpm, voltage of 14kV to obtain aligned fibres. The 
distance between the needle and the collector was 15 cm. The fibres were collected on 
coverslips. 
 
2.8. Statistical analysis 
Data sets have been expressed along with their mean ± standard deviation. The data, where 
appropriate, were compared using the ANOVA and t-test. The differences were considered 
significant when *p<0.05, **p<0.001. p value greater than 0.05 (p >0.05) was interpreted as 




























Production and characterisation 









Medium chain length PHAs have been extensively used in soft tissue engineering due to their 
elastomeric properties and low Young’s modulus. These properties are adjustable based on the 
production conditions and hence can be tailored specifically to match with the properties of the 
tissue being regenerated.  They have been explored for their application in biological implants 
such as the heart valves, cartilage tissue engineering and in wound healing (Kim et al., 2007). 
In addition to the different properties obtained with different MCL-PHAs, the production of 
co-polymers, blends and composites further increase their range of applications. However, 
despite the varied applicability of these polymers, widespread use of the MCL-PHAs remain 
limited, mainly because of the lack of availability of these materials in large quantities (Rai et 
al., 2011).  
 
This chapter describes the production and characterisation of two MCL-PHAs, P(3HO) and 
P(3HN-co-3HHP) produced from Pseudomonas mendocina CH50 using sodium octanoate and 
sodium nonanoate as the carbon sources respectively. Novel cardiac patches of neat and blend 
polymers have been fabricated and characterised with respect to their thermal properties, 
mechanical properties and biocompatibility with respect to human induced pluripotent stem 
cells derived cardiomyocytes (hiPSC-CM)s and neonatal ventricular rat myocytes (NVRM)s. 
 
3.2. Results 
3.2.1. Production of Poly(3-hydroxyoctanoate), P(3HO) and poly (3-hydroxynonanoate -
co-3-hydroxyheptanoate), P(3HN-co-3HHP) by bacterial fermentation 
 
Production of Poly(3-hydroxyoctanoate), P(3HO) 
Poly(3-hydroxyoctanoate), P(3HO) production by P. mendocina CH50 using sodium octanoate 
as the sole carbon source was carried out as described in section 2.3.2. The fermentation was 
carried out in a 2L fermenter for 48 hr and the growth profile is shown in Figure 3.1. During 
the fermentation, the OD450 increased from 0.21 to 0.88 showing slow growth for the initial  
9 hours of fermentation, indicating a lag phase of growth. After this there was a steady increase 
in growth and the OD value reached a maximum of 5.7. Biomass estimation was carried out 
by weighing the freeze dried cells. Dry cell weight was also found to show the highest value 
of 2.8 g/L at 48 h. The initial nitrogen concentration of 0.52 g/L decreased to 0.11 g/L at 12 h, 
0.003 g/L at 36 h and continued to decrease until 48 h, which was accompanied by a 
simultaneous increase in polymer accumulation. The pH of the culture also increased from 7 
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to a maximum of 7.9. The PHA yield was determined every 9 h. In case of P(3HO), there was 
no polymer found in the 9 h sample, but a 5.12% dry cell weight (dcw) yield was observed at 
18 h. Following that 11.37% dcw and 21.65% dcw polymer yield was obtained at 27 h and  
36 h respectively. A maximum polymer yield of 45.76% dcw was obtained at 48 h. 
 
Figure 3.1: A temporal profile of the fermentation of Pseudomonas mendocina CH50 using 
sodium octanoate as the carbon source. OD at 450 nm, pH, Dry cell weight 
(g/L), nitrogen concentration (g/L) 
 
Production of poly(3-hydroxynonanoate)-co-(3-hydroxyheptanoate), P(3HN-co-3HHP)    
P. mendocina CH50 was grown using sodium nonanoate as the sole carbon source as explained 
in section 2.3.2 for the production of poly(3-hydroxynonanoate)-co-(3-hydroxyheptanoate). 
The fermentation profile is shown in Figure 3.2. Here too a lag phase was observed in the initial 
9 h, with an increase in OD450 from 0.164 to 0.280. After this there was a steady increase in the 
growth and the OD450 value reached a maximum value of 4.2 at 48 h. The biomass was 
estimated to be a maximum of 2.26 g/L at 48 h, which also coincided with time required to 
reach the maximum OD450 value. Nitrogen concentration decreased from the initial value of 
0.503 g/L to 0.333 g/L in 12 h, which further decreased to 0.116 g/L by 27 h and finally 
decreased to 0.0002 g/L by 48 h. The pH of the culture also showed an increase from 7 to a 
maximum of 7.4. The yield for P(3HN-co-3HP) was determined to be 2.34% dcw at 9 h, 6.1% 




Figure 3.2: A temporal profile of the fermentation of Pseudomonas mendocina CH50  using 
sodium nonanoate as the carbon source. OD at 450 nm, pH, Dry cell weight 
(g/L), Nitrogen concentration (g/L) 
 
3.2.2. Characterisation of polymers 
Fourier Transform Infrared spectroscopy (FTIR)  
Preliminary chemical characterisation of the P(3HO) and P(3HN-co-3HHP) produced using 
P.mendocina CH50 was carried out by using ATR-FTIR (Figure 3.3). Presence of 
characteristic MCL-PHA-specific peaks at 1727.97 cm-1 and 1159.15 cm-1, corresponding to 
the ester carbonyl bond and C-O stretching due to vibration was confirmed by the FTIR spectra 
of the polymer (Randriamahefa et al., 2003). In addition, the peaks at 2956, 2927.41 and 
2857.97 cm-1 corresponded to the aliphatic C-H group of the polymer backbone while the peak 








Figure 3.3: FTIR spectra of the polymers. (a) P(3HO) and (b) P(3HN-co-3HHP) with major 





Nuclear Magnetic Resonance spectroscopy (NMR) 
The structure of the MCL-PHA obtained from P.mendocina CH50 when grown using sodium 
octanoate as the sole carbon source was confirmed using 1H and 13C NMR analysis. These 
spectra were analysed and the identification of the PHA was carried out by comparing the 
spectrum obtained with that of the NMR spectra of previously known PHAs. The spectra 
obtained in this case were identical to that obtained previously for P(3HO) as shown in Rai et 
al.,2010. In the 1H NMR spectrum, five peaks were obtained as there are five different 
environments for the protons in P(3HO) as seen in Figure 3.4 (a) and (b). The 1H NMR analysis 
showed the presence of protons bonded to C2 (-CH2 group), C3 (-CH group), C4 (-CH2 group), 
C5, C6, C7 (-CH2 group) and C8(-CH3 group) with chemical shifts of 2.5, 5.2, 1.6, 1.2 and 0.8 
ppm respectively. In the 13C NMR analysis, eight different peaks were obtained corresponding 
to the eight different environments for the carbon atoms in the molecule. The chemical shift at 
169.38 ppm corresponded to C1 (carbon of ester group), 70.82 ppm to C3 (–CH group linked 
to electronegative oxygen of ester group), 39.08 to C2 (-CH2 group), 23 – 35ppm to C4, C5, 
C6, C7 (-CH2 groups) and 13.95 ppm to C8 (-CH3).  These observations confirmed that the 
MCL-PHA produced was P(3HO). 
 
The polymer extracted from P. mendocina CH50 grown in sodium nonanoate was also 
analysed similarly using the 1H and 13C NMR. The proton spectrum showed five different 
environments for the hydrogen in the polymer as shown in the Figure 3.5 (a) and (b). These 
spectra were compared with those seen in Rai et al., 2010. The peak at 5.2 ppm corresponded 
to protons bonded to C3 (-CH group), 2.5 ppm to C2 (-CH2 group), 1.6 ppm to C4 (-CH2 group), 
1.2 ppm to C5 and C6 (-CH2 group of 3HHP), C5, C6, C7, and C8 (-CH2 group of 3HN) and 
0.8 ppm to C7 (-CH3 group of 3HHP) and C9 (-CH3 group of 3HN). The 
13C spectrum, Figure 
6(a), showed 10 peaks, corresponding to 10 different environments for the carbon in the 
extracted polymer. The chemical shift at 169.07 ppm corresponded to C1 (carbon of ester 
group), 71.01 ppm to C3 (–CH group), 39 to C2 (-CH2 group), 33.5 to C4 (-CH2 group), 32 
ppm to C5, (-CH2 group) 28.9 ppm to C6 (-CH2 group of 3HHP), 27 ppm to C6 (-CH2 group 
of 3HN), 25 ppm to C7 (-CH2 group of 3HN), 22.5 ppm to C8 (-CH2 group of 3HN), 13.5 ppm 
to C7 (-CH3 group of 3HHP) and C9 (-CH3 group of 3HN). Hence, it was concluded that the 
monomers present in the polymer were 3-hydroxyheptanoate and 3-hydroxynonanoate. Hence 
the copolymer produced was P(3HN-co-3HHP). 
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Hence, the 1H and 13C NMR spectra of the PHAs obtained using sodium octanoate and sodium 
nonanoate as the sole carbon source confirmed that the PHAs produced were poly(3-
hydroxyoctanoate), P(3HO) and poly(3-hydroxynonanoate-co-3-hydroxyheptanoate) (P(3HN-





Figure 3.4: (a) The 13C NMR of P(3HO). (b)The 1H NMR of P(3HO) confirming the polymer 
to be the homopolymer P(3HO). The structure of P(3HO) is shown as an insert within the 
spectra. 







Figure 3.5: (a) The 13C NMR of P(3HN-co-3HHP). (b)The 1H NMR of P(3HN-co-3HHP) 
confirming the polymer to be the copolymer P(3HN-co-3HHP). The structure of P(3HN-co-




Preparation of neat and blend 2D scaffolds using P(3HO) and P(3HN-co-3HHP) for use 
as cardiac patches 
P(3HO) and P(3HN-co-3HHP) were blended together in different ratios and films were cast in 
perti dishes using solvent cast technology. These 2D scaffolds were prepared with different 
ratios of P(3HO) and P(3HN-co-3HHP) which are 100:0, 20:80, 50:50, 80:20 and 0:100, were 
air dried for 2 weeks and further freeze dried for a week. In this thesis, HO will be used to 
represent neat P(3HO) scaffolds,  HO:HN(20:80) will be used to represent P(3HO):P(3HN-co-
3HHP) (20:80) scaffolds, HO:HN(50:50) will be used to represent P(3HO):P(3HN-co-3HHP) 
(50:50) scaffolds, HO:HN(80:20) is used to represent P(3HO):P(3HN-co-3HHP) (80:20) 
scaffolds and HN will be used to represent P(3HN-co-3HHP) scaffolds. 
 
Thermal properties of the different polymers 
The thermal properties of neat P(3HO) and P(3HN-co-3HHP) were determined using 
differential scanning calorimetry (DSC) as explained in section 2.4. Differential scanning 
calorimetry (DSC) determines the heat released or absorbed by the material when it undergoes 
phase transformation. The material loses its rigid glassy properties and begins to behave as a 
rubbery polymer at its glass transition temperature, Tg (Sin et al., 2012, Liu et al., 1995). The 
Tg and melting temperature, Tm, for the neat polymers and the blends are shown in Table 3.1, 
Figure 3.6. It can be seen that P(3HO) and P(3HN-co-3HHP) are characterised by low Tg and, 
therefore, they are in a rubbery state at room and body temperatures. The Tg of P(3HN-co-
3HHP) is slightly lower than P(3HO).  
 
The glass transition temperature (Tg) and melting temperature (Tm) values of the 
P(3HO):P(3HN-co-3HHP) blends were found to be low, around -36.3ºC and -38.8 ºC 
respectively. Thus blending the homopolymer P(3HO) and copolymer P(3HN-co-3HHP) 
complicates the stacking of the monomer units. As a result, the free volume increases in 
polymer blends. The lowest Tg was observed for polymer blends with 50:50 of P(3HO) and 
P(3HN-co-3HHP) indicating that in this composition stacking is hindered and the largest free 
volume is achieved. The change in enthalpy (ΔH) at melting was also recorded. The enthalpy 
change gives an idea about the crystallinity of the substance and hence ΔH is directly 
proportional to the degree of crystallinity. From the results obtained, due to the high change in 
enthalpy (ΔH), P(3HO) was found to be the most crystalline material and P(3HO):P(3HN-co-
3HHP) (20:80) was the least crystalline. On comparing only the blends, it was observed that 
with the increase in P(3HO) there was an observed increase in the ΔH  and hence also the 
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degree of crystallinity, where P(3HO):P(3HN-co-3HHP) (20:80) was the least crystalline and 
P(3HO):P(3HN-co-3HHP) (80:20) was the most crystalline. 
 
Table 3.1: The Tg and Tm and ΔH values of the neat P(3HO), P(3HO):P(3HN-co-3HHP) 





    
 Tg (°C)   Tm (°C) ΔH (J/g) 
 P(3HO)    -36.3  59.3 20.3 
 P(3HO):P(3HN-co-3HHP) (80:20)    -36.6 
  
 59.3 17.2 
 P(3HO):P(3HN-co-3HHP) (50:50)   -38.8  57.8 16.4 
 P(3HO):P(3HN-co-3HHP) (20:80)   -37.8  55.0 12.0 




Figure 3.6: DSC curves of the neat P(3HO), P(3HO):P(3HN-co-3HHP) (80:20), 








The mechanical properties of the neat and the blend films were measured using the Instron as 
described in section 2.4. The tensile testing results are summarised in Table 3.2 and Figure 3.7. 
Both the neat polymers were found to be highly elastomeric in nature with an elongation at 
break value of around 700%. P(3HO) was found to be more stiff than P(3HN-co-3HHP), but  
these polymers had similar values of tensile strength. All the three blends were found to be 
stiffer and less elastomeric materials than the neat polymers with higher Young’s modulus 
values and lower elongation at break values (Table 3.2, Figure 3.7). More than two times 
increase in stiffness was achieved for P(3HO):P(3HN-co-3HHP) (80:20) as compared to the 
neat P(3HO). Out of all the scaffolds, the 20:80 blend of P(3HO) and P(3HN-co-3HHP) was 
found to have the lowest tensile strength and stiffness. These results indicate that by combining 
and blending the two polymers it is possible to alter the mechanical properties of the neat 
polymers and achieve a scaffold of desirable mechanical values.  
 
Table 3.2: Mechanical properties of the solvent cast neat polymer and polymer blend scaffolds; 










P(3HO) 8.61.0 10.42.6 700100 
P(3HO):P(3HN-co-3HHP) (80:20) 20.01.6 12.01.6 44030 
P(3HO):P(3HN-co-3HHP) (50:50) 12.20.8 9.71.9 50070 
P(3HO):P(3HN-co-3HHP) (20:80) 11.81.0 8.30.8 51025 





Figure 3.7: Stress vs Strain graph depicting the mechanical properties of  the neat P(3HO), 
P(3HO):P(3HN-co-3HHP) (80:20), P(3HO):P(3HN-co-3HHP) (50:50), P(3HO):P(3HN-co-
3HHP) (20:80) and neat P(3HN-co-3HHP) (n=5) 
  
Wettability analysis 
The surface hydrophilicity / hydrophobicity of the films was determined by measuring the 
water contact angle of the films (Table 3.3). Polymer films with θ values less than 70○ are 
considered to be hydrophilic in nature whereas θ values greater than 70○ are considered to be 
hydrophobic in nature (Wang et al., 2008). All the scaffolds had almost similar water contact 
angle values as shown in Table 3.3. 
Table 3.3: Table depicting water contact angle values (θ) of the neat P(3HO), P(3HO):P(3HN-
co-3HHP) (80:20), P(3HO):P(3HN-co-3HHP) (50:50), P(3HO):P(3HN-co-3HHP) (20:80) 
and neat P(3HN-co-3HHP) films. (n=9). 
Samples Water contact angle (º) 
P(3HO) 101.11.5 
P(3HO):P(3HN-co-3HHP) (80:20) 100.75.0 
P(3HO):P(3HN-co-3HHP) (50:50) 94.94.6 






Scanning electron microscopy 
The surface analysis of the neat and blend films revealed that both neat and blend films had a 
smooth, uniform and regular surface (Figure 3.8). These results were similar to that of Rai et 
al., 2011, where P(3HO) films were described to be smooth and without any grooves.  
 
Figure 3.8: SEM images of the scaffolds: (a) Neat P(3HO) scaffold, (b) Neat P(3HN-co-3HHP) 
scaffold, (c) P(3HO):P(3HN-co-3HHP) blend (80:20), (d) P(3HO)/P(3N-co-3HHP) blend  
(50:50) and (e) P(3HO)/P(3N-co-3HHP) blend (20:80).  
 
3.2.3. In vitro degradation study 
In vitro degradation study was carried out for the neat and blend P(3HO) and P(3HN-co-3HHP) 
polymer films. The film strips were cut and immersed in 1 ml of PBS. Measurements at specific 
time periods of 1, 2 and 3 months. % Water uptake, % weight loss, and pH change were 
measured. 
 
Water uptake of the degrading films 
The film strips were immersed in PBS and the strips were weighed after wiping the excess 
PBS. The water uptake was measured as explained in section 2.4. The final % water uptake 
was recorded for a period of 3 months and was observed to increase in the following order 
(Figure 3.9): P(3HO):P(3HN-co-3HHP) (80:20) 2.5% < P(3HO):P(3HN-co-3HHP) (50:50) 






Figure 3.9: Water uptake by the neat P(3HO), neat P(3HN-co-3HHP), P(3HO):P(3HN-co-
3HHP) blend film (80:20), P(3HO):P(3N-co-3HHP) blend film (50:50) and P(3HO):P(3HN-
co-3HHP) blend film (20:80) during the degradation study in PBS media for a period of  
3 months. (n=3), no significant difference, ANOVA. HO is used to represent the neat P(3HO) 
scaffolds,  HO:HN(20:80) is used to represent P(3HO):P(3HN-co-3HHP) (20:80) scaffolds, 
HO:HN(50:50) is used to represent P(3HO):P(3HN-co-3HHP) (50:50) scaffolds, 
HO:HN(80:20) is used to represent P(3HO):P(3HN-co-3HHP) (80:20) scaffolds and HN is 
used to represent the P(3HN-co-3HHP) scaffolds. This nomenclature will be used in all the 
figures in this thesis.  represents 1st month, represents 2nd month and 
represents 3rd month.  
 
Weight loss of the degrading films 
The wet strips were dried by keeping them in an incubator at 37ºC for 2 days. The weight loss 
was calculated as mentioned in section 2.4.  The final % weight loss observed (Figure 3.10), 
by the end of 3 months, was observed to decrease in the following order  P(3HO):P(3HN-co-







Figure 3.10: Weight loss by the degrading neat P(3HO) scaffold, P(3HO):P(3HN-co-3HHP) 
blend scaffold (80:20),  P(3HO):P(3HN-co-3HHP) blend scaffold (50:50), P(3HO):P(3HN-
co-3HHP) blend scaffold (20:80)and neat P(3HN-co-3HHP), in PBS media for a period of 3 
months. (n=3), *p<0.05,**p<0.001, ANOVA. represents 1st month, represents 2nd 
month and represents 3rd month. 
  
pH measurements of the degrading films 
The pH was also recorded by measuring the pH of PBS at the specified time points of 1, 2 and 
3 months as explained in section 2.4. The pH of the media in all the films was observed to 
decrease in the course of 3 months from 7.4 to around 6.9. All the films recorded a similar final 




Figure  3.11: pH measurements of neat P(3HO), P(3HO):P(3HN-co-3HHP) blend scaffold 
(80:20), P(3HO):P(3HN-co-3HHP) blend scaffold (50:50), P(3HO):P(3HN-co-3HHP) blend 
scaffold (20:80) and neat P(3HN-co-3HHP) during the degradation study in PBS for a period 
of 3 months. (n=3), *p<0.05,**p<0.001, ANOVA..  represents 1st month,  
represents 2nd month,  represents 3rd month. 
 
3.2.4. In vitro biocompatibility study by growing induced pluripotent stem cell derived 
cardiomyocytes (iPSC-CMs) 
The human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs) were seeded 
on coverslips coated with P(3HO), P(3HN-co-3HHP) and the blends of the two polymers. The 
cells were simultaneously also seeded on 0.1% gelatin which was used as positive control. The 
cells were analysed on day 14 for various parameters including cell viability using Live/Dead 
assay, phenotypic analysis (structural similarity as compared to control) by 
immunofluorescence staining, beating rates, calcium transient analysis, sarcomere length and 
nuclear density.   
 
Live and dead assay 
The live and dead assay was conducted on day 14 on the positive control (gelatin), P(3HO), 
P(3HN-co-3HHP) and the blend scaffolds (Figure 3.12). The live cells took up the dye and 
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fluoresced, exhibiting green colour while the dead cells exhibited red colour. It was observed 
that the cells on both, the gelatin and PHA scaffolds showed large patches of live (green) cells 
as compared to the dead (red) cells and exhibited uptake of the dye. hiPSC-CMs were cultured 
for 14 days on the neat and blend films of P(3HO) and P(3HN-co-3HHP). The number of live 
and dead cells remained unchanged on the scaffolds indicating they were all suitable for cardiac 
tissue engineering (Figure 3.13).  
 
Figure 3.12: Representative images of hiPSC-CMs on control gelatin, neat P(3HO),  
P(3HO):P(3HN-co-3HHP) 80:20, P(3HO):P(3HN-co-3HHP) 50:50, P(3HO):P(3HN-co- 
3HHP) 20:80, neat P(3HN-co-3HHP). The green indicator is Calcein AM that designates live 




Figure 3.13: Quantification of the cell viability of live  and dead  cells on the polymer 
blends including gelatin as positive control, P(3HO), P(3HO):P(3HN-co-3HHP) (80:20), 
P(3HO):P(3HN-co-3HHP) (50:50), P(3HO):P(3HN-co-3HHP) (20:80), P(3HN-co-3HHP) 
(n=6), no significant difference, ANOVA. 
 
Beat rate measurement 
Each polymer blend has a different elasticity, which could impact the hiPSC-CM phenotype, 
hence beat rate measurements were made. There was a significant increase in the beat rate of 
hiPSC-CMs cultured on the more elastic P(3HN-co-3HHP) scaffold in comparison to gelatin 
or P(3HO). The beat rate of cells grown on all the other PHA scaffolds were comparable to that 





Figure 3.14: Quantification of the number of beats per minute on the polymer blends including 
gelatin as positive control, P(3HO), P(3HO):P(3HN-co-3HHP) (80:20), P(3HO):P(3HN-co-
3HHP) (50:50), P(3HO):P(3HN-co-3HHP) (20:80), P(3HN-co-3HHP). (n=6, *** p<0.001, 
ANOVA) 
 
Calcium transient studies 
The effect of calcium transients on the contractions of hiPSC-CM was also studied on all the 
scaffolds and different parameters were analysed. These experiments were conducted along 
with Ms. Eleanor Humphrey at National Lung and Heart Institute (NHLI), Imperial College. 
At 1Hz stimulation, it was observed that there was a significant decrease in the fluorescent 
amplitude and time to transient peak in hiPSC-CMs cultured on P(3HN-co-3HHP) as compared 
to gelatin and P(3HO) (Figure 3.15(a)). The time to decay 50% was similar for all the scaffolds 
and the time to decay 90% was observed to be significantly lower for P(3HO) in comparision 
with control gelatin. At the 1.5Hz stimulation, the time to transit peak in hiPSC-CMs cultured 
on P(3HN-co-3HHP) was lower than that observed on control gelatin and P(3HO). Also, the 
value observed for P(3HO)  was lower than that observed on gelatin (Figure 3.15(b)). However, 
there was no significant change observed in fluorescent amplitude, time to 50% decay and time 









Figure 3.15: Fluorescence amplitude (f/ f0), time to peak (Tp), time to 50% decay (T50) and 
90% decay (T90) of the calcium transient in cells field stimulated at (A) 1Hz and (B) 1.5 Hz. 
(n= 6), * p<0.05, *** p<0.001, ANOVA. 
 
Sarcomere length and nuclei density 
The ultrastructure of the cells were analysed by studying the length of the sarcomeres and the 
nuclei density. This work was also conducted along with Ms. Eleanor Humphrey at National 
Lung and Heart Institute (NHLI), Imperial College. There was a significant increase in the 
nuclei density in hiPSC-CMs grown on P(3HN-co-3HHP) compared to gelatin and P(3HO) 
(Figure 3.16). No significant difference in sarcomere length was observed. The length of the 
sarcomeres observed in all the scaffolds was around 2µm. (Figure 3.17 and Figure 3.18). 
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Figure 3.16: Quantification of the nuclei density in hiPSC-CMs on polymer blends including 
control, P(3HO), P(3HO):P(3HN-co-3HHP) (80:20), P(3HO):P(3HN-co-3HHP) (50:50), 
P(3HO):P(3HN-co-3HHP) (20:80), P(3HN-co-3HHP) (n=6, * p<0.05, **p<0.01, ANOVA). 
 
Figure 3.17: Quantification of the sarcomere length in hiPSC-CMs on polymer blends 
including control, P(3HO), P(3HO):P(3HN-co-3HHP) (80:20), P(3HO):P(3HN-co-3HHP) 




Figure 3.18: Representative images of hiPSC-CMs on control, P(3HO), P(3HO):P(3HN-co-
3HHP) (80:20), P(3HO):P(3HN-co-3HHP) (50:50), P(3HO):P(3HN-co-3HHP) (20:80), 




P. mendocina CH50 was grown in the presence of two different carbon sources i.e. sodium 
octanoate and sodium nonanoate, and it was found to accumulate different MCL-PHAs which 
were P(3HO) and P(3HN-co-3HHP) respectively. The two fermentations exhibited a similar 
trend in the growth profile. The amount of carbon and nitrogen present in the production 
medium at the beginning of fermentation and also the type of carbon feed provided, plays a 
crucial role in the type of PHA being produced. In the present study, the bacterium was grown 
in media with an initial molar ratio of carbon to nitrogen (C/N) of 20 in both the fermentations. 
The maximum yield of the polymer obtained was approximately 45% dcw in both cases. The 
C/N ratio is known to play a very important role in the growth and PHA accumulation of PHA-
producing bacteria. Studies carried out on P. stutzeri 1317 showed that there was an 
accumulation of 52% dry cell weight of polymer when grown on glucose and ammonium 
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sulphate at a C/N ratio of 39 (He et al., 1998). In a study conducted by Tian et al., P. mendocina 
CH50 strain 0806 was grown in glucose media. It was observed that with increase in the C/N 
ratio, the PHA formation in the cell was favoured. It was thus concluded that nitrogen limitation 
was a major factor for the triggering of PHA synthesis (Tian et al., 2000). Hence, these studies 
showed that in all cases limiting nitrogen concentration favoured polymer accumulation. In this 
study, for both P(3HO) and P(3HN-co-3HHP) fermentations, the nitrogen concentration was 
seen to decrease drastically until 48 hrs, leading to nitrogen limiting conditions. This promoted 
accumulation of polymer and resulted in an increased polymer yield. 
 
Another parameter which was observed in these fermentations was pH. This parameter is 
known to play an important role in the yield of the polymer which affects both the accumulation 
and degradation of the polymer. The pH of the culture also showed an increase from 7 to a 
maximum of 7.8/7.4. A similar increase in pH was found when Pseudomonas mendocina was 
grown on heptanoate, where the pH of the fermentation media increased from 7 to 7.7 (Rai et 
al., 2011). A study was conducted on P. aeruginosa S2 where the pH of the fermenter was 
maintained at 6.8. The performance of the pH-stat fermenter was found to be better as 
compared to the fed batch process. Hence, pH is one of the most important environmental 
parameters of PHA fermentation (Chen et al., 2007).  
 
It can be seen that P(3HO) and P(3HN-co-3HHP) are characterised by low Tg and, therefore, 
they are in a rubbery state at room and body temperatures. The Tg of P(3HN-co-3HHP) was 
slightly lower than P(3HO). The Tg and Tm of polymers are governed by the molecular structure 
of the polymer. The Tg value of MCL-PHAs are known to decrease with an increase in the 
number of carbon atoms in the monomeric unit, which in turn leads to an increase in the length 
of the side chain. The latter leads to poor stacking of the polymer chains (larger free volume) 
resulting in higher mobility of the polymer chains, leading to lower Tg values (Walle et al., 
2001). Hence, P(3HO) with a C8 monomeric unit, is  expected to have a higher Tg value that 
that of P(3HN-co-3HHP), a copolymer of C7 and C9 monomeric units, as observed in this study. 
In a similar study, P. oleovorans was grown on n-alkanoates by Gross et al. (Gross et al., 1989), 
which led to the production of PHAs with monomers ranging from C6-C10 carbon units. The 
Tg value of the PHA produced when hexanoate was used as carbon source (Tg = -25ºC) was as 
predicted, higher than that of the polymer produced using decanoate as the sole carbon source 




The Tg and Tm values of the P(3HO):P(3HN-co-3HHP) blends were found to be lower as 
compared to the values for the neat polymers. Thus blending a homo-PHA and the copolymer 
PHA complicates the stacking of monomer units. As a result, free volume increased in the 
polymer blends. The lowest Tg was observed for polymer blends with equal amounts of P(3HO) 
and P(3HN-co-3HHP) indicating that in this composition stacking was hindered and the largest 
free volume was achieved. When the polymer blend was dominated by one of components free 
volume decreased and the Tg increased. An important point to note is that all the blends had 
one value of Tg which indicated that the blends were indeed miscible blends. Similar results 
were observed when a blend of PVC/PHA was prepared by Hill et al. The Tg was found to be 
lowered with the insertion of oligomeric PHA groups as compared to the polymeric PHA. The 
presence of a single, composition-dependent Tg in the blends was used to classify the blends 
as miscible (Hill et al., 1996). MCL-PHAs crystallize very slowly and some copolymers do not 
crystallize at all, hence, for these polymers no Tm values were observed. Choi et al., 1994, 
observed no Tm when they characterized the polymer produced by P. citronellois using 
heptanoate as the sole carbon source. In this study, however, both the MCL-PHAs and their 
blends had a characteristic value of Tm. Thus, the thermal properties of PHAs depend on the 
monomeric units incorporated within the polymer which in turn depends on the carbon source 
used for their production. These properties are crucial for the processability and hence the 
applicability of the polymer produced. 
 
The stress-strain curves for neat P(3HO), P(3HN-co-3HHP) and P(3HO):P(3HN-co-3HHP) 
blends were used to determine the mechanical properties of the polymers. All the scaffolds 
were elastomeric nature with high elongation at break values, making them all highly suitable 
for cardiac patch development. However, the neat polymers were slightly more elastomeric in 
nature than the blends. Stiffness is another important mechanical property for a cardiac patch. 
Amongst all the scaffolds, the 80:20 blend of P(3HO) and P(3HN-co-3HHP) was found to have 
the highest Young’s modulus value and hence was the stiffest of all the blends. Within the 
blends an increase in stiffness was observed with increase in P(3HO) content, i.e. the MCL 
PHA with a smaller pendant group. At the molecular level, large pendant side groups in P(3HN-
co-3HHP) make it difficult to have a close packing in a regular three dimensional fashion to 
form a crystalline array (Preusting et al., 1990; Sánchez et al., 2003). While P(3HO), with 
small pendant groups, can accommodate easily within the spaces created by the longer side 
chain, thus creating a packed structure with low mobility of the side chains which increases the 
stiffness of the blend material (Leceta et al., 2015).  Finally, tensile strength was the third 
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mechanical property measured for the different types of scaffolds.  The 80:20 blend of P(3HO) 
and P(3HN-co-3HHP) was also found to have the highest tensile strength. Thus, the strength 
of the material also increased due to the close stacking of the polymeric side chains in this 
blend, leading to an increase in the load carrying capacity of the material. These results thus 
confirm that the blending of P(3HN-co-3HHP) to P(3HO) can be used to predictably change 
the stiffness and tensile strength of the blends. The mechanical properties of human myocardial 
tissue include a Young’s modulus value of 0.2- 0.5 MPa, elongation at break 100-300% and 
tensile strength 3-15 KPa. (Watanabe et al., 2006). Hence, the elongation at break of the 
P(3HO):P(3HN-co-3HHP) (80:20) blend was similar to that of the myocardial tissue. However, 
the Young’s modulus and tensile strength values obtained for these scaffolds in the form of 
films are not in the range of the myocardial tissue. These values are expected to decrease with 
the incorporation of porosity within the scaffolds. Further, higher Young’s modulus, tensile 
strength and elongation at break value of the scaffold might have a positive effect on the 
infarcted heart as after myocardial infarction, the abrupt loss of myocardium triggers 
ventricular remodelling which includes dilatation, hypertrophy, and the formation of a collagen 
based scar that increases the load on the infracted region (Martin et al., 2000).  
 
All the scaffolds described in this chapter exhibited similar water contact angle values of 
around 100º, indicating a high degree of hydrophobicity in all the scaffolds. It is expected that 
the cellular environment around cardiac tissue being hydrophilic, the surface of the scaffold 
should be hydrophilic in order to allow interaction of various proteins with the scaffold and 
promote cell attachment. But the in vitro interactions of the PHA scaffolds and the 
cardiomyocytes have been found to be very promising, in fact in some cases out-performing 
the positive control for cell attachment and viability. Possibly, proteins within the in vitro 
culture conditions bind to the PHA scaffolds in such a manner, that they create a hydrophilic 
conducive environment for the cellular interaction. This aspect will also be researched in future 
(Fields et al., 1998; Altankov et al., 1996). 
 
Surface roughness is an important parameter for cell proliferation and differentiation. It is 
known that increase in surface roughness enhances cell adhesion and proliferation (Deligianni 
et al., 2000). Hence, further experiments will be conducted to improve the surface roughness 
of the scaffolds by incorporating porosity, physical and chemical functionalization of the 
polymer. For example, Rai et al., 2010 demonstrated that there was a change in the surface 
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topography of the P(3HO)/n-BG  composite  film  due  to  the  addition  of nano-bioactive  
glass (n-BG) particles within the P(3HO) matrix which led to enhanced cell adhesion.  
 
The scaffolds were subjected to in vitro degradation in PBS and water uptake, weight loss and 
pH change were recorded for 3 months. A slow degradation process was observed for all the 
films. There are several factors which govern the rate of degradation of a polymer including 
crystallinity, steric hindrance caused due to bulky groups and their stacking behaviour and 
copolymer composition (Wang et al., 2004, Gijpferich et al., 1996). Water uptake is an 
important process that speeds up the degradation process. This was found to increase in case 
of all MCL-PHAs over the period of 3 months. It is extremely difficult to penetrate into the 
hydrophobic environment of a polymer (Renard et al., 2004). Hence, we observed a very low 
water uptake in this study, maximum being 4% for P(3HO). This is possibly because P(3HO) 
has the least bulky pendant group, allowing water absorption by the film surface. Minimum 
absorption was observed in the case of P(3HO):P(3HN-co-3HHP) (80:20) due to the steric 
hindrance and close stacking of the side chains. The degradation rate and weight loss of the 
polymer films is also affected by crystallinity, as mentioned above. The higher the crystallinity 
of the substance, the slower is the degradation process. The enthalpy of melting (ΔH) is directly 
proportional to the degree of crystallinity of the polymer. Hence the P(3HO):P(3HN-co-3HHP) 
(20:80)  blend with the lowest  value of  H, had the lowest crystallinity and hence degraded 
fastest among all the blends. This blend was also observed to have the lowest Tm. It has been 
observed, that materials with lower melting temperatures have higher biodegradability (Tokiwa 
et al., 2004). Hence, based on the combined effects of Tm, crystallinity, hydrophobicity of the 
alkyl pendant group, steric hindrance and stacking of the copolymer chains, the weight loss in 
the scaffolds were observed to be in the following order: P(3HO):P(3HN-co-3HHP)(20:80) > 
P(3HO) > P(3HN-co-3HHP) > P(3HO):P(3HN-co-3HHP)(50:50) > P(3HO):P(3HN-co-
3HHP) (80:20). The pH of the media with the degrading films was observed to decrease with 
time but it was not significantly low. This can be explained as the degrading films release the 
monomers of the polymer including 3-hydroxyoctanoic acid and 3-hydroxynonanoic acid and 
3-hydroxyheptanoic acid. These monomers exist in their acidic form which slightly decreases 
the pH of the media. A decrease was also observed during the degradation of PLA where the 
monomer lactic acid were released (Li et al., 2007). However, the decrease of pH observed for 
PHAs is much lower than that observed for PLA, where the final pH of the media with 
degrading PLA film had the pH of 1.8 as compared to that of 6.9 for the PHA scaffolds. Hence, 
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PHAs are considered to be better than PLA for tissue engineering applications (Gijpferich et 
al., 1996). 
 
In vitro cell culture studies were conducted on the scaffolds using hiPSC-CMs which were 
seeded on the scaffolds and cell viability and physiology was examined. These studies showed 
that there were similar number of live cells on all the scaffolds and were comparable to the 
positive control gelatin. Hence, the PHA scaffolds are indeed promising biomaterials for 
cardiac tissue engineering. Basnett et al., performed indirect cytotoxicity experiments with 
P(3HO)/P(3HB) blend films and neat P(3HO) films using human microvascular endothelial 
cells (HMEC-1). There was no observed cytotoxicity and hence no toxic by-products were 
released from the films (Basnett et al., 2013).  
 
Further to the in vitro cell viability, the functioning of the cells was analysed by measuring the 
beating rate of the cardiomyocytes. Engler et al., 2008 have shown that the culturing of 
embryonic cardiomyocytes on a series of substrates of different elasticity had a significant 
effect in the transmission of contractile function and that cells in a rigid matrix are deficient in 
the assembly of contractile proteins and their beating frequency slows down over time. As a 
result, the extracellular matrix to which cardiomyocytes attach is a key factor for a highly 
regulated system such as the heart. It was observed that there was an increase in the beating 
rate of hiPSC-CMs cultured on P(3HN-co-3HHP) in comparison to the positive control, 
gelatin. The beat rate observed on all other scaffolds were similar to that on gelatin. This 
increase in beating rate could be due to immature pacemaker mechanisms in terms of the 
activity of the hyperpolarisation-activated pacemaker (If) or the inward rectifier potassium (IK1) 
currents, leading to spontaneous activity in the cells (Kim et al. 2015). So following on from 
this result, it is important to study the calcium transients in these cells on the scaffolds. 
  
It has been studied that the increase in intracellular calcium levels lead to an increase in the 
contraction force which results in a higher contraction amplitude until the calcium levels 
reached a saturation point and the contraction force declined. This is a continuous process 
which controls the cardiac contractions (Bers, 2000). In the experiments carried out in this 
work, there was a decrease in the fluorescence amplitude in the P(3HN-co-3HHP) as compared 
to the control, gelatin and P(3HO), at a frequency of 1Hz but no difference was observed at 1.5 
Hz. The decrease in calcium transient amplitude indicated that there might be a decrease in the 
cytosolic calcium levels on this scaffold, which suggests that the sarcoplasmic reticulum (SR) 
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is less developed and so does not release much calcium through the process of calcium-induced 
calcium release (Dolnikov et al. 2006). At 1.5 Hz a significant decrease was observed for the 
time to transient peak on P(3HN-co-3HHP) and P(3HO) as compared to gelatin. This shorter 
time to transient peak could also be explained due to the general reduction in cytosolic calcium 
in the cell (Galie et al. 2013).  These results showed that the scaffolds did not have an adverse 
effect on the calcium concentrations, supported the calcium exchange within the cell tubules 
and promoted contractions.  
 
The length of the sarcomeres and the nuclei density are responsible for the cardiomyocyte 
contraction and maturation of the cells respectively. Thee parameters were observed on the 
hiPSC-CMs grown on the different PHA scaffolds. The sarcomere length was observed to be 
similar on all the scaffolds which was around 2 μm. In adult human myocardium, the length of 
the sarcomere was observed to be around 2.2 μm while that on immature cardiomyocytes were 
around 1.65 μm, hence it was concluded that the hiPSC-CMs on the PHA scaffolds exhibited 
the physiology of adult cardiomyocytes (Bird et al., 2003; Lundy et al. 2013). The sarcomeres 
observed on the PHA scaffolds, did not exhibit anisotropy and were seen to be randomly 
oriented. The sarcomeres are aligned in the adult native myocardium, enabling them to generate 
a great force of contraction (Bird et al., 2003). Thus anisotropy is required for efficient 
functionality of the cardiomyocytes. There was an increase in the nuclei density observed on 
the P(3HN-co-3HHP) scaffold as compared to the P(3HO) scaffold. Since there were similar 
number of cells observed on all the scaffolds, it can be suggested that most of the cells on 
P(3HN-co-3HHP) were binucleated. Adult cardiomyocytes often exhibit binucleation, so it 
could be suggested that the hiPSC-CMs on P(3HN-co-3HHP) scaffolds were more mature than 
those on P(3HO) (Olivetti et al. 1996; Brodsky et al. 1991; Soonpaa et al. 1996).  
 
In conclusion, the polymers P(3HO) and P(3HN-co-3HHP) were produced using Pseudomonas 
mendocina CH50.  Neat polymer 2D scaffolds and their blends were produced and extensively 
characterised with respect to their chemical, thermal and mechanical properties. These films 
have also been proven to be excellent materials for the adhesion and proliferation of human 
induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs) and even showed higher 
biocompatibility than gelatin, the positive control. The sarcomeres observed on the scaffolds, 
exhibited adult myocardium like characteristics which confirmed that the PHA scaffolds are 
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Numerous techniques can be used to generate cell culture scaffolds such as electrospinning and 
micropatterning which mimic the extracellular matrix and enhance cell attachment. In this 
study electrospinning was used to generate random and aligned fibres. Electrospinning has 
received much attention for biomedical applications mainly due to a growing interest in 
nanotechnologies and their unique material properties. Electrospinning is an established 
method to create nanoscale polymer fibres with diameter range from 3–5000nm. Nanofibres 
are suitable to mimic the biological environment because they are in the same scale as 
biological molecules. In fact, nanomaterials like nanoparticles, nanofibrous morphologies or 
other complex forms, have been shown to result in improved interaction with cells, for 
example, selective endocytosis, adhesion and orientation (Kim et al., 2006). 
 
In this chapter, random and aligned Poly(3-hydroxyoctanoate)/Poly(3-hydroxynonanoate-co-
3-hydroxyheptanoate), P(3HO):P(3HN-co-3HHP), neat and blend electrospun fibres were 
fabricated, as a potential to be used in cardiac patch development. P(3HN-co-3HHP) was 
blended with P(3HO) in order to alter P(3HO) properties to further closely mimic that of 
myocardial tissue. Addition of P(3HN-co-3HHP) provides a tool for the introduction of a subtle 
variation in material properties, biocompatibility and biodegradation. The solvent cast patches 
have been previously characterised with respect to their mechanical, thermal and surface 
microstructural properties as described in Chapter 3. In this Chapter, in vitro cytocompatibility 
of the patches was assessed using human induced pluripotent stem cell-derived-
cardiomyocytes, hiPSC-CMs.  The electrospun fibre mats provide a substrate which would 
promote the anisotropy of the hiPSC-CMs, a feature essential to their functionality. A 
comparative study has been conducted on the cell growth, orientation and function on the 
random and aligned fibres. 
 
4.2. Results 
4.2.1. Fabrication and morphological characterization of electrospun random fibres 
Random fibres were electrospun using neat P(3HO) and P(3HN-co-3HHP) and blends in the 
ratio of 20:80, 50:50, 80:20 respectively. The polymer fibres were electrospun as described in 
section 2.3. The electrospinning parameters and conditions were optimized for the formation 
of bead-free smooth and uniform fibres. The fibres were distributed in random directions. The 
optical images (Figure. 4.1) show the examples of electrospun fibre matrices. (It is very 
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difficult to image MCL-PHAs using SEM. These polymers have low melting points and melt 
when bombarded with high energy electron beams) Samples from the same batch were used 
for seeding the cells. The water contact angle of a scaffold changes with surface topography 
and the chemical composition of the material in consideration.  The water contact angle of the 
PHA fibres are summarised in Table 4.1. It is known that materials with water contact angles 
above 70º are hydrophobic in nature while those below are hydrophilic (Wang et al., 2008). 
The water contact angle of all the fibres was observed to be above 100º and so they were all 
hydrophobic in nature. 
 
Figure 4.1: Representative optical images of the electrospun random fibres of the P(3HO), 
P(3HO):P(3HN-co-3HHP) (80:20). All the other blends P(3HO):P(3HN-co-3HHP) (50:50), 
P(3HO):P(3HN-co-3HHP) (20:80) and neat P(3HN-co-3HHP) also looked similar.  
 
 
Table 4.1: Table summarising water contact angle values (θ) of the neat P(3HO), 
P(3HO):P(3HN-co-3HHP) (80:20), P(3HO):P(3HN-co-3HHP) (50:50), P(3HO):P(3HN-co-
3HHP) (20:80) and neat P(3HN-co-3HHP) fibres (n=5) 
Samples Water contact angle (º) 
P(3HO) 104.8±3.8 
P(3HO):P(3HN-co-3HHP) (80:20) 106.6±9.3 
P(3HO):P(3HN-co-3HHP) (50:50) 101.3±3.7 






4.2.2. In vitro biocompatibility of hiPSC-CMs on the random fibres 
The hiPSC-CMs were grown on the random fibres and live and dead assay was conducted to 
evaluate the viability of the cells (Figure 4.2). In the random fibre scaffold it was observed that 
neat P(3HO) and P(3HN-co-3HHP) showed significantly higher cell viability in comparision 
to all the blend scaffolds. P(3HN-co-3HHP) also showed significantly higher % cell viability 
as compared to the non-fibrous gelatin (Figure 4.3).   
 
Figure 4.2: Representative images of live (green) and dead (red) hiPSC-CM cells as grown on 
the control, gelatin, neat P(3HO), neat P(3HN-co-3HHP), P(3HO):P(3HN-co-3HHP) (20:80), 







Figure 4.3: Quantification of the % cell viability of live   and dead  cells grown on 
the control, gelatin, neat P(3HO), P(3HO):P(3HN-co-3HHP) (80:20), P(3HO):P(3HN-co-
3HHP) (50:50), P(3HO):P(3HN-co-3HHP) (20:80) and neat P(3HN-co-3HHP) random fibres 
(n=6) *p<0.05, **p<0.001, ANOVA. 
 
Beat rate analysis 
The beat rate of the cells was also measured as described in section 2.4. The beating rates 
measured are shown in Figure 4.4. All the beating rates were similar to that observed on gelatin. 
Thus, the beat rate of the cells did not show any anomalous behaviour when compared with 
that on gelatin, which was used as a positive control. 
 
Figure 4.4: Graph depicting the beat rate of the hiPSC-CMs grown on gelatin, neat P(3HO), 
P(3HO):P(3HN-co-3HHP) (80:20), P(3HO):P(3HN-co-3HHP) (50:50), P(3HO):P(3HN-co-





The SEM analysis was also carried out on the hiPSC-CM cells grown on the scaffold surface 
in order to observe the surface topography and attachment and proliferation of the cells. The 
cells were seen to attach and grow on all the different types of PHA fibres including P(3HO), 
P(3HO):P(3HN-co-3HHP) (80:20), P(3HO):P(3HN-co-3HHP) (50:50), P(3HO):P(3HN-co-
3HHP) (20:80) and P(3HN-co-3HHP). (Figure 4.5).  
  
 
Figure 4.5: Representative SEM image of the growth and proliferation of the hiPSC-CMs on 
random PHA fibres.  
 
Immunofluorescence staining 
Immunofluorescence staining was carried out on the cells by staining the filamentous actin (F-
actin), myosin heavy chain (MHC) and nuclei. The staining showed the arrangement of the 
structural proteins (F-actin in green and MHC in red) along with the nuclei (Figure 4.6). The 
staining on the fibres was very similar to that observed on gelatin. Hence, the phenotypic 




Figure 4.6: Images of immunofluorescence staining of hiPSC-CMs for various cardiac 
proteins such as F-actin (green), MHC (red) and nuclei (blue) grown on the positive control, 
gelatin, neat P(3HO), neat P(3HN-co-3HHP), P(3HO):P(3HN-co-3HHP) (20:80), 
P(3HO):P(3HN-co-3HHP) (50:50) and P(3HO):P(3HN-co-3HHP) (80:20) random fibres. 
 
4.2.3. Aligned fibres 
Fabrication of aligned fibres of the neat and blend polymers 
Fibres of neat P(3HO) and P(3HN-co-3HHP) and blends in the ratio of 20:80, 50:50 and 80:20 
were electrospun in an aligned manner on coverslips. The light microscope was used to observe 
the fibres which looked well aligned (Figure 4.7). A water contact angle study was carried out 
on the fibres and as shown in the Table 4.2 it was seen that all the fibres had a water contact 
angle of around 100º which indicated that scaffolds were hydrophobic in nature. 
 
 
Figure 4.7: Representative optical images of electrospun P(3HO):P(3HN-co-3HHP) (80:20) 
and P(3HO):P(3HN-co-3HHP) (50:50) with similar images observed in P(3HO), 





Table 4.2: Water contact angle measurement for the P(3HO), P(3HO):P(3HN-co-3HHP) 
(80:20), P(3HO):P(3HN-co-3HHP) (50:50), P(3HO):P(3HN-co-3HHP) (20:80) and neat 
P(3HN-co-3HHP) aligned fibres. (n=5) 
Samples Water contact angle (º) 
P(3HO) 101.11.9 
P(3HO):P(3HN-co-3HHP) (80:20) 100.53.5 
P(3HO):P(3HN-co-3HHP) (50:50) 95.54.0 
P(3HO):P(3HN-co-3HHP) (20:80) 99.06.0 
P(3HN-co-3HHP) 97.510.2 
 
In vitro biocompatibility and anisotropy of the cells on the aligned fibres 
Live and Dead assay 
The live and dead assay was conducted on the hiPSC-CMs grown on the aligned fibres, gelatin, 
which was used as a positive control and the number of cells were counted. Image of the cells 
are shown in Figure 4.8. These were further quantified as shown in Figure 4.8. The cell viability 
on the aligned fibres, unlike on the random fibres indicated that there was no change in the % 
cell viability on all the scaffolds and were all comparable to the non-fibrous gelatin which was 
used as a positive control (Figure 4.9).  
 
The cells on the aligned fibres were also seen to be aligned in one direction (Figure 4.8). It was 
further quantified and the percentage of aligned cells with respect to the total number of fibres 
was calculated.  It was recorded that in P(3HO) around 56% cells, in (P(3HO): P(3HN-co-
3HHP)) (80:20) 50% cells, in (P(3HO): P(3HN-co-3HHP)) (50:50) 54% cells, in (P(3HO): 
P(3HN-co-3HHP)) (20:80) 54% cells and in P(3HN-co-3HHP) 44% cells while in non-fibrous 
gelatin 14% cells showed a mean deviation of 0º-10º deviation from the fibres  (Figure 4.10). 




Figure 4.8: Images showing the live (green) and dead (red) hiPSC-CM cells on the control, 
gelatin,  neat P(3HN-co-3HHP), neat P(3HO), P(3HO):P(3HN-co-3HHP) (20:80), 
P(3HO):P(3HN-co-3HHP) (50:50) and P(3HO):P(3HN-co-3HHP) (80:20) aligned fibres as 
positive control. The white arrow shows the alignment of the cells on the individual scaffolds.  
 
 
Figure 4.9: Quantification % cell viability of live  and dead  cells using the live/dead 
assay on cells grown on the control, gelatin, neat P(3HO), neat P(3HO):P(3HN-co-3HHP) 
(80:20), P(3HO):P(3HN-co-3HHP) (50:50) and P(3HO):P(3HN-co-3HHP) (20:80) aligned 
fibres. (n=6), no significant difference, ANOVA. 
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Figure 4.10: Quantification of the alignment of the cells on non-fibrous gelatin used as control, 
neat P(3HN-co-3HHP)P(3HO), P(3HO):P(3HN-co-3HHP) (20:80), P(3HO):P(3HN-co-
3HHP) (50:50), P(3HO):P(3HN-co-3HHP) (80:20) and neat P(3HO) aligned fibres. 
(n=6),p<0.001, ANOVA. 
 
SEM analysis of the cells on the aligned fibres 
The surface morphology of the cells was observed by SEM analysis and the anisotropic nature 
of the cells was observed by cell elongation on the fibres. Further, it was also observed that the 
cells reached confluence in 14 days and were aligned in a particular direction. The SEM images 




Figure 4.11: Representative image of an SEM micrograph showing the alignment and 
confluence of the cells on the fibres.  
 
Immunofluorescence staining of the hiPSC-CMs on aligned fibres 
The immunofluorescence staining images of the hiPSC-CMs on the aligned fibres show the 
staining of the F-actin, MHC and nuclei. The images indicate that the cytoskeleton of the cells 
comprising of the F-actin have been aligned in a particular direction, thus being directed by the 
scaffold they were seeded on (Figure 4.12).  The cells appear to be elongated in the direction 
of the fibres. 
 
Figure 4.12: Immunofluorescence staining of the cells of hiPSC-CM for various cardiac 
proteins such as F-actin (green), MHC (red) and nuclei (blue) grown on the different aligned 
fibres. The white arrows indicate the directionality of the cells grown on the aligned fibres in 




The extracellular matrix is a complex combination of proteins which serves to enhance cell 
attachment, survival, migration, proliferation and differentiation. Thus, to provide such 
structural support, an engineered scaffold should ideally mimic the structure, morphology, 
chemical and biological signals found in the natural tissue. Electrospinning has been widely 
used to fabricate the structures and scaffolds which fulfil the above mentioned criteria. In this 
work, fibrous scaffolds were fabricated by electrospinning neat P(3HO), P(3HN-co-3HHP) and 
their blends P(3HO):P(3HN-co-3HHP) (80:20), P(3HO):P(3HN-co-3HHP) (50:50), 
P(3HO):P(3HN-co-3HHP) (20:80). Separate studies were conducted on the random and 
aligned fibres of the above mentioned compositions. The fibres were electrospun on the 
coverslips and optical images confirmed the successful formation of the random and aligned 
fibres. As mentioned before, SEM images could not be observed due to the low melting 
temperature of the MCL-PHAs, which led to melting of the MCl-PHAs when bombarded with 
the high energy electron beam. The material characterization including the thermal properties 
and mechanical properties of the solvent cast polymer films were described in Chapter 3. The 
mechanical properties of the fibres could not be measured in this study due to the difficulty in 
removing the fibres from the surface of the coverslips. Few of fibres which were successfully 
removed from the coverslips were very sticky and were difficult to handle for performing the 
tensile tests.  On the other hand, due to the similarity in the polymer material composition of 
the fibres with the plain solvent cast films (fabrication explained in Chapter 3), it can be 
considered that stiffness of the fibres would be in range or lower with that of the plain films. 
Electrospinning introduces porosity in the fibrous scaffold and porosity tends to decrease the 
stiffness of the material in comparison to the plain films (Mogosanu et al., 2014).  
 
The wettability analysis of all the fibres were also carried out. The water contact angles, depend 
on chemical composition and surface topography of the scaffold which hence reflects the 
hydrophilicity of scaffolds, relating to protein absorption and cell attachment (Wang et al. 
2008).  The water contact angle of the random and aligned fibres were observed to be in the 
range of 100º-106º. This indicated that the fibrous scaffolds were hydrophobic in nature.  It is 
known that the contact angle measurements of electospun fibres are not accurate quantitative 
estimates of the degree of hydrophobicity. Due to the surface topography of the fibres and their 
porosity, it can be stated that the results are purely qualitative as the water drop does not make 
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full contact with the polymer surface (Kai et al., 2011). Hence the values obtained in this study 
can be considered to be a qualitative interpretation of the hydrophobicity of the fibres. 
 
In vitro biocompatibility studies were conducted on the random and aligned fibres by seeding 
hiPSC-CMs and cell viability was performed after 14 days of seeding. On the random fibre 
scaffolds, a significantly higher cell viability was observed on  P(3HN-co-3HHP) and P(3HO) 
as compared to all the blend scaffolds (P(3HO): P(3HN-co-3HHP) (20:80), P(3HO): P(3HN-
co-3HHP) (50:50) and P(3HO): P(3HN-co-3HHP) (80:20)) and P(3HN-co-3HHP) also showed 
higher cell viability as compared to non-fibrous gelatin. The beating rate were also found to be 
similar in all the scaffolds and were comparable to the non-fibrous gelatin. Thus it can be 
confirmed that the random fibre scaffolds resulted in improved cell viability and provided good 
contractile property as compared to gelatin, which was used as a positive control. In aligned 
fibrous scaffolds, all the scaffolds exhibited similar cell viability and were all comparable to 
that of non-fibrous gelatin. The fibrous polymer scaffolds were thus found to have a positive 
effect on the hiPSC-CM growth. The fibrous polymer scaffolds were thus found to have a 
positive effect on the hiPSC-CM growth. These results suggest that P(3HO), P(3HN-co-3HHP) 
and their blends  P(3HO):P(3HN-co-3HHP) (80:20), P(3HO):P(3HN-co-3HHP) (50:50), 
P(3HO):P(3HN-co-3HHP) (20:80) have excellent biocompatibility with the hiPSC-CMs in the 
form of fibrous scaffolds and hence are suitable materials to be used in cardiac patch 
applications. On the aligned fibres, the alignment of the cells was also measured in order to 
observe if there was any directionality and anisotropy directed by the aligned fibres onto the 
cells. It was observed that around 50-60% cells were aligned with respect to the fibrous scaffold 
which was not seen in the non-fibrous gelatin which was used as a control. This shows that the 
cells exhibit anisotropy which is directed due to the alignment of the fibres, as the cells grown 
on the control non fibrous gelatin show isotropic behaviour. The electrospun fibre scaffolds 
resemble the fibrous extracellular matrix of the tissue providing an in vitro anisotropic 
resemblance to the cardiac tissue, hence promoting cell growth in an aligned manner. In other 
studies too, aligned fibres were electrospun and cardiomyocytes were grown to promote 
anisotropy. For example, in one study, non-woven PLGA aligned fibres were electrospun. 
Human induced pluoripotent stem cells derived cardiomyocytes were grown on the fibres and 
highly oriented growth along with anisotropy of rat cardiomyocytes was observed (Khan et al., 
2015). Rockwood et al., 2008, also showed highly oriented and anisotropic growth of the 
cardiomyocytes on the electrospun aligned polyurethane (PU) fibres which also exhibited 
higher levels of ventricular maturation. 
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Immunofluorescence studies were also carried out to stain the F-actin, MHC and nuclei of the 
control, random and aligned fibres of the neat and blend polymers. The staining of the structural 
proteins of the cell indicated a healthy phenotype for all the cells. The confocal images also 
showed a directionality of the cells on the aligned fibres and a non-directional growth on the 
random fibres. The alignment of the cells on the aligned fibres provided a conducive 
environment to the cells, mimicking the extracellular matrix, hence also enhanced 
cardiomyocyte maturation and provided better healing to the infarcted tissue and help in 
functional recovery of the tissue  (Kenar et al.,2011). In another study, the cardiomyocytes 
seeded on the aligned scaffolds acquired the structure of the fibres, and organized into aligned 
tissue. Analysis of cell alignment revealed that contrary to randomly oriented scaffolds, where 
the cells were not organized, and vast majority of the cells cultured on the aligned scaffolds 
exhibited organized growth in the direction of the fibres, assembling into an anisotropic tissue 
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Scaffold permeability is an important parameter in determining cell attachment. It is governed 
by different parameters which include porosity, pore size and distribution, pore 
interconnectivity and pore orientation. Thus porosity is a crucial property of a scaffold to be 
tailored carefully in tissue engineering. A porous scaffold is also important in providing higher 
surface area for the cells to attach to the scaffold. The interconnectivity of the pores in the 
scaffold helps in cell penetration, tissue ingrowth, vascularization and nutrient delivery (Chen 
et al., 2008). The size of the pores is an equally important parameter. Previous speculation 
regarding cell activity within porous scaffolds has indicated that there exists an optimal pore 
size, or range for each distinct cell type. Pore size has an influence on cell attachment, as seen 
with collagen-GAG scaffolds where cell attachment increased with decrease in pore size. This 
was explained by the fact that a lower specific surface area in scaffolds with a larger mean pore 
size, resulted in a lower ligand density available for adhesion. In another study conducted on 
collagen-GAG, porous scaffolds were prepared with different pore sizes ranging from 95.9-
150.5 µm. MC3T3 cells were grown on these scaffolds and cell viability studies were 
conducted. A linear relationship was found between cell attachment and speciﬁc surface area 
and it was thus confirmed that cell viability was governed by the specific surface area available 
for binding(O’Brien et al., 2007).  
 
There are many methods to prepare a porous scaffold, including electrospinning  (Demir et al., 
2002; Lee et al., 2003), solvent casting/salt leaching (Fromstein et al., 2002) , laser excimer 
(Doi et al., 1996) and thermally induced phase separation (Saad et al., 1996). Scaffolds 
prepared by solvent casting/porogen leaching method have the advantage of high level of 
control on the pore size governed by the size of the salt particles used. 
 
The aim of this study was the preparation of 2D and 3D scaffolds using the MCL-PHA 
polymer, poly(3-hydroxyoctanoate), P(3HO). This was used to investigate the effect of 
porosity on the scaffold properties in the context of cardiac tissue engineering. Neat scaffolds 
were prepared using solvent casting, while the porous scaffolds were prepared using the 
porogen leaching method, with sucrose of size 250-300 µm as the porogen. The films were 
characterized with respect to their mechanical properties and surface 
hydrophilicity/hydrophobicity in order to assess their applicability in cardiac tissue 
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engineering. Further, in vitro biocompatibility studies were also carried out using C2C12 cells 
on these scaffolds. 
 
5.2. Results 
5.2.1. Preparation of 2D porous P(3HO) scaffolds using the porogen leaching method 
using different salt concentration 
5wt % P(3HO) neat and porous scaffolds were prepared. The porous scaffolds had 0.5%, 1% 
and 1.5% porogen concentration with pore size of 250-300 µm in diameter. Different P(3HO) 
porous scaffolds were fabricated and compared with the neat P(3HO) constructs.  
Mechanical analysis 
The mechanical properties of the scaffolds were measured using the Dynamic Mechanical 
Analyser in the static mode. The Young’s modulus, tensile strength and elongation at break for 
the 5 wt% porous P(3HO) scaffolds with 0.5%, 1.0% and 1.5% porogen concentration were 
recorded to be significantly low as compared to the 5 wt% neat P(3HO) scaffold (Table 5.1). 
Thus the porous scaffolds exhibited lower stiffness as compared to the neat P(3HO) scaffolds.  
Table 5.1: Mechanical properties of the solvent cast porous and neat P(3HO) films including 









P(3HO) 8.3±0.7 10.1±2.6 674.7±98.5 
0.5% porogen P(3HO) 0.46±0.7 2.2±1.2 336±80.2 
1% porogen P(3HO) 1.6±1.1 2.2±1.4 345.8±6.3 
1.5% porogen P(3HO) 0.46±0.6 1.2±0.5 490.9±54.6 
 
Water contact angle analysis 
The surface hydrophilicity/hydrophobicity of the films was determined by measuring the water 
contact angle of the films. Water contact angle of the P(3HO) neat film was measured as 100.7º 
while that of the 0.5%, 1.0% and 1.5% porous films were found to be 90.1º, 76.8º and 73.9º 
respectively (Table 5.2). Hence, there was a decrease in the water contact angle of the porous 
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film with increasing porogen concentration. The higher surface area on the porous film with 
respect to that of the neat film, increased accessibility for the water molecules in the former, 
leading to increased hydrophilicity. Water contact angle measurements indicated a 
significantly lower water contact angle for the porous P(3HO) film created using 1.5 wt% 
sucrose as the porogen when compared to the neat P(3HO) film. 
Table 5.2: Water contact angle measurements indicating lower water contact angle for the 
porous P(3HO)  films created using 0.5%, 1.0% and 1.5% porogen as compared to the neat 
P(3HO) film. (n=5) 
Samples Water contact angle (º) 
P(3HO) 101.1±1.5 
0.5% porogen P(3HO) 90.1±1.1 
1% porogen P(3HO) 76.8±1.2 




The porosity of the porous film was calculated using the equation 2.1 described in Chapter 2 
and was found to be 52.29% for the 0.5% porous P(3HO) film, 61.1% for 1.0% porous P(3HO) 
film and 78.5% for 1.5% porous P(3HO) film. 
Scanning Electron Microscopy (SEM) 
The surface analysis of the neat and porous films reveal that the neat film has a smooth surface 
while a porous film has pores scattered on the smooth surface with pore size ranging from 250-




Figure 5.1: Scanning electron microscopy image of the surface of (a) neat P(3HO) film at 
110X. (b) and (c) Porous P(3HO) films at 65X and 150X magnification. 
 
5.2.2. In vitro cytocompatibility study 
The C2C12 myoblast cells were grown on the neat and porous films and cell proliferation was 
observed for 24hrs. The observation showed that the 0.5% porous films exhibited 36.5%, 1% 
porous films shows 38.5% and 1.5% porous films showed 44.4% cell proliferation as shown in 
Figure 5.2. SEM images of the porous films with cells show that the cells cover the pores and 
prefer to grow near them, as shown in Figure 5.3. Hence, the cell proliferation rate was highest 
in the scaffold with the highest porosity. There was significant increase in the cell proliferation 
on the 1.5% porous film as compared to the neat P(3HO) film. There was also observed an 
increase in 0.5% porous film and 1.0% porous film when compared with neat P(3HO) 
indicating a higher cell proliferation on the porous structures. 
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Figure 5.2: Graph depicting cell proliferation rate of C2C12 myoblast cells grown on different 
5wt% neat and porous films after 24 h. (n=3), *p<0.05, **<0.001, ANOVA. 
 
 




Fabrication of 3D porous P(3HO) scaffolds 
3D P(3HO) scaffolds were also prepared, as explained in section 2.4. The scaffold was 
observed to be very soft and spongy due to the porous nature of the scaffold and elastomeric 
property of the polymer. It was in the shape of a cylinder, 1cm in diameter, 0.5 cm in height. 
   
Scanning electron microscopy study 
Scanning electron microscopy of the scaffold showed that the porous scaffold exhibited pore 
diameters ranging from 250-300 μm. The surface of the scaffold was also observed to have 
pores with the same dimensions (Figure 5.4(B)). The cross section of the scaffold also revealed 




Figure 5.4:(A) Cross sectional view of the 3D porous P(3HO) scaffold showing well- formed 
pores within the structure. (B) Surface view of the 3D porous P(3HO) scaffold.  
 
MicroCT analysis indicating interconnected pores 
The microCT analysis was conducted and it was observed that the 3D porous structure had 
interconnected pores. The microCT video conducted on the 3D structure depicts it passing 
through the height of the whole scaffold, thus analysing it layer by layer (Figure 5.5). As the 
video passes through each section of the scaffold it is evident that the pores interconnect the 





A            10sec                                 B             15sec                          C               21 sec 
 
Figure 5.5: Snapshots of the video taken at (A) 10sec (B) 15 sec (C) 21 sec from the microCT 
of porous scaffold indicating an interconnected porous 3D scaffold. (Complete video provided 
with the thesis) 
 
 
Cell culture study on all the porous scaffolds using C2C12 cells 
The porous scaffolds were seeded with C2C12 cells and the cell proliferation assay was used 
to quantify cell proliferation after 2 days. It was analysed that the cell proliferation of the 
C2C12 cells on the 3D P(3HO) porous scaffold was found to be 99%, a 5 times increase as 
compared to the 20% cell proliferation observed on the neat P(3HO) scaffold. Figure 5.6 shows 
SEM images of C2C12 cells grown on neat P(3HO) scaffold and the 3D porous P(3HO) 
scaffold surface and cross sectional view, where the 3D scaffold exhibited dense cell growth 
and the cells were seen covering the pores of the scaffold. The white arrows on the image 
indicate the growth and proliferation of the cells through the pores while covering the porous 




Figure 5.6: Growth of C2C12 cells on (a) neat P(3HO) film (b) and (c) 3D porous P(3HO) 
scaffold (d) Cell proliferation assay on the neat and 3D porous P(3HO) scaffolds (n=3) 
**p<0.01, t-test, unpaired, two-tailed. The white arrows indicate cell migration and 
proliferation within the pores and are seen to overlap the pores. 
 
5.3. Discussion 
The neat and porous P(3HO) scaffolds were successfully prepared using solvent cast 
technology. The size of the pores in the porous scaffolds were selected such that they were 
similar to the size of human myocytes (250-300 µm), allowing the myocytes to infiltrate in to 
the scaffold and lead to efficient tissue regeneration. In addition, introducing porosity in a 
scaffold also leads to increased roughness, which is an important property that influences cell 
adhesion and migration. Hence, in order to obtain a high cell density on the scaffold, the 
scaffold needs a high surface area and optimal pore architecture in order to accommodate the 




The mechanical property of a scaffold is another crucial parameter as it helps to provide support 
for the adhesion of new cells until new extracellular matrix is synthesized by the cells (Chen et 
al., 2008) and acts as a support to the diseased organ during regeneration. It is also important 
for the scaffold to mimic the mechanical property of its host tissue so that its biological 
functioning is not hindered (Chen et al., 2008). 
 
The mechanical properties of the porous scaffolds were compared to that of the neat P(3HO) 
scaffold. As expected, the stiffness of the P(3HO) porous scaffold was lower than that of the 
neat scaffold and the Young’s modulus value of the former were in the range of human 
myocardial tissue, ideal for cardiac tissue engineering. The tensile strength of the porous film 
was lower in comparison to the neat P(3HO) scaffold and the values measured for the porous 
scaffolds were also found to be in the range of the myocardial tissue. The elongation at break 
for the neat scaffold was higher than that of the porous structures. The mechanical properties 
of the 3D porous P(3HO) scaffold could not be measured in this study and this will be carried 
out in future. In a similar study carried out by Wang et al., porous scaffolds were prepared 
using poly(1,8-octanediol-co-citric acid) (POC) and the Young’s modulus value was found to 
decrease with increase in porosity, decreasing from 3.5kPa for 60% porosity to 1.5 kPa for 80% 
porosity.  This was explained by the fact that the pores created large empty spaces in the 
scaffold which made the structure less stiff and result in a decreased Young’s modulus value. 
Similar studies have also been carried out using poly(glycerol sebacate), where the porous 
scaffold exhibited a low Young’s modulus of 0.28MPa and minimum elongation at break of 
267% (Wang et al., 2002).  In another study conducted on the effect of collagen in electrospun 
scaffolds of poly(ester urethane)/collagen blends, it was found that the Young’s modulus of the 
scaffold decreased from 8MPa to 2MPa and the elongation at break increased from 220% to 
270%, with scaffolds including 90% collagen (Stankus et al., 2004). Also, scaffolds made of 
polyester urethane urea were characterised for their use in soft tissue engineering. The tensile 
strength of the scaffold ranged from 0.97-1.64MPa, while the elongation at break was 214%-
294% (Yin et al., 2003). It was also observed that after 2 weeks, due to polymer degradation, 
the mechanical properties of the scaffold changed with an elongation at break of 150% and a 
tensile strength of 0.8 MPa.  
 
The surface property of the films is yet another very important factor that governs cell 
attachment and proliferation on a scaffold, ultimately determining their success in regeneration 
of the diseased tissue. Biomaterials interact with the biological environment on the surface, 
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making the characterization of the surface crucial for understanding subsequent biological 
effects. Water contact angle analysis was conducted on the films and the related static water 
contact angle measured for the neat and porous P(3HO) films. The water contact angle (θH2O) 
is a measure of the hydrophilic or hydrophobic property of a material surface, which is in turn 
directly related to cell adhesion. Cell adhesion to a surface occurs by adhesion receptors present 
on the cell that binds to proteins adsorbed on the biomaterial surface and the conformation of 
these proteins depends on the surface wettability (Lee et al., 2003). Surfaces with θH2O less 
than 70o are considered to be hydrophilic and θH2O greater than 70o are considered to be 
hydrophobic in nature (Peschel et al., 2008). The water contact angle on the neat P(3HO) film 
was higher than the porous films. Hence, the P(3HO) neat film was found to be much more 
hydrophobic than the P(3HO) porous film, which indicated that the porous P(3HO) films have 
a greater potential as a scaffold as compared to the neat film. It has also been found that 
hydrophobic films pre-coated with matrix proteins such as laminin, exhibit a lower 
hydrophobicity and are a better surface for the adhesion of cardiomyocytes. Cardiomyocytes 
do not attach well on hydrophobic films but attached well on the films precoated with laminin 
protein (McDevitt et al., 2003). In another study, a composite scaffold was made using poly 
(lactic-co-glycolic acid), poly(DL-lactide-co-caprolactone) and type I collagen. PLGA/PCL 
polymers are strong but hydrophobic, and hence are not conducive for cell adhesion. Type I 
collagen was used to coat the surface of the composite to form a modified scaffold which 
promoted cell proliferation and attachment. The growth of cardiomyocytes and presence of TnI 
(a marker of contractile protein) on the cardiomyocytes were found to be higher on the 
composites coated in collagen as compared to the collagen and PLGA controls (Park et al., 
2005). Thus, hydrophilic surfaces are considered to be better than hydrophobic surfaces for cell 
attachment in cardiac tissue engineering. The porosity of the film was also calculated with 
respect to the neat film. The pores on the films help in cell attachment and provide a higher 
surface area for the cells to adhere to the surface (Lebourg et al., 2008). In vitro cell 
proliferation analysis also confirmed that the increase in porosity promoted cell growth and 
hence a highest cell proliferation rate was observed on the porous scaffold produced using 1.5% 
porogen as compared to other porous and neat scaffolds. The SEM image of the porous 
scaffolds with C2C12 myoblast cells also depicted that the cells preferred to attach on the pores, 
hence, the presence of the pores increased the cell proliferation rate.  The SEM image of the 
neat P(3HO) scaffold presented a smooth surface. The SEM image of the porous scaffolds 
revealed pores on the surface which increased the surface area and provided roughness to the 
scaffold which would help in cell adhesion. With regard to roughness of the surface affecting 
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the growth of different kinds of cells, researchers have observed that increased surface 
roughness has a positive effect on cell adhesion (Richert et al., 2008). The result of the neat 
P(3HO) scaffold was found to be similar to that of Rai et al., 2011, as the neat film was found 
to be smooth and without any grooves. This film surface was found to be smoother as compared 
to that of the P(3HB) film.   
 
The scanning electron microscopy of the surface and cross section view of the 3D porous 
P(3HO) scaffold was found to have pores of diameter 250-300 μm which were formed by the 
salt leaching. The porosity was evenly distributed throughout the surface and the bulk of the 
scaffold. The microCT videos which scanned the scaffold through every plane also confirmed 
a well-connected porosity of the structure. Pok et al. (2012) in a similar study, prepared a 3D 
structure comprising of self-assembled PCL which was sandwiched between a gelatin-chitosan 
hydrogel which resulted in a porous structure and was used for cardiac tissue engineering. The 
biocompatibility of this structure was analysed in vitro by seeding neonatal rat ventricular rat 
myocytes (NVRM). A higher rate of cell adhesion and functioning was observed in all the 
different ratios of gelatin-chitosan with PCL structures as compared to neat PCL scaffolds. 
This can be explained to be due to the lack of cell binding sites in the neat PCL scaffolds as 
compared to the higher surface area provided by the 3D sandwich porous structure. In the 
present study, in vitro cytocompatibility with C2C12 was conducted on the scaffold. The cell 
proliferation study indicated that the 3D porous structure exhibited significantly higher 
proliferation rate as compared to the 2D neat P(3HO) scaffold. This indicates that the 3D 
P(3HO) scaffold not only provided support for cell attachment but also promoted a high cell 
proliferation rate. In a study conducted on Bombyx mori silk fibroin scaffold for cardiac tissue 
engineering, it was also observed that the 3D porous structure provided better support and 
exhibited higher growth rate for the menstrual blood-derived stem cells (MenSCs) and bone 
marrow-derived mesenchymal stem cells (BMSCs) (Rahimi et al., 2014).  
 
Hence in this chapter, different 2D and 3D porous P(3HO) scaffolds were studied with respect 
to their mechanical properties and in vitro cytocompatibility with C2C12 cells. A drastically 
lower stiffness of the 2D porous scaffold was observed as compared to the neat P(3HO) 
scaffold. The in vitro cell compatibility also confirmed a higher cell proliferation rate on the 
2D porous scaffolds as compared to the neat structure. The 3D porous structure produced, 
exhibited a well-connected network of pores within the scaffold which hence provided better 
attachment and significantly higher cell proliferation rate for the C2C12 cells. These studies 
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6.1. Introduction  
Conductive polymers have been useful in a variety of applications including battery 
technology, photovoltaic devices and biomedical applications. Examples of such polymers 
include polypyrrole (PPy), polyaniline (PANI). Polyaniline (PANI) is one of the most popular 
conducting polymers to be used in tissue engineering. Various properties of polyaniline such 
as good conductivity, low toxicity, better defined electrochemical response as compared to 
other conducting polymers, make it suitable to be used in tissue engineering applications.  
 
Tissue regeneration is a complex process and involves several promoters/growth factors. 
Several growth factors such as Vascular Endothelial Growth Factor (VEGF), fibroblast growth 
factor (FGFs) are required for different essential activities of the cell. Peptides such as RGD 
are known to enhance cellular adhesion on the scaffold. Hence, incorporation of growth factors 
and peptides in a scaffold promotes better adhesion and differentiation of the cells on the tissue 
engineering scaffold. The biocompatibility of the scaffold also depends on its ability to adsorb 
specific proteins which the cells would interact with, instead of the material alone. Unspecific 
protein interactions need to be prevented as it can lead to many problems including acute 
chronic inflammation and fibrous encapsulation. Hence, surface modification of the scaffold 
in order to enable binding of the desired protein and prevention of non-specific protein binding 
is desirable. Polymers such as poly(hydroxyethyl methacrylate), poly(acrylamide), poly(N,N-
dimethyl acrylamide), dextran, poly(oxazoline) and poly(ethylene glycol) (PEG) have been 
explored for such applications.  
 
In this chapter, modification of the PHA scaffold has been carried out using two different 
approaches. The first approach involved the incorporation of electrical conductivity in to the 
P(3HO) scaffold achieved by blending with PANI followed by analysis of material 
characteristics and effect on cardiomyocyte proliferation and function. The second approach 
involved the incorporation of the six-armed star-shaped poly(ethylene oxide-stat-propylene 
oxide) with isocyanate end groups (NCO-sP(EO-stat-PO) with P(3HO):P(3HN-co-3HHP) 
(80:20) and its functionalization with RGD, YIGSR peptides and VEGF growth factor. 
Electrospun fibres of the blend of P(3HO):P(3HN-co-3HHP) (80:20)/modified (NCO-sP(EO-






6.2.1. Chemical characterisation of P(3HO):PANI blend films by FTIR 
P(3HO):PANI blend films, prepared as described in section 2.4, were dark green coloured and 
0.20 cm in thickness. For the chemical characterization of these P(3HO):PANI blend films, 
FTIR was conducted (Figure 1). It was observed that P(3HO), exhibited the characteristic peaks 
of 1734 cm-1 and 1160 cm-1 confirming the carbonyl double bond and the ester C-O stretching 
respectively. These were also observed in the spectrum of the P(3HO):PANI blend. Additional 
peaks were observed in the P(3HO):PANI blends at 1035 cm-1 indicating the asymmetrical 
stretching of the sulfonyl group present on the backbone of PANI chains which originated from 
the camphor sulphonic acid (CSA) and 3235 cm-1 which corresponded to the N-H stretching 
of the aniline group. Other peaks observed were at 2961 cm-1 and 2860 cm-1 for the alkyl 
groups. Some other significant peaks indicating the bonding of the CSA with PANI and 
formation of a blend of P(3HO)-PANI, 1260 cm-1 indicated the C-N bond stretching, 1223 cm-
1 for the C-N vibrational mode, 1010 cm-1, 864 cm-1 indicates the asymmetric stretching of the 
sulfonyl S-O-H group all of which are representative of the emeraldine salt (Mendes et al., 
2011; Qazi et al., 2014).  
 
Figure 6.1: FTIR spectra of P(3HO) (purple line) and P(3HO):PANI scaffold (black line) 




The electrical conductivity of the scaffolds were measured using a multimeter (Figure 6.2). As 
expected, with the increase in the volume % of PANI, there was a corresponding increase in 
the electrical conductivity. Also, P(3HO): PANI 30 vol% (the P(3HO)/PANI blend containing 
30 vol% of PANI) showed a significantly higher electrical conductivity as compared to the 
P(3HO):PANI 10 vol%.  This showed that all the P(3HO):PANI blends had an inherent 
electrical conductivity due to the addition of PANI in the blend. 
 
Figure 6.2: Graph depicting the electrical conductivity of the P(3HO):PANI scaffolds. (n=3, 
*p<0.05, ANOVA. 
Water contact angle study 
The water contact angle of the films with P(3HO):PANI 10 vol%, P(3HO):PANI 20 vol% and 
P(3HO):PANI 30 vol% were measured and summarised in Table 6.1. This showed that all the 
scaffolds are slightly hydrophobic in nature as the value is just higher than 70º. There was no 
significant difference found among the values observed for the P(3HO):PANI blends but it also 
showed that the introduction of PANI with P(3HO) has significantly reduced the 
hydrophobicity of neat P(3HO). 
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Table 6.1: Water contact angle of the P(3HO):PANI blend scaffolds with 10 vol%, 20 vol% 
and 30 vol% PANI (n=3) 
Samples Water contact angle (º) 
P(3HO) 101.11.9 
P(3HO):PANI 10 vol% 82.1±9.8 
P(3HO):PANI 20 vol% 85.3±11.2 




The degradation study was also characterized by comparing the % water uptake, % weight loss 
and pH change for a period of 30 days and was measured at day 5, day 15 and day 30.  The 
values were calculated as explained in detail in section 2.4.  
 
The % water uptake was measured on 5, 15 and 30 days as depicted in Figure 6.4, after 30 days  
the P(3HO):PANI 20 vol% and P(3HO):PANI 30 vol%  showed a gradual and significant 
decrease while P(3HO):PANI 10 vol% showed a slight increase. The % weight loss was also 
recorded for the scaffolds on day 5, 15 and 30 as shown in Figure 6.5. It was observed that 
there was significant increase in % weight loss in P(3HO):PANI 20 vol%  and P(3HO):PANI 
30 vol% at the end of 30 days while there was a significant decrease observed in P(3HO):PANI 




Figure 6.3: Water uptake % of the P(3HO):PANI blend scaffolds with P(3HO):PANI 10 vol% 
(brown), P(3HO):PANI 20 vol% (orange), P(3HO):PANI 30 vol% (green) for 5, 15 and 30 




Figure 6.4: Weight loss % of the P(3HO):PANI blend scaffolds with P(3HO):PANI 10 vol% 
(brown), P(3HO):PANI 20 vol% (orange), P(3HO):PANI 30 vol% (green) for 5, 15 and 30 
day. (n=3), *p<0.05,**p<0.001, ANOVA. 
 
A pH study was conducted in PBS for a period of 30 days (Figure 6). It was observed that the 
pH of all the scaffolds i.e. P(3HO):PANI 10 vol% , P(3HO):PANI 20 vol%  and P(3HO):PANI 




Figure 6.5: pH profile study of the P(3HO):PANI blend scaffolds with P(3HO):PANI 10 vol% 
(brown), P(3HO):PANI 20 vol% (orange), P(3HO):PANI 30 vol% (green) for 5, 15 and 30 
days.(n=3), *p<0.05,**p<0.001, ANOVA. 
In vitro cell compatibility with the P(3HO): PANI blend scaffolds 
The in vitro cytocompatibility of the P(3HO):PANI blend scaffolds were tested using Neonatal 
Ventricular Rat Myocytes ( NVRMs). The cells were grown on the scaffolds and a live and 
dead assay was carried out on day 3 (Figure 6.7 and 6.8). As seen in Figure 6.7, the cells 
attached and grew well on all the P(3HO):PANI blend scaffolds equally.  The higher amount 




Figure 6.6: Representative images of live NVRM cells (green) and dead NVRM cells (red) on 
different P(3HO):PANI blend scaffolds. 
 
 
Figure 6.8: In vitro cell viabiltiy study indicating live NVRM cells (brown) and dead NVRM 
cells (green) on the P(3HO)/PANI blend scaffolds after conducting a live/dead assay. (n=6), 






6.2.2. P(3HO): P(3HN-co-3HHP) (80:20)/NCO-sP(EO-stat-PO) electrospinning 
The polymer solution including a 80:20 blend of P(3HO) and P(3HN-co-3HHP) and NCO-
sP(EO-stat-PO), VEGF,  RGD and YIGSR were electrospun using the method described in 
section 2.4. The solutions used were as follows: 
 80:20 blend of P(3HO) and P(3HN-co-3HHP) polymer with only NCO-sP(EO-stat-
PO) 
 80:20 blend of P(3HO) and P(3HN-co-3HHP) polymer with NCO-sP(EO-stat-PO) and 
VEGF 
 80:20 blend of P(3HO) and P(3HN-co-3HHP) polymer with NCO-sP(EO-stat-PO) and 
RGD and YIGSR 
 80:20 blend of P(3HO) and P(3HN-co-3HHP) polymer with NCO-sP(EO-stat-PO) and 
VEGF and RGD and YIGSR 
Good quality fibres were obtained with no beading (Figure 6.9). 
 
The water contact angle of the fibres obtained were measured as summarised in Table 6.2. 
There was no significant difference among the scaffolds, however, the scaffolds exhibited 
significantly lower water contact angles for the P(3HO):P(3HN-co-3HHP) (80:20) fibres with 
NCO-sP(EO-stat-PO), including RGD,YIGSR peptides and the VEGF growth factor as 
compared to the neat P(3HO):P(3HN-co-3HHP) (80:20) fibres. This observation indicated the 
presence of the hydrophilic groups of NCO-sP(EO-stat-PO), RGD,YIGSR and VEGF on the 
surface of the P(3HO):P(3HN-co-3HHP) (80:20) fibrous scaffolds. Hence, the one step method 
of functionalisation using NCO-sP(EO-stat-PO) was indeed successful. 
   
Figure 6.8: Representative images of electrospun fibres of P(3HO):P(3HN-co-3HHP)(80:20) 
with NCO-sP(EO-stat-PO),RGD,YIGSR and VEGF. 
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Table 6.2: Table indicating water contact angles of the different constructs including 
P(3HO):P(3HN-co-3HHP) (80:20) with NCO-sP(EO-stat-PO) VEGF, RGD and YIGSR 
peptides. (n=5). 
Samples Water contact angle (º) 
P(3HO)/P(3HN-co-3HHP) (80:20) with NCO- 
sP(EO-stat-PO) 
74.7º±2.0 
P(3HO)/P(3HN-co-3HHP) (80:20) with NCO- 
sP(EO-stat-PO) and VEGF 
79.7º±3.0 
P(3HO)/P(3HN-co-3HHP) (80:20) with NCO- 
sP(EO-stat-PO), RGD and YIGSR  
79.6º±3.5 
P(3HO)/P(3HN-co-3HHP) (80:20) with NCO- 
sP(EO-stat-PO), VEGF, RGD and YIGSR 
82.7º±3.4 
P(3HO): P(3HN-co-3HHP) (80:20) 100.53.5 
 
 
In vitro cell cytocompatibility with the functionalized fibres 
The neonatal ventricular rat myocytes (NVRMs) were grown on the fibres for 3 days. The 
number of live and dead cells were counted on the fibres and analysed (Figure 6.10). It was 
observed that the scaffold P(3HO):P(3HN-co-3HHP) (80:20)/NCO-sP(EO-stat-PO) with all 
the three active molecules including the VEGF growth factor, RGD and YIGSR peptides and 
P(3HO):P(3HN-co-3HHP) (80:20)/NCO-sP(EO-stat-PO) with two (RGD and YIGSR) 
additives, exhibited significantly higher number of live cells as compared to that on the 




Figure 6.9: In vitro cell viability showing live cells (brown) and dead cells (green) of NVRMs 
grown on different scaffolds where (i) star-PEG(SP) indicates P(3HO)/P(3HN-co-3HHP) with 
NCO-sP(EO-stat-PO) (ii)SP+VEGF indicates scaffolds with P(3HO)/P(3HN-co-3HHP) with 
NCO- sP(EO-stat-PO) and VEGF (iii) SP+YIGSR+RGD indicates P(3HO)/P(3HN-co-3HHP) 
with NCO-sP(EO-stat-PO), RGD and YIGSR peptides (iv) SP+YIGSR+ RGD+VEGF indicates 




 In this chapter different modifications were performed with the polymers in order to improve 
their cytocompatibility. In the first part P(3HO) was blended with PANI  in different volume 
% which were 10 vol%, 20 vol% and 30 vol%. The scaffold films were fabricated and dark 
green coloured films were formed. The confirmation of the incorporation of the PANI was 
carried out by conducting FTIR of the blend films. Specific peaks were observed involving the 
presence of sulphonic acid group from CSA and the ester carbonyl double bond from the 
P(3HO), which confirmed the successful blending of hydrophobic P(3HO) and hydrophilic 
PANI. This result has also been confirmed by Qazi et al., 2014 where PGS was blended with 
PANI in different volume %. Hsiao et al., also successfully blended a hydrophobic polymer 
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PLGA with the hydrophilic PANI and was successful in fabricating aligned fibrous meshes. 
Neonatal ventricular rat myocytes were grown on these meshes and the cells were seen to align 
themselves on the fibres with the expression of connexion 43, a gap junction protein.   This 
study showed that PANI was an excellent conducting polymer and could be used to stimulate 
seeded cardiomyocytes into beating synchronously (Hsiao et al., 2013) 
 
The electrical conductance of the scaffold is one of the major desirable attributes of a scaffold 
to be used for cardiac tissue engineering. In a study conducted by Roberts-Thomson et al. the 
conductivity of the native myocardium was founded to be in the range of 0.0016 S cm-1 
longitudinally to 5x10-5 S cm-1 transversally. In this work the P(3HO):PANI blends showed 
values of conductivity ranging from 1.38 x10-5 S cm-1 - 2.92x10-4 S cm-1. These values were 
found to be in the range found in literature for other polymer blends. In a study by Qazi et al., 
PANI-PGS blend films were fabricated with 15 vol%, 20 vol%, 25 vol% and 30 vol% of PANI 
and electrical conductivities of 1.4x10-5, 2.8x10-5, 1.7x10-4 and 1.03x10-3 S cm-1 respectively 
were measured after 4 days (Qazi et al., 2014). In another study blend and coaxial fibrous mats 
of poly(L-lactide-co-ɛ-caprolactone) (PLCL) and PANI were electrospun with different ratios 
of (PLCL/PANI) ranging from of 0, 15 and 30% of PANI content. Neat PLCL fibres did not 
show detectable conductivity. While the incorporation of PANI into PLCL fibres significantly 
increased the conductivity according to the amount of PANI; from 0.160 ± 0.046 S/cm for the 
PLCL/PANI-15 fibres to 0.296 ± 0.064 S/cm for the PLCL/PANI-30 fibres (Jun et al., 2009).  
 
The water contact angle of the scaffolds were measured in order to observe the wettability of 
the films with the incorporation of PANI in P(3HO). In this study it was observed that the static 
water contact angle of the PANI blended scaffolds decreased significantly as compared to the 
neat P(3HO) scaffold.  Hence, as expected, the incorporation of PANI in P(3HO), made the 
blend more hydrophilic. This was also observed in a study conducted on Co3O4 and PANI, 
where the core shell structure was fabricated using PANI which formed the shell and the core 
comprised Co3O4 and PANI-Co3O4 nanocomposites were formed. It was observed that the 
water contact angle of the PANI coated composite was 48.88º as compared to the neat Co3O4 
which was 67.74º (Hai et al., 2016). In a similar study conducted on polyvinyl alcohol 
(PVA)/PANI films, it was observed that the films with higher thickness of PANI exhibited 
lower contact angles and hence lower hydrophobicity. This was explained to be due to an 
increase in the porosity and hydrophilicity of the PANI coated films (Patil et al., 2011). In 
another study a mixed matrix of polyethersulfone (PES) with PANI-co-MWCNTs 
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(polyaniline-co-multi walled carbon nanotubes) composite nanoparticles were used to produce 
a nanofiltration membrane. Different amounts of the PANI-co-MWCNT composite 
nanoparticles were used with a constant concentration of PES. It was observed that with 
increasing concentration of the PANI-co-MWCNT in the composite, the water contact angle 
decreased from 69.43º for the scaffold with no particles to 43.76º for scaffolds with 1% PANI-
co-MWCNT nanoparticles. Thus the results showed that with an increase in PANI-co-
MWCNT concentration, there was an increase in the hydrophilicity of the membrane. The 
addition of PANI makes the scaffold porous in nature allowing access to water molecules, 
lowers the contact angle, thus resulting in a higher apparent hydrophilicity of the scaffolds 
(Bagheripour et al., 2016). The lowering of the water contact angle enables various growth 
factors to interact and support cell proliferation. 
 
In vitro degradation was also carried out for a duration of 30 days and samples were analysed 
at day 5, 15 and 30. There was a gradual and significant decrease in the % water uptake 
observed in P(3HO):PANI 20 vol% and P(3HO):PANI 30 vol% and an increase observed in 
P(3HO):PANI 10 vol% over the period of 30 days. Due to the higher PANI content in scaffolds 
with 20 vol% and 30 vol%, they absorbed more water in the initial days of the experiment and 
became saturated earlier over the course of time while in scaffold with 10 vol% PANI, the 
water was absorbed gradually and hence an increase was observed. The % weight loss was also 
measured and with P(3HO):PANI 20 vol% and P(3HO):PANI 30 vol% , a significant increase 
was measured while with P(3HO):PANI 10 vol% blend, a decrease in the % weight loss was 
observed. This could be explained in conjunction with the % water uptake. As the 
P(3HO):PANI 20 vol% and P(3HO):PANI 30 vol% had a higher % water uptake during the 
course of the experiment, they exhibited a higher weight loss during this period due to enhanced 
hydrolytic degradation and loss of the absorbed water. The P(3HO):PANI 10 vol% had a 
gradual increase in the water uptake, hence the weight loss was not initially enhanced and in 
turn a decrease in the weight loss was observed. A lower pH was observed for all the scaffolds. 
This lowering of the pH can be explained by the leaching of the CSA dopant from the scaffolds 
as a result of the degradation. This was also observed by Qazi et al. (2014) where the pH of 
PGS/PANI constructs dropped from 7.4 to ~ 6.9 after 30 days, in an in vitro degradation study.  
 
Cell compatibility is an important desirable property for a scaffold, in order to be suitable for 
tissue engineering applications. In this work, NVRM cells were seeded on the P(3HO): PANI 
blend scaffolds and it was observed that the number of live cells increased with the increase in 
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PANI volume content. This study thus demonstrated that the NVRMs proliferated well on the 
P(3HO):PANI blend scaffolds and the scaffolds did not leach out any toxic by-product for the 
whole duration of the experiment i.e. 3 days. A study conducted by Qazi et al. (2014), showed 
a higher cytocompatibility and cell proliferation of the C2C12 cells on the PANI-PGS 
scaffolds. Jun et al. (2009) also conducted cell compatibility studies by seeding C2C12 cells 
on the PLCL/PANI scaffolds and cell proliferation was observed for 8 days with the formation 
of myotubes. In another study conducted on the PCL/PANI scaffolds, human mesenchymal 
stem cells (hMSC) were grown resulting in a cardiac tissue like growth. The cell survival test 
was investigated by using the MTT colorimetric assay. Immunoassay studies using antibodies 
specific for sarocomeric α-actinin also confirmed the interaction of the cells with PANI/PCL 
(Borriello et al., 2011).  
 
The NCO-sP(EO-stat-PO) (poly(ethylene oxide-stat -propylene oxide) with isocyanate end 
groups) is a hexameric molecule which has been used in the functionalization of the polymers 
with various peptides and has been found to be highly effective. In this work, NCO-sP(EO-
stat-PO) was electrospun with a blend of P(3HO) and P(3HN-co-3HHP) in the ratio of 80:20. 
The optical images of the fibres indicated successful electrospinning of the fibres. There have 
been various studies which have used NCO-sP(EO-stat-PO) and combined with other polymers 
and peptides to form scaffolds for tissue engineering applications. In a study poly(D,L-lactide-
co-glycolide) (PLGA) was combined with NCO-sP(EO-stat-PO) in acetone and the resulting 
solution was used for electrospinning. The fibres were then functionalized with the peptide 
Gly-Arg-Gly-Asp-Ser (GRGDS) and cell adhesion studies were carried out by seeding human 
dermal fibrobasts. Higher number of adherent cells were observed on the scaffold with peptide 
functionalization and the overall survival rate was found to be above 88%.  The wettability of 
the fibres were also recorded. It was observed that the PLGA fibres had a contact angle of 120º 
but the PLGA/NCO-sP(EO-stat-PO) fibres absorbed the water droplet within seconds thus 
showing the highly hydrophilic nature of the fibres with the additive (Grafahrend et al., 2010). 
Similar results were observed in this study where the water contact angle of P(3HO):P(3HN-
co-3HHP) scaffold was around 100º but with the functionalisation of the RGD, YIGSR and 
VEGF using NCO-sP(EO-stat-PO) on the polymer, a significantly lower water contact angle 
was observed ranging from 74.6 º (P(3HO):P(3HN-co-3HHP)/ NCO-sP(EO-stat-PO)), 79.6º 
(with RGD and YIGSR), 79.7º (with VEGF) and 82.7º (with both peptide and VEGF).  The 
cell compatibility on the scaffolds were also analysed by growing NVRMs onto the 
functionalized fibres and deducing the cell viability on the fibres. The NCO-sP(EO-stat-PO) 
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star additive rendered the PHA to be hydrophilic in nature. The surface segregation of the 
hydrophilic PEO based hydrophilic molecule within the hydrophobic polymer groups provides 
a conducive surface for interaction of cells (Grafahrend et al., 2010). The % cell viability was 
highest on the P(3HO):P(3HN-co-3HHP) (80:20)/ NCO-sP(EO-stat-PO) functionalized with 
VEGF, RGD and YIGSR and was found to be significantly higher as compared to the 
P(3HO):P(3HN-co-3HHP) (80:20)/ NCO-sP(EO-stat-PO). The cells on P(3HO):P(3HN-co-
3HHP) (80:20)/ NCO-sP(EO-stat-PO) functionalized with RGD and YIGSR also showed 
higher cell viability as compared to the P(3HO):P(3HN-co-3HHP) (80:20)/ NCO-sP(EO-stat-
PO) scaffold.  This can be explained as the peptides and the growth factors interact positively 
with the cells and hence promote cell adhesion and proliferation. The NCO-sP(EO-stat-PO)) 
does not have any impact on the structure of the peptides and hence the adhesive peptides 
























Polyhydroxyalkanoates (PHAs), in recent times have gained a lot of attention in medical 
applications due to their biodegradability and biocompatibility. In cardiac tissue engineering, 
there is need for a material which can give support to the infarct region along with help in 
reviving the heart tissue. For this purpose, in this project mcl PHAs, P(3HO) and P(3HN-co-
3HHP) were used for the fabrication of a suitable cardiac patch. Different 2D and 3D scaffolds 
were fabricated using neat P(3HO), P(3HN-co-3HHP) and their blends. To increase the patch 
efficiency, a conducting polymer, polyaniline was incorporated in order to enhance the 
electrical performance of the patch. Also, in order to promote cell adhesion and angiogenesis, 
RGD peptide, YIGSR peptide and VEGF were introduced in to the scaffold.  
 
In the first part of the project, P(3HO) and P(3HN-co-3HHP) polymers were synthesised using 
Pseudomonas mendocina CH50 using MSM media, sodium octanoate and sodium nonanoate 
as the carbon source respectively, with nitrogen being the limiting factor. The bacteria were 
successfully cultured and the purified polymers were successfully extracted. The growth profile 
of the two fermentations were obtained. The maximum polymer content of the P(3HO) and 
P(3HN-co-3HHP) extracted after 48 hrs was measured to be 45.76% dry cell weight and 
42.34% dry cell weight respectively. The preliminary structure of the polymers, expected to be 
mcl-PHAs were confirmed using FTIR. Final confirmation of the structure of the polymers 
were carried out by 13C and 1H NMR spectroscopy.  
 
Five weight percent 2D neat scaffolds were fabricated using neat P(3HO), P(3HN-co-3HHP) 
and their blends in the ratio of 20:80 (P(3HO):P(3HN-co-3HHP)), 50:50 (P(3HO):P(3HN-co-
3HHP)) and 80:20 (P(3HO):P(3HN-co-3HHP)) by solvent casting technology. The scaffolds 
were examined to be hydrophobic in nature along with smooth and plain surface topography. 
These scaffolds were assessed as possible candidates for cardiac patch development. One of 
the important aspects of a cardiac patch is its biodegradability. In vitro degradation studies 
suggested there was an increase in % water uptake and % weight loss along with a small 
decrease in pH in all the scaffolds over a period of 3 months. It is also highly important for the 
material to have biocompatibility with the seeded cells (Chen et al., 2008). The cardiac patch 
ideally is seeded with suitable cells and is implanted onto the infarct cardiac tissue. In vitro 
biocompatibility was compared among the films by seeding them with human induced 
pluripotent stem cell derived cardiomyocytes (hiPSC-CM). The live and dead assay showed 
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that all the scaffolds showed a comparable % cell viability with the positive control, gelatin. 
The material was biocompatible with the hiPSC-CM cells and hence promoted cell growth on 
the polymers, thus indicating that they were all suitable for cardiac patch development. The 
beating rate also indicated that the hiPSC-CM cells were viable and actively beating on all the 
scaffolds and gelatin but a significantly higher beat rate was measured on the neat P(3HN-co-
3HHP) scaffold. This result confirmed that there were no deleterious effects caused by the 
polymer on the contractile properties of the cardiomyocytes. To study this in further detail, 
calcium transients were analysed which is an essential parameter for regulating cardiac 
contractions. The calcium transients analysed on all hiPSC-CMs which were grown on the 
PHA scaffolds were found to be comparable to the calcium transients when these were grown 
on gelatin. There was a decrease in the fluorescence amplitude in the P(3HN-co-3HHP) as 
compared to gelatin at  a stimulation frequency of 1Hz but no difference was observed at a 
stimulation frequency of 1.5 Hz. The sarcomere length of the cardiomyocytes grown on all the 
constructs were found to be around 2µm which is comparable to that of the adult human 
myocardium. This confirmed that the cells grown on the films exhibited properties of adult 
cardiomyocytes. The nuclei density was found to be highest on the neat P(3HN-co-3HHP) 
scaffold. 
 
 In another part of the study, random aligned fibres were successfully electrospun using 
P(3HO), P(3HN-co-3HHP) and their blends in the ratio of 20:80 P(3HO):P(3HN-co-3HHP), 
50:50 P(3HO):P(3HN-co-3HHP) and 80:20 P(3HO):P(3HN-co-3HHP). The fibres were 
hydrophobic in nature. The mechanical properties of the fibres could not be measured since 
they had a sticky texture and were difficult to handle on their own. In vitro biocompatibility of 
the fibres were analysed by growing hiPSC-CM cells on the electrospun sheets. The cells were 
found to be viable on the electrospun sheets and the beat rate was also comparable to the healthy 
cells. The live and dead assay showed a highest % cell viability was on the P(3HN-co-3HHP) 
scaffold for random fibres, while for aligned fibres all the scaffolds exhibited similar % cell 
viability. Cardiomyocytes exhibit anisotropy in vivo, so the cells on the scaffold should also be 
able to align themselves in order to exhibit maximum functionality. Hence, an ideal scaffold 
structure should be able to guide and support cellular alignment (Rockwood et al., 2008). A 
quantification of alignment was conducted on the cells grown on the aligned fibres and in all 
the fibrous scaffolds, around 50% of the cells, while in non-fibrous gelatin 14% cells, showed a 
mean deviation of 0º-10º from the control line. This showed that the cells exhibited anisotropy which 
was directed due to the alignment of the fibres, as the cells grown on the non-fibrous gelatin show 
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isotropic behaviour. Thus, 50% of the cells exhibited anisotropy which was influenced because 
of the aligned fibrous scaffold. 
 
In the next part of the study, 2D and 3D porous scaffolds were fabricated using P(3HO). The 
2D porous films had a significantly lower Young’s modulus value as compared to neat P(3HO), 
an important parameter to be considered for cardiac patch development. The hydrophilicity of 
the porous P(3HO) scaffolds produced using 0.5%, 1.0% and 1.5% porogen increased 
significantly as compared to the neat P(3HO) film. It was not possible to measure the water 
contact angle on the 3D P(3HO) scaffold as the water would not form a drop on the scaffold 
instead would fill in the pores of the scaffold. The in vitro cytocompatibility study on porous 
scaffolds with C2C12 myoblast cells indicated a significant increase in cell proliferation rate 
with increase in porogen concentration, confirming the positive role of porosity in cell 
attachment and proliferation. 
 
Electrical conductivity plays a crucial part in the initiation of contraction in heart tissue, hence 
it is an added benefit to the scaffold to have intrinsic electrical conductivity when used as a 
cardiac patch. In this project, polyaniline was used as the conducting polymer. Polyaniline was 
synthesised and was successfully doped with camphor sulphonic acid (CSA). Different 
amounts of PANI were blended with P(3HO) and the solvent cast films were successfully 
produced. The films were characterised using FTIR and it was confirmed that polyaniline was 
successfully incorporated in all the P(3HO) films. All the blended films were measured to be 
electrically conductive. The in vitro degradation of all the films were studied and a decrease in 
% water uptake was observed in P(3HO):PANI 20 vol% and 30 vol% while an increase in % 
water uptake was observed in P(3HO):PANI 10 vol% after a 30 day period. An increase in % 
weight loss was observed in P(3HO):PANI 20 vol% and 30 vol% while a decrease in % weight 
loss was observed in P(3HO):PANI 10 vol% after a 30 day period. A small decrease in pH was 
observed in all the films after a 30 day period. The in vitro cytocompatibility of the blend films 
was analysed using NVRMs and the presence of a large number of viable cells was confirmed 
by the live/dead assay, confirming cytocompatibility of the P(3HO): PANI blends. 
 
In the final part of the project, surface functionalisation of the scaffolds was carried out by 
incorporating the RGD and YIGSR peptides along with the growth factor VEGF using NCO-
sP(EO-stat-PO) on 80:20 (P(3HO):P(3HN-co-3HHP)) polymer blend electrospun fibres. 
Hence, a one-step method of surface functionalisation was successfully achieved using the 
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NCO-sP(EO-stat-PO) with 80:20 (P(3HO):P(3HN-co-3HHP)) blend. There was an increase in 
hydrophilicity of these fibres as compared to the non-functionalised fibres confirming the 
presence of the peptides/protein on the surface of the fibres. The in vitro cytocompatibility of 
these fibres showed that the highest cell viability was observed on the fibres functionalised 
with RGD, YIGSR peptide and the VEGF growth factor, exhibiting an additive activity of the 
three factors.  
 
7.2. Future work 
Based on the research and results carried out in this study the following areas could be further 
investigated for an optimal cardiac patch development: 
 MCL-PHAs have been used for soft tissue engineering but the use of P(3HO) which is 
a homopolymer and P(3HN-co-3HHP) is novel in the field of cardiac patch 
development. Production of P(3HN-co-3HHP) with 42% dcw yield has been described 
in this project but it would be good to study the optimisation of the production of 
P(3HN-co-3HHP) from Pseudomonas mendocina CH50. This can be achieved by 
changing the fermentation conditions including pH of the media, C/N ratio and stirrer 
speed for increasing the yield of the polymers. These would have an impact on the 
growth of the cells and would promote polymer accumulation. Response surface 
analysis could be used to study the different fermentation conditions. 
 Alignment and porosity are important parameters that a scaffold should have for its 
application in cardiac tissue engineering applications. In this work, P(3HO) and 
P(3HN-co-3HHP) and their blends have been fabricated into aligned fibres fabricated 
using electrospinning. There are many other techniques being used for the fabrication 
of aligned scaffolds. It would be interesting to achieve 3D aligned scaffolds using 3D 
printing technology. Porosity was also studied in this work by using porogen leaching 
technology and solvent casting.  Freeze drying is another alternative technique which 
has shown to induce porosity including aligned porosity in various other elastomeric 
polymers. Hence, it would be a good study to fabricate 3D porous scaffolds using this 
technique (Frydrych et al., 2013) in the future. 
 As scaffolds with inherent electrical conductivity is an important property for a cardiac 
patch, PANI was blended with P(3HO) to form conducting scaffolds. To mimic the 
extracellular matrix of the cardiomyoctes, further optimisation of these scaffolds could 
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be brought about by blending and electrospinning polyaniline with P(3HO) and P(3HN-
co-3HHP) and produce aligned fibrous conducting scaffolds.  
 The use of the additive NCO-sP(EO-stat-PO) for surface functionalisation of the 
scaffold in a one step process was proven to be a very simple and convenient process. 
The use of this additive could be further investigated for the generation of highly 
bioactive scaffold structures and its impact on cell adherence and viability. The use of 
RGD and YIGSR peptides was observed to increase cell attachment and proliferation. 
The combined use of RGD, YIGSR and VEGF could be further investigated by varying 
the concentration of the active molecules and determining an optimal concentration.  
 Continuing with this work, further detailed study could be conducted on attachment, 
growth and alignment of hiPSC-CMs and NVRMs on the P(3HO) based cardiac patches 
by including an in depth analysis of the various known genetic markers linked to the 
process of cardiac differentiation.  
 Along with an in vitro study, an in vivo study is essential to confirm the compatibility 
of the material with the infarcted heart tissue. The interaction of the surrounding tissues 
with the scaffold material will be an essential step forward in understanding of the  
in vivo functionality of the developed cardiac patch. 
 Based on latest research in cardiac tissue engineering, the combination of bioprinting 
of gelatin methacryloyl (GelMA), microfluids and endothelial stem cells has been 
explored in an endothelial-myocardium-on-a-chip platform (Zhang et al., 2016). This 
could provide an enabling technology for the development of next-generation human 
organ models for the diseased and infarcted myocardium. In relation to this work, 
studies could be conducted with the elastomeric P(3HO)/P(3HN-co-3HHP) polymers 
to enable the formation of an perfusion network on the chip with the help of the 
bioprinted polymer, endothelial cells and stem cells which could in future be used to 
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